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The use of emergency department electronic health data for 
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programmes in England. 
Helen E Hughes 
Public health surveillance allows for the identification and monitoring of trends in human 
health. Syndromic surveillance is a relatively recent addition to these activities, offering the 
potential to monitor trends on a (near) real-time basis and is often more timely than may 
be possible through other, traditional, surveillance routes.  
Emergency department (ED) syndromic surveillance systems have been developed and 
successfully operated worldwide. The Public Health England Emergency Department 
Syndromic Surveillance System (EDSSS) was developed in preparation for the London 2012 
Olympic and Paralympic Games and remains as a public health legacy of the Games. 
This thesis aimed to describe and provide evidence of how emergency department 
syndromic surveillance (as performed by EDSSS) provides additional benefit to public health 
surveillance and added value to emergency care services in England. Additionally the 
potential for further development and future improvements to public health surveillance is 
described. 
The EDSSS is shown here to have been successfully used to describe the impact of the 
rotavirus vaccine, indicating that EDSSS has the potential to be used for future rapid, stand 
alone, investigation of impact of vaccines in England. In the first cross-national study of its 
kind, the EDSSS (alongside OSCOUR, its counterpart in France) was successfully used to 
describe the changes in human health indicators during periods of poor air quality. 
In addition to reporting on both infectious and non-infectious disease, emergency 
department syndromic surveillance also successfully described the impacts of human 
behaviour on ED attendances. During the EURO 2016 football tournament ED attendances 
were found to differ from the expected during match periods, not only in France the host 
country, but also in the UK home nations where fans followed team progress from home. 
The EDSSS is also the first example of a syndromic surveillance system having input into the 
development of a standardised national dataset, which has been mandated across EDs in 
England. Primarily aimed to improve patient care and the wider workings of EDs, this 
improved data collection has resulted in improvements in the EDSSS itself, which was 
subsequently expanded from a small sentinel to truly national surveillance system.  
The standardisation of ED data collection and reporting, alongside improved geographical 
coverage and near real-time surveillance reporting, enabled rapid feedback on the impact 
of the COVID-19 pandemic on ED attendances in England. EDSSS described general trends 
in ED attendances, encompassing both infectious and non-infectious indicators, prompting 
the refinement of public health messaging, encouraging continued use of emergency care 
as required by the general public. 
The evidence presented in this thesis has demonstrated where the ED syndromic 
surveillance has added value for public health surveillance in England, utilising the system 
flexibility and timeliness of reporting. Successful collaborative working has provided the 
potential for future cross-system learning for further system development, as well as the 
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Background and introduction 
1.1 Public health surveillance 
Public health surveillance is “…the continuous, systematic collection, analysis and 
interpretation of health-related data needed for the planning, implementation, and 
evaluation of public health practice”.1 These surveillance activities cover all health 
conditions, from infectious disease, to obesity, to cancer, amongst many others. The 
information and intelligence gathered through surveillance activities aim to; identify and 
warn of future public health issues, provide detail and monitoring of ongoing, known, 
situations, as well aid in the determination of need for, and confirm and quantify the effect 
of, any public health interventions.  
This information can then be acted upon by public health authorities, including immediate 
actions (such as outbreak investigation and control) or the development of interventions 
and public health strategies and policies (such as vaccination programmes). Additionally, 
public health surveillance can also provide reassurance during a known event (such as 
periods of poor air quality), where no impact on human health has been detected. 
Traditional public health surveillance methods 
Traditional public health surveillance activities generally rely on either the active reporting 
of individual cases of illness by a health professional, or the passive reporting of laboratory 
confirmations of specified diseases and conditions. Both active and passive reporting of 
illness require a clinical diagnosis to have been made by a health care professional. This is 
true for the surveillance of both infectious and non-infectious disease of public health 
concern (information flow for infectious disease surveillance shown in Figure 1-1). 
In England there is a legal requirement2,3 for registered medical practitioners to report 
selected communicable diseases, and for laboratories to report results to Public Health 
England (PHE) when specified organisms are isolated.4 This statutory notification of 
infectious disease is primarily for outbreak detection to allow for rapid public health 
response. Information is also collected by PHE for cases of specified non-communicable 
diseases and conditions, with surveillance activities carried out in a wide range of areas 
including the National Cancer Registration and Analysis Service5 and National Congenital 
Anomaly and Rare Disease Registration Service.6 The routine reporting of disease to PHE 
results in the provision of public health advice, support or action, as appropriate.  
Figure 1-1:  Information flow for traditional public health surveillance of infectious 
disease in England. 
 
Public health surveillance also allows long term monitoring and investigation at a 
population level, forming the basis for the identification and monitoring of risk. Again these 
longer term surveillance activities are carried out for both communicable and non-
communicable diseases such as; investigation into vaccine effectiveness7 and surveillance 
of levels of cancer diagnoses in specified geographical areas, for the detection of clusters.8 
Traditional public health surveillance methods rely on a degree of certainty being reached 
in a diagnosis before public health authorities are informed. Where diagnosis requires 
investigations to be carried out there may be a delay before testing is performed, followed 
by a necessary wait for results to be confirmed and communicated to the treating 
physician, who may then report a case to the relevant public health authorities (Figure 1-1). 
Even where a statutory notifiable disease is suspected there is no immediate requirement 
for reporting to public health authorities, with a 3-day delay permitted (24 hours if 
considered ‘urgent’). These factors can result in a lag between the initial patient 
presentation and eventual inclusion in surveillance analysis and reporting.  
Furthermore, in cases of self-limiting illness, or where treatment does not require a 
confirmation of pathogen (e.g. diarrhoea due to unknown cause may be successfully 
treated without laboratory confirmation of the organism involved), a final or confirmed 
diagnosis may not be reached, meaning no report is made to public health authorities.  
Syndromic surveillance  
Traditional surveillance activities have been augmented by the relatively recent 
developments of syndromic surveillance systems, which are able to detect and report on 
trends in public health in near real-time. First developed in the late 1990s,9 this type of 
public health surveillance is termed syndromic surveillance as it relies on the grouping of 
patient presenting symptoms/complaints into ‘syndromic indicators’.10 These indicators can 
be based on patient reported (or observed) symptoms, which are often recorded by 
healthcare providers from the first patient contact, alongside preliminary/working 
diagnosis, in the absence of confirmatory testing. 
Syndromic indicators may be a very generic capture all grouping, such as ‘all respiratory 
conditions’ which may be anything from very non-specific symptoms such as ‘cough’ or 
‘shortness of breath’, through to more detailed diagnoses such as ‘pneumonia’ or ‘asthma’.  
Generic, ‘all conditions’, indicators give an indication of the levels of all broad groupings of 
illness (such as all respiratory) identified within the syndromic surveillance system. Where 
the patient care record allows for the entry/selection of more detailed options, more 
specific groupings can be created for syndromic indicators such as ‘acute respiratory 
infection’. If the level of information recorded is even more detailed, the granularity of the 
indicator grouping can be taken a step further, identifying conditions such as ‘bronchiolitis’ 
or ‘influenza-like illness’. The limitation of these more detailed syndromic indicators is that 
they are likely to include a much smaller number of patient contacts: many patients attend 
for respiratory conditions; a subset can be classified as acute respiratory infection; a smaller 
number may be diagnosed with influenza-like illness.  
Syndromic surveillance has the potential to include cases of symptomatic illness not 
identified by traditional public health surveillance. Where a patient has presented with self-
limiting illness and laboratory confirmation is not required for effective treatment, they are 
unlikely to be reported through traditional surveillance methods (Figure 1-2). Traditional 
surveillance methods may therefore under-estimate disease burden and are often biased 
towards certain groups e.g. the elderly and severely ill hospitalised patients. However, the 
ability to monitor levels of illness in the community remains an important factor in public 
health surveillance. Although the individuals may be less severely ill there are likely to be 
large numbers affected with notable social and economic impacts, such as time taken from 
work/education or even caring for others. 
Figure 1-2:  Information flow for public health surveillance of infectious disease in 
England, comparing traditional and syndromic surveillance. 
 
Though the level of detail available may be limited, the use of syndromic surveillance allows 
the identification of trends (increases, decreases or even stable in the absence of change 
over time) in indicator levels in more timely way than may be possible through other 
surveillance routes. Syndromic surveillance systems offer the ability to monitor these 
trends on a (near) real time basis i.e. daily, or more frequent. 
(Near) real-time syndromic surveillance 
The provision of health care has developed in the digital age. Contemporaneous recording 
of information during each patient contact has become the norm, be that a telephone call 
(e.g. NHS 111), a patient consultation in primary care (e.g. with a general practitioner; GP) 
or treatment in an emergency department (ED). Electronically recorded information 
gathered during a patient contact with a health care provider provides detail on symptom 
presentations and initial diagnoses. The storage of this information in databases may then 
potentially be made available quickly for public health surveillance purposes, presenting 
opportunities for syndromic surveillance.  
The use of automated processes for the identification, batching and transfer of data can 
make this a passive process. No extra work is required from the health care provider. These 
factors mean that there can be minimal delay between a patient contact with health care 
and that information being used for surveillance purposes (Figure 1-2).  
1.2 Syndromic surveillance in England 
Those people experiencing periods of ill health may access health care or advice from 
different types of health care provider in England. This may range from large numbers of 
people with relatively mild illness who may, at most, seek advice on self-care, to a smaller 
number who are severely ill requiring emergency hospital level care and even fewer dying 
from their condition (Figure 1-3). The PHE Real-time Syndromic Surveillance Team (ReSST) 
has developed and maintains a suite of national syndromic surveillance systems, providing 
a daily service monitoring and identifying trends in patients making contact with several of 
the different levels of health care/advice providers across England.9  
Initially the ReSST syndromic surveillance service was focussed on infectious disease 
monitoring, particularly the surveillance of influenza-like illness as part of the national 
monitoring of influenza through each winter period. The first PHE syndromic surveillance 
system was established in 1999, based on the data gathered from calls made to a newly 
launched NHS telephone helpline (NHS Direct, which transitioned into NHS 111).11-13 
Following a successful pilot in the West Midlands, England-wide roll-out established the 
NHS 111 syndromic surveillance system as one of the first national syndromic systems to be 
created and integrated into a public health system.12 NHS 111 call records include the 
selected ‘pathway’ for each call providing a record of the symptoms reported, chosen from 
a limited number of non-specific options e.g. cold/flu or sore throat. The NHS 111 
syndromic surveillance system uses anonymised information from those generally seeking 
health advice, rather than treatment; those at the less severe end of the surveillance 
pyramid (Figure 1-3).  
Figure 1-3:  Disease severity pyramid: where (and how many) people access health 
service or advice, dependent on severity of illness 
 
The development of a GP in hours syndromic surveillance system in 200614 further 
extended the PHE surveillance capability for monitoring levels of illness in the community 
across England. The GP in hours syndromic surveillance system initially monitored weekly 
consultations within a network of GPs across the UK.14 The healthcare treatment and advice 
provided by GP services constitute the next level in terms of disease severity, those 
symptomatic and seeking treatment for their illness or condition (Figure 1-3). The 
electronic record of each GP consultation collects symptoms as well as diagnoses, including 
a greater degree of clinical detail than a NHS 111 call record. Items such as cough/cold may 
still be selected, but more detailed diagnoses such as acute respiratory infection or even 
influenza-like illness may also be recorded. 
In preparation for the London 2012 Olympic and Paralympic Games (London 2012) the 
national syndromic service was reviewed in light of the enhanced surveillance requirements 
for the Games. This review highlighted that although near real-time (daily) systematic 
surveillance of less severe types of illness in the community could be carried out as 
standard, the same was not possible for the more severe presentations of illness. As a 
result, two new syndromic surveillance systems were developed and implemented ahead of 
London 2012. These new systems focussed on the more severe end of the disease severity 
pyramid, those people seeking unscheduled urgent care and treatment (Figure 1-3). 
First, a new syndromic surveillance system focussed solely on GP contacts outside of usual 
office hours (GP out-of-hours)15 was developed, complementing and extended the pre-
existing GP in hours surveillance system. The GP out-of-hours syndromic surveillance 
system filled in the gaps in the surveillance picture; providing the ability to monitor trends 
in disease presentation during evenings and weekends, by those unable to wait for a week-
day, day time, appointment for medical care.  
A second new syndromic surveillance system was developed to monitor trends in disease 
presentation by those most severely ill and requiring urgent, potentially lifesaving care in 
EDs.16 At that time the UK did not have an ED surveillance system, despite ED syndromic 
surveillance being relatively common internationally. Syndromic surveillance systems using 
ED data and the use of ED syndromic surveillance globally are systematically reviewed and 
described in Chapter 2. The development of the ED syndromic surveillance system in 
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Syndromic surveillance is a relatively new addition to the public health surveillance arsenal, 
providing opportunities for timely monitoring of disease at a population level. Though 
primary care provision and access may vary greatly from country to county, emergency care 
is generally a universal provision, available and accessible to all as and when required. 
This systematic review describes the evolution and development of emergency department 
syndromic surveillance globally, from small local surveillance systems requiring active 
participation, often used for a short time period, to full national systems making use of 
technological advancements for the passive and rapid transfer of data from individual 
patient records for (near) real-time analysis and surveillance outputs. Variation in system 
structures is discussed, along with potential for further developments and improvements, as 




Syndromic surveillance provides public health intelligence to aid in early warning and 
monitoring of public health impacts (e.g. seasonal influenza), or reassurance when an 
impact has not occurred. Using information collected during routine patient care, 
syndromic surveillance can be based on signs/symptoms/preliminary diagnoses. This 
approach makes syndromic surveillance much timelier than surveillance requiring 
laboratory confirmed diagnoses.  
The provision of healthcare services and patient access to them varies globally. However, 
emergency departments (EDs) exist worldwide, providing unscheduled urgent care to 
people in acute need. This provision of care makes ED syndromic surveillance (EDSyS) a 
potentially valuable tool for public health surveillance internationally. 
The objective of this study was to identify and describe the key characteristics of EDSyS 
systems that have been established and used globally. 
Methods 
We systematically reviewed studies published in peer review journals and presented at 
International Society of Infectious Disease Surveillance conferences (up to and including 
2017) to identify EDSyS systems which have been created and used for public health 
purposes. Search criteria developed to identify “emergency department” and “syndromic 
surveillance” were applied to NICE healthcare, Global Health and Scopus databases. 
Results 
In total, 559 studies were identified as eligible for inclusion in the review, comprising 136 
journal articles and 423 conference abstracts/papers. From these studies we identified 115 
EDSyS systems in 15 different countries/territories across North America, Europe, Asia and 
Australasia. Systems ranged from local surveillance based on a single ED, to comprehensive 
national systems. National EDSyS systems were identified in 8 countries/territories: 2 
reported inclusion of ≥85% of ED visits nationally (France and Taiwan). 
Conclusions 
EDSyS provides a valuable tool for the identification and monitoring of trends in severe 
illness. Technological advances, particularly in the emergency care patient record, have 
enabled the evolution of EDSyS over time. EDSyS reporting has become closer to ‘real-
time’, with automated, secure electronic extraction and analysis possible on a daily, or 
more frequent basis. 
The dissemination of methods employed and evidence of successful application to public 
health practice should be encouraged to support learning from best practice, enabling 
future improvement, harmonisation and collaboration between systems in future. 
Prospero number CRD42017069150 
  
2.2 Background 
Syndromic surveillance is a relatively recent addition to the public health surveillance 
toolbox, with the earliest reported systems established during the mid-1990s.1 Syndromic 
surveillance uses symptom and/or preliminary diagnosis information and rapid data 
collection methods to provide information for public heath action. Syndromic surveillance is 
more timely than other more traditional options for public health surveillance, such as 
statutory notifications of disease or laboratory reporting.2 The non-specific nature of 
syndromic surveillance and its rapid data collection also makes it sensitive and flexible 
enough to respond to different situations/scenarios including infectious outbreaks and non-
infectious disease events. The data used for syndromic surveillance are primarily gathered 
from patient contacts with a health care service, although increasingly non-health care 
syndromic surveillance data are being explored e.g. social media3 or internet search data.4,5 
The sources of patient health information used for syndromic surveillance are as varied as 
the different types of health care provision that exist. Examples of syndromic surveillance 
data range from calls from those who are ill in the community to telehealth advice phone 
lines,6,7 to patients attending in person in primary care (family doctors)8,9 or in emergency 
care situations including emergency departments (ED). 
Patients seen in the ED are generally expected to be presenting with severe illness requiring 
immediate, often lifesaving, medical attention and treatment. This severe level of acute 
illness is of particular interest to public health surveillance to enable the identification and 
monitoring of public health issues requiring an acute response. Conversely, this surveillance 
may also provide reassurance, confirming that there is no public health impact from an 
incident already identified. 
Healthcare systems vary, however, EDs are commonly found worldwide, providing 
unscheduled emergency care to patients as required. The global presence of EDs has 
facilitated the increasing use of ED clinical data for syndromic surveillance purposes. To 
date there has not been a review of the ED systems developed worldwide, with only one 
systematic review on the use of ED syndromic surveillance (EDSyS) for influenza.10  
Here, we systematically review the available literature to identify and describe the range of 
EDSyS systems reported to have been developed for public health use globally. We describe 
the different models developed to collect and analyse ED data, and the public health uses 
of EDSyS. Additionally, we discuss the changes and development of these systems over time 
and the potential for future development. 
2.3 Methods 
This systematic review was carried out following the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA)11 and was registered on Prospero,12 
reference number: CRD42017069150. 
Identification of studies 
Searches were carried out using the NICE healthcare database (HDAS, accessing PubMed, 
MedLine, EmBase, Health Business Elite, Health Management Information Consortium, 
PsycINFO, British Nursing Index, and Cumulative Index to Nursing and Allied Health 
Literature), in addition to the Global Health (accessed through EBSCO) and Scopus online 
databases.  
Search terms were developed to identify published papers demonstrating an operational 
EDSyS system collecting, analysing and reporting in near real-time for public health 
purposes. These papers required inclusion of terms related to both syndromic surveillance 
AND to ED, in the title and/or abstract. The electronic HDAS search string was:  
("emergency department" OR "emergency room" OR "emergency care" OR "emergency 
medical" OR "chief complaint" OR "presenting complaint" OR "triage") AND ("syndromic 
surveillance" OR "real-time surveillance" OR "real time surveillance" OR "syndrome 
surveillance").ti,ab 
Where review-type studies were identified, the references from each were searched to 
identify any primary research studies describing an eligible system not identified elsewhere 
during the search. 
The restriction to English language peer reviewed publications was recognised as a possible 
bias against ED systems established in non-English speaking countries/territories, or smaller 
systems which may not be written up for formal publication. In order to counteract this 
potential selection bias, all available abstracts/papers for the International Society for 
Disease Surveillance (ISDS) annual conferences up to 2016 were also included in the search 
(including predecessor conferences, beginning 2002: no conference was held in 2017). ISDS 
conference abstracts which included the eligible search terms were identified through 
searching of conference abstract archives available in online journals.13-26 Abstracts for the 
2009 conference were obtained through personal communication with ISDS as an online 
archive was not available. 
Included studies 
We included all studies which included reference to an operational EDSyS system, defined 
as an EDSyS which collected, analysed and reported on ED data in real time, for public 
health purposes. The search was limited to studies published up to and including 31 
December 2017, with no limitation on the search start date.  
Excluded studies 
We excluded studies reporting on the use of retrospectively accessed ED data from a 
source other than an operational EDSyS system (e.g. directly from an ED information 
system or other database). These retrospective studies generally investigated the potential 
use and/or benefits of ED data for syndromic surveillance purposes. Non-English language 
journal articles were excluded, as were book chapters, non ISDS conference 
abstracts/papers, dissertations and reports.  
Screening 
The selection of studies for inclusion was carried out independently by two reviewers (HEH 
and OE) using Covidence.27 All titles and abstracts were initially screened to identify only 
those which reported on, or appeared to report on, an operational EDSyS system. Full text 
screening was carried out by both reviewers selecting studies that met the inclusion 
criteria. Any conflicts were resolved by HEH. 
Data extraction 
Following full text screening, studies meeting selection criteria were then subjected to 
qualitative data extraction. The data extracted included: EDSyS location; motivation for 
system creation; system start date; coverage; and the dates and coverage of any research 
project reported. Where available, information was also extracted describing the technical 
details of the system (timings, frequency and methods of data collection and transfer of 
data from the ED to the syndromic surveillance database). Qualitative data details included: 
the syndromic indicators used (data source, format and syndromes of interest); the 
analytical techniques used; and public health actions carried out in response to the 
surveillance findings.  
Data extraction from all studies was carried out by the primary reviewer (HEH). The 
secondary reviewer (OE) undertook a quality control check by extracting information from a 
random 10% sample of studies.  
2.4 Results 
In total 1,273 journal articles were identified, with publication dates from 2002-2017. 
Duplicate (n=892) and articles not eligible for inclusion (n=111) were removed. Additionally, 
795 ISDS conference abstracts were identified for inclusion. Of these the full conference 
papers were available for conferences held in 2003 and 2004 (Figure 2-1).  
Title and abstract screening of the resulting 1,065 studies (270 journal articles and 795 ISDS 
conference abstracts/papers) excluded 237 studies that did not clearly describe an 
operational EDSyS system (or the use of data from one) and two studies that were 
identified as non-ISDS conference abstracts. The resulting 796 studies were included for full 
text screening (Figure 2-1).  
The full text screen identified one systematic review,10 one case study of three separate 
EDSyS systems28 and one review of automated outbreak detection in syndromic 
surveillance systems (not limited to EDSyS).29 These three manuscripts included description 
of multiple EDSyS systems, two of which had not been identified by the original search. 
These two additional EDSyS systems had primary references, which were added to the full 
data extraction (Figure 2-1). 
In total 559 studies were identified as eligible for inclusion in the review comprising 136 
journal articles and 423 ISDS conference abstracts/papers. A full list of all references is 
included in this review are available in Appendix A, which includes a detailed summary of 
all EDSyS systems identified, by country/territory, with sub national breakdown where 
appropriate. 
The eligibility criteria allowed for individual EDSyS systems to be described in multiple 
references. The quality control check with the second reviewer extracting did not reveal 
any errors.   
Figure 2-1:  PRISMA flow diagram of the screening process and numbers of articles 
identified 
 
Summary of global EDSyS 
Each EDSyS included in the review had a single underlying aim to provide information for 
public health action. This aim encompassed the use of EDSyS in the monitoring of seasonal 
and sporadic, infectious and non-infectious disease activity, as well as the detection and the 
monitoring of the impact of unusual/unanticipated events (including natural disasters and 
bioterrorism). 
The descriptions of EDSyS systems identified in the review were grouped by 
country/territory in order to summarise the reporting of the large number of systems. The 
following description of findings is based on this grouping, with individual examples 
highlighted as appropriate. A full list of EDSyS systems identified in the review is provided in 
Appendix A. 
The 559 studies included from the full screen comprised 115 EDSyS systems, in 15 countries 
and territories, across North America, Europe, Asia and Australasia (Table 2-1). The first 
EDSyS systems identified were all in the United States of America (USA), with four reported 
to have started data collection in 199930-33 and a fifth reported in a study using data from 
1999.34  
EDSyS systems in four countries were identified solely from journal articles (Albania, Italy, 
New Zealand, Spain), whereas systems from three countries (Greece, Jamaica and 
Singapore) were identified only in ISDS conference abstracts/papers, (Figure 2-2, Table 
2-1). Although the number of conference abstracts greatly outnumbered the journal 
articles, the number of journal articles published each year increased over time, from one 
in 2002, to 26 in 2017 (the only year during which there was no ISDS conference).  
Figure 2-2:  Number of journal articles and International Society for Disease 
Surveillance (ISDS) conference abstracts identified, by year of 
publication/conference and country/territory 
 
Table 2-1:  Summary of Emergency Department Syndromic Surveillance (EDSyS) systems by country/territory, detailing the number of systems, start date, 









Initial design of system(s) 










Albania 1 2013* ✓ - Standard surveillance No specific event 1 0 
Australia 3 2003 - ✓
Preparation Mass gathering (sport) 
18 2 
Standard surveillance No specific event 
Canada 19 2002 - ✓
Preparation Mass gathering (religious) 
14 18 
Standard surveillance No specific event 
China 2 2004* - ✓ Response Outbreak (SARS) 0 2 
France 1 2004 ✓ - Response Natural disaster (heatwave) 7 25 
Greece 1 2002 - ✓ Preparation Mass gathering (sport) 0 2 
Italy 2 2000 - ✓ Standard surveillance No specific event 5 0 
Jamaica 1 2007 ✓ - Preparation Mass gathering (sport) 0 1 
Republic of 
Korea 
1 2002 ✓ - 
Preparation Mass gathering (sport) 
2 1 
Standard surveillance No specific event 
New 
Zealand 









Initial design of system(s) 









Singapore 1 2013* ✓ - - - 0 1 
Spain 1 2010* - ✓ Standard surveillance No specific event 2 0 
Taiwan 2 2003 ✓ ✓ Response Outbreak (SARS) 3 5 
UK*** 1 2010 ✓ - Preparation Mass gathering (sport) 15 3 
USA 78 1999 ✓ ✓
Preparation 
Mass gathering (sport) 
67 365 
Mass gathering (political) 







No specific event 
* Start date not specified in all systems, so estimated from data used/ text ** excluding reviews     *** UK: England & Northern Ireland 
✓ EDSyS system in this category identified  -  no EDSyS system in this category/no information identified 
Geographical coverage 
ED services are a globally recognisable type of healthcare provision but access to these 
services and the administrative/organisational structures vary greatly. There is also 
variation in the organisation and delivery of public health services (delivered at national 
and sub-national levels), both between and within countries/territories. Each of these 
factors are likely to have impacted on the geographical and population coverage of EDSyS 
systems, which ranged from very local (including a single ED), to national systems, with 
many levels in between.  
Six countries described having EDSyS systems developed with national coverage (Albania, 
France, Jamaica, Republic of Korea, Singapore, United Kingdom (UK): Table 2-1, Appendix 
A). ‘National’ coverage varied in geographical (and consequently population) terms, with 
most being sentinel (Appendix A). Where national ED systems had been developed, they 
were not solely used for national level investigation and reporting, with sub-national and 
localised geographical analyses also undertaken (e.g. overseas territories reported 
separately from France,35 and London reported from the UK36). 
Seven countries had EDSyS systems working solely on a sub-national basis. Single, locally 
run systems were identified in Greece, New Zealand and Spain, whereas multiple stand-
alone systems were identified in Australia, Canada, China and Italy (Table 2-1, Appendix A). 
EDSyS systems which had been separately developed at both national and sub-national 
levels were identified in Taiwan and USA (Table 2-1). The USA national system 
developments have been built upon (and subsequently extending) pre-existing local, sub-
national EDSyS systems. Population-based systems were also identified in the USA, with 
dedicated military (including veteran) EDSyS operated at both state (North Carolina, in 
addition to a civilian EDSyS system) and national (potentially global) level (Appendix A). 
Descriptions of the EDSyS systems in both France and Taiwan reported ED participation to 
be ‘required’ (Taiwan)37 and ‘mandatory’ (France),38 with both reportedly receiving data 
from 85% or more of all ED visits (Appendix A). 
The rationale for the development of EDSyS systems 
This review identified three broad themes for EDSyS development and implementation. 
Firstly, EDSyS systems developed in preparation for an expected event (mass gathering or 
predictable natural disaster); secondly, those developed in response to an unanticipated 
event (natural disaster, outbreak or terrorism); or finally, EDSyS systems developed as a 
new standard surveillance format that was generally aimed to supplement and 
complement existing public health surveillance, adding resilience should any of the above 
events occur in future, including bioterrorism (Table 2-1). 
In seven countries/territories, EDSyS systems were reportedly introduced in preparation for 
a mass gathering event (e.g. politics/religion/sport related), or even in advance of a 
predicted natural disaster (e.g. hurricane). A number of these systems were designed and 
run as short term, event-based systems, created shortly before and intended to be 
disbanded shortly after the event.30,39-43 Some of these short-lived event-based systems 
were subsequently redeveloped into ongoing operational EDSyS systems.30 EDSyS systems 
created in preparation for a specific event have also been intentionally designed from the 
outset to remain in place as standard surveillance capability, continuing as a legacy of the 
event.36,44 
EDSyS systems developed in response to events of public health importance were 
implemented in response to infectious disease outbreaks (namely SARS45-47), terrorist 
events (September 200148-51) and natural disasters (heat wave52). The speed at which these 
systems were implemented was dependent on the level of immediate threat. Again, the 
design and structure of these systems may have been optimised for short lived surveillance 
(particularly when created quickly), but then further developed to become a routine 
surveillance system (e.g. New York City53,54). Those responding to a non-immediate threat 
were created less rapidly as an ongoing, routine surveillance system (e.g. France55). 
The creation of EDSyS systems solely to augment standard public health surveillance 
(including for the identification of bioterrorist threats) was identified as the primary 
purpose for the set-up of some systems, particularly small systems operating at a local level 
across the USA as well as others in New Zealand56 and Republic of Korea.57 
Data analysis 
Real-time data collection and analysis on a more frequent than daily basis were described 
in systems from Australia,58 Canada59 and the USA.60-62 The analysis of EDSyS data was, 
however, most commonly reported to be conducted on a daily basis, even where data 
collection occurred more frequently.63-65 
The methods by which syndromic EDSyS data were analysed for exceedances or temporal 
spikes were often not clearly presented in the studies. The specific statistical methods 
applied to operational syndromic surveillance data in some studies were simply described 
as the use of ‘statistical algorithms’ or ‘aberration detection’. Statistical algorithms using or 
based on commonly used syndromic surveillance tools were reported in several EDSyS 
systems. This included reporting: the surveillance system used e.g. the Electronic 
Surveillance System for the Early Notification of Community-Based Epidemics (ESSENCE II)66 
or Real-time Outbreak and Disease Surveillance (RODS);67 the algorithm used e.g. Early 
Aberration Reporting System (EARS);68 or the tool used e.g. SatScan69 for statistical analyses 
carried out. A bespoke statistical analysis method (Rising Activity, Multi-level Mixed effects, 
Indicator Emphasis, RAMMIE) was reported as a standard statistical method used for EDSyS 
in the UK.70 
Studies describing the development of statistical/analytical methods for use on syndromic 
data (rather than the application in day-to-day practice) were common. These studies 
focussed largely on the range of statistical methods and techniques that were available, 
proposals for potential statistical approaches and future developments.40,71-87 
Indicators monitored in EDSyS systems 
Syndromic indicators were often-described for detecting ‘bioterrorist’ events.54,88,89 
Syndromic indicators were also identified for a wide range of infectious and non-infectious 
diseases, particularly for the identification and monitoring of seasonal trends in illness. 
Indicators used to monitor infectious diseases were reported in all 15 countries/territories. 
Respiratory infection indicators were described in all 15 countries/territories (influenza 
surveillance was specifically mentioned in 13/15 countries/territories) and infectious 
gastrointestinal illness indicators were described in 13/15 countries/territories (Table 2-2). 
The development and application of non-infectious syndromic indicators was also reported, 
particularly for the impact of weather events (storms/hurricanes – chiefly in the USA and 
hot (6/15) and cold (5/15) weather); injury surveillance (4/15); impact of alcohol (4/15) and 
drugs (2/15; Table 2-2). 
Table 2-2:  Summary of emergency department syndromic surveillance systems (EDSyS) included in the review, by country/territory, with source and format 
of information used to define syndromic indicators and of areas of public health surveillance supported the EDSyS. 
Country/ territory 
Syndromic indicator Infectious diseases Extreme weather Other non-infectious 
Source* Format Respiratory Influenza Gastrointestinal Heat Cold Injury/trauma alcohol drug 
Albania diagnosis coded ✓ ✓ ✓ - - - - - 
Australia diagnosis coded ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Canada chief complaint text ✓ ✓ ✓ ✓ ✓ ✓ - - 
China chief complaint coded ✓ ✓ - - - - - - 
France diagnosis coded ✓ ✓ ✓ ✓ ✓ ✓ ✓ - 
Greece chief complaint pick list ✓ - ✓ - - - - - 
Italy chief complaint text/ coded ✓ ✓ ✓ - - - - - 
Jamaica "daily analysed data" ✓ - ✓ ✓ - - - - 
Republic of Korea diagnosis coded ✓ ✓ ✓ - - - - - 
New Zealand diagnosis coded ✓ ✓ - - - - - - 
Singapore unknown coded ✓ ✓ ✓ - - - - - 
Spain chief complaint coded ✓ ✓ ✓ - - - - - 
Taiwan chief complaint text/ coded ✓ ✓ ✓ - - - - - 
UK** diagnosis coded ✓ ✓ ✓ ✓ ✓ - ✓ - 
USA chief complaint text ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
* EDSyS may collect more than one data item for syndromic indicators, but each reported a primary field used as standard 




For methods used in the mapping of ED data to syndromic indicators there was an apparent 
divergence between EDSyS systems based in (or using a surveillance tool developed in) 
North America and other countries. Non-North American systems primarily use coded 
diagnosis information (most commonly International Classification of Diseases (ICD) and 
Snomed CT code sets; Table 2-2). Over the time period included in this review there was 
increasing provision of coding lists adding detail of which diagnoses were selected for the 
various indicators used in EDSyS systems using coded diagnostic information. 
Conversely, EDSyS systems and surveillance tool solutions developed in North America 
primarily used chief complaints or triage/signs/symptoms collected as text, which is then 
mapped to syndromic indicators. These fields are cited as being available more closely to 
real-time than diagnostic coded information, which is often also collected at a later point in 
time (in ICD code format).90-96 
The complexity of indicator recognition in a (free) text-based system is much greater than 
in a coded system. Text-based chief complaint EDSyS systems regularly provided case 
definitions,97-101 keywords used (including negations),99,102-104 or simply described the use of 
an algorithm (either bespoke,54 or ‘CoCo’67,76). Although free text chief complaint data was 
the primary source of information for the identification of a syndromic indicator, diagnosis 
data was collected where available and also used to supplement indicator 
development.90,104  
Information for public health action 
All systems reported the use of EDSyS data to identify and monitor incidents of public 
health importance. Effective communication is necessary between those administering the 
surveillance and those responsible for public health action in order for the EDSyS system to 
enable swift public health action.  
EDSyS systems which collected data at a patient level (i.e. not aggregated) were mostly 
designed and run to collect patient identifiable information (PII; defined here as patient 
name, date of birth, full postal/zip code or any ID number not unique to the EDSyS system). 
The use of PII supported local health protection functions through the identification of 
individual cases or contacts of infectious disease (e.g. gastrointestinal outbreaks,105-107 
measles contact tracing,108 TB case follow-up109). One EDSyS was reported to have the 
facility to include PII if required, however the use of PII was not routine.44 
 
 
A small number of systems, working at both national (France110 and UK111) and sub-national 
levels (Canada,67 Australia112 and USA66,112,113) were specifically stated to be restricted to the 
collection of non PII data only. The methods for this anonymisation included the use of 
patient age in years (rather than date of birth) and partial postal/zip codes. The surveillance 
outputs from these EDSyS systems were reportedly communicated to public health 
protection colleagues, similar to the non-anonymised systems, although individuals could 
not be directly identified and followed up from this data source alone.  
The methods used to communicate the findings of EDSyS to local public health colleagues 
ranged from the provision of summary reports114 to the sharing of line listings of cases.93,115 
In some instances, direct online access to the ED surveillance database or bespoke 
surveillance dashboards was described as being available to those working in public 
health.116-118 The EDSyS systems in France and the UK reported the regular publication of 
national surveillance findings on publicly available platforms.111,119 
Cross-system working 
EDSyS systems have been developed and implemented separately in multiple locations, 
however, collaborations between systems for public health risk assessment and 
investigation purposes have been reported. Within the USA, cross-system collaboration 
crossing multiple health/government jurisdictions was identified for particular events,120,121 
for increased coverage across sub-national borders122,123 and in response to an 
outbreak/incident.45,124 
These collaborations developed further over time with the move to a single National 
Syndromic Surveillance Program (NSSP) across the USA (building upon the earlier 
DiSTRiBute and BioSense systems).125 The consolidation into NSSP has aided in collaborative 
working across larger areas of the USA as well as introducing EDSyS where it had not 
previously been available.126 This collaboration demonstrated the evolution of locally 
developed EDSyS systems into a national network. 
Examples of public health process research (rather than data combining/sharing) were 
found across EDSyS in Canada.127-129 Collaborative working across international borders was 
identified less often. The Real-time Outbreak Disease Surveillance (RODS) tool had been 
reported to be used for EDSyS in Canada, Taiwan and USA, however, outside of the USA no 
international cross-border use of the tool was identified.130 
A single report of an international cross-EDSyS system collaboration was identified where 
the impact of poor air quality was examined using EDSyS data from EDSyS systems in France 
 
 
and the UK.131 One other instance of potential cross border working was identified, 
however it relied on a comparison with a bespoke ED data collection, rather than a second 
syndromic surveillance system.132 
Evolution 
The evolution of EDSyS was a recurring theme of the studies identified. Expanding 
coverage, improved data quality/completeness and more real-time surveillance have 
become the norm. Several of the earliest ED systems utilised a ‘drop in’ surveillance format, 
requiring relatively labour-intensive manual data collection processes, before the manual 
transfer of information to a central surveillance point.30,45 
Developments in technology have facilitated improvements in data collection in EDs and 
accessibility of the data from the ED clinical patient record. These changes have provided 
opportunities for EDSyS, allowing extraction of data from EDs with secure and automated 
processes transferring data to EDSyS databases. These processes in turn require no extra 
work from data providers. The frequency of collection in these systems varies from ‘near 
real-time’ (i.e. the collation and transfer of data on a daily basis133-135 or more 
frequently63,65), to truly ‘real-time’ (i.e. data available as entered in the ED system, or very 
soon after).67,77,136 
Furthermore, the availability of ED data has further improved as the working practice in the 
ED has changed to collect electronic clinical information. This change has removed the need 
to wait for a data entry clerk to enter billing information or even paper-based diagnosis 
records several days later. These factors increase the potential for diagnosis information to 
be made available, along with other details such as clinical measurements carried out in the 
ED. 
2.5 Discussion 
With the relatively common provision of ED services globally it is therefore unsurprising 
that EDSyS systems were identified in 15 countries and territories, on four different 
continents. The earliest EDSyS systems identified in this review were created in 1999 and 
are some of the first examples of syndromic surveillance in general. However, the 
references describing these systems (or their use) were not published until several years 
later. The earliest EDSyS paper identified was published during September 2002,53 two 
weeks before the first ISDS conference (which was the US National Syndromic Surveillance 
Conference at that time).14  
 
 
Historically the threat from bioterrorism provided much impetus as well as funding for the 
early development of syndromic surveillance, and in particular EDSyS systems.54,88,89,137,138 
The bioterrorism threat has also influenced the need for more timely public health 
reporting and action, necessitating rapid surveillance activities. Though some EDSyS 
systems were identified to collect truly real-time data, the majority of EDSyS activities 
appear to have settled to a daily rhythm of analysis and reporting. The daily time frame is in 
most instances both necessary and appropriate (simplifying the transfer and storage of data 
by allowing time for records to be completed during the patient journey through the ED 
and sent at a time when the local network is less busy, rather than continually 
updated/refreshing/transmitting) whilst also enabling provision of easily understood and 
actionable information in a suitable timeframe for action by public health authorities, which 
do not generally work on a minute-by-minute basis. 
EDSyS has been shown to be an effective form of public health surveillance, providing 
information for action (or even reassurance of no public health impact) across a wide range 
of situations, both infectious and non-infectious conditions, during seasonal and sporadic 
events. Although initially largely focused on infectious diseases (particularly influenza) 
EDSyS has developed to encompass many of the different types of conditions seen and 
treated in EDs, providing information for public health action. This valuable source of data 
augments laboratory surveillance of infectious diseases (providing information more quickly 
than laboratory systems and on those conditions for which a confirmatory test may not be 
carried out) and extends the ability of public health to identify and respond to non-
infectious diseases in a timelier manner than would be possible without EDSyS. 
An important feature of the early examples of EDSyS was rapid system establishment to 
provide valuable public health information for action in preparation for known mass 
gatherings and/or in response to an outbreak/unanticipated events. These early versions 
provided the first evidence of the value of EDSyS, whilst highlighting the limitations in terms 
of the workload and sustainability, particularly of drop-in systems. Technological and 
working practice developments within EDs, which have occurred for patient care purposes 
(particularly the immediate collection and storage of electronic patient records), have 
enabled developments in the automation of secure data collection and transfer for EDSyS 
purposes. The greater opportunity for secure automated data collection has made EDSyS 
data collection easier and more sustainable. 
 
 
As a result, EDSyS systems are developing rapidly and largely in the same direction: utilising 
electronic patient ED records which are completed immediately and can be made available 
for public health surveillance rapidly. The observed dichotomy between systems utilising 
either chief complaint or coded diagnosis data may become less distinct in future. EDSyS 
systems may base their indicators primarily on either diagnosis codes or chief complaints, 
however, in practice they generally collect both data fields when they are available. With 
coded diagnosis data being made available more quickly and methods for working with text 
based chief complaint data becoming more mainstream, the use of both chief complaint 
and coded diagnosis data to group clinical encounters/episodes into syndromic indicators is 
likely to become standard. Additional detail may also be added as appropriate, such as 
clinical measurements e.g. body temperature.  
It is important to acknowledge that while EDSyS systems comprise some of the earliest 
examples of syndromic surveillance systems, there are examples of other morbidity 
sentinel surveillance networks that were operational decades before EDSyS. Sentinel 
surveillance systems such as the Royal College of General Practitioners Weekly Returns 
Service (England) and the French ‘Réseau Sentinelles’ physician network have been 
collecting weekly returns of community-based morbidity data using semi-automated 
methods since 1966 and 1984 respectively.139,140 
Strengths and limitations of this review 
Through the identification and interrogation of both journal articles and abstracts/papers 
from syndromic surveillance themed conferences, we were able to identify a large number 
of EDSyS systems, in more countries/territories than would have been possible from journal 
articles alone. The exclusion of non-English language publications may still have limited the 
findings of this review. Other novel descriptions of EDSyS systems, such as websites and 
reports are also likely to have added further detail, though may not be searchable in a 
systematic manner. 
As the terminology for healthcare provision is not globally standardised this review relied 
on the identification of studies including the term ‘emergency’ (while allowing for global 
variation with the addition of room/department/care) or an indication of data collected 
during unscheduled emergency hospital care (such as triage) in the title and/or abstract. In 
the absence of these terms any other EDSyS that is described as ‘hospital’ based syndromic 
surveillance systems will have been excluded. Furthermore, the description of EDSyS in the 
literature is occasionally obscured by the use of names of syndromic surveillance systems 
 
 
and tools in titles and abstracts, rather than explicitly describing the use of data from an ED 
source. These difficulties may be due to the surveillance system being reported collecting 
data from a range of sources. Several syndromic surveillance systems collect data from 
multiple data sources (e.g. ambulance call outs, poison centre calls, and/or over the 
counter sales), with analysis and interpretation on a whole system basis, rather than a 
single data source. We are aware that a number of references excluded during the 
identification phase of this review were indeed related to EDSyS, but did not include any 
term related to the ED in the title or abstract, instead relying on the reader being familiar 
with the system name (e.g. ESSENCE or RODS both of which were described elsewhere in 
references used in this review).  
The level of information available in conference abstracts in particular was minimal in some 
cases, providing little detail other than an EDSyS system existed. These references instead 
focused on a research question (such as a natural language processing algorithm, or a 
statistical technique). Discussion of research in both conferences and the published 
literature is important, however the day-to-day working and the value added to public 
health by EDSyS was less obvious. The inclusion of multiple information sources for each 
EDSyS when found (both research papers and conference abstracts), allowed the available 
information to be pieced together, filling in gaps where possible. 
In those countries with large numbers of standalone EDSyS systems, e.g. Canada and USA, 
there is potential for this review to have incorrectly estimated the number of EDSyS 
systems, as not all have been described individually. The evolution of systems over time 
with occasional overlap/merging of once separate systems, or addition of new national 
surveillance layers above what may still remain as stand-alone systems locally is, however 
an encouraging sign that EDSyS continues to be used and developed. Geographical (and 
population) coverage is increasing, aiding in both the developments of systems themselves, 
but importantly increasing the potential to achieve the primary aim of providing 
information for public health action. 
Finally, it is inevitable that between the execution of this review and the peer review 
publishing of results there will have been further developments or significant events in the 
field that the review does not capture, for example the COVID-19 pandemic. Whilst this 
can’t be avoided, we acknowledge that the EDSyS systems included in this systematic 
review will not capture all systems in operation at the time of publication. Reviews of this 
kind require continual updating to remain timely and representative. 
 
 
Future work and developments 
This review provides a pragmatic exploration and description of international EDSyS, giving 
some insight into where, and how, it has been used and how systems have evolved over 
time. A previous review focussed solely on the use of EDSyS for influenza surveillance.10 
Similar detailed reviews may be useful for the description of other syndromic indicators or 
even the statistical methods in use or even those proposed for or discounted from use in 
future. 
Increased sharing of indicator detail (diagnosis coding lists/algorithms for free text 
processing) will enable syndromic surveillance systems to learn from each other. Further 
developments in the standardisation of, and increased breadth of, information available 
from electronic patient records and real-time entry of data into the ED patient record are 
allowing for additional, more granular detail to be made available in (near) real-time for 
surveillance purposes. The collection of patient observation details, particularly 
temperature, has been discussed for the more reliable identification of patients attending 
ED with a clinical fever (rather than self-reported).141 Future exploration into the use of 
combinations of data fields from the ED patient care record (e.g. diagnosis/chief 
complaint/tests and measurements) for the identification of syndromic indicators should be 
carried out to utilise and expand on the experience gained through the past 20 years of 
EDSyS globally.  
Artificial intelligence (AI) and deep machine learning are exciting areas of development 
within syndromic surveillance. These methods have the potential to improve analysis tools, 
detection algorithms and syndromic surveillance activities in general. However, because of 
the relatively recent advent of these technologies they have not been included in this 
systematic review. A further review of the application of AI and deep machine learning in 
syndromic surveillance would be an interesting and relevant addition to this field. 
Furthermore, the timing of this review has precluded the COVID-19 pandemic, which has 
further highlighted the importance of EDSyS.142,143 It will be important to undertake a future 
systematic review of EDSyS in the aftermath of COVID-19 to assess changes to EDSyS 
globally and how systems were used in response to the pandemic.144  
The monitoring of syndromic indicators of public health importance is effective and, in 
some situations, provides the only real-time method for monitoring rapidly evolving events. 
The identification of similarities between EDSyS systems presents opportunities for 
harmonisation and collaboration in future. The USA has developed NSSP,125 there has been 
 
 
an investigation of cross-border working in Europe with the Triple S project145 and the first 
examples of multi country, multi EDSyS analysis in France and the UK.146,147 
Infectious and of non-infectious disease events of public health importance do not respect 
geopolitical borders. Additionally, patients may cross these borders when seeking/receiving 
health care. Countries with linked and unified health information systems have a major 
advantage for EDSyS system development, but unified systems are rarely applied across 
borders. Therefore, cross-border cooperation is a vital and necessary development for 
EDSyS and wider syndromic surveillance. International cooperation and collaborations to 
oversee a coordinated syndromic surveillance approach would strengthen public health 
surveillance. The ISDS developed such a model providing a much-needed international 
forum for sharing and discussing ED syndromic surveillance, as evidenced by the number of 
EDSyS identified from conference abstracts (including several not identifiable elsewhere in 
the literature). However, during 2019 a loss of funding resulted in the dissolution of ISDS: 
the field of syndromic surveillance has since missed the leadership of ISDS, particularly 
during the COVID-19 pandemic. The ‘Triple-S’ program also sought a programme of 
syndromic surveillance standardisation across Europe, however, without ongoing funding 
this initiative was not sustained. However, the trans-European system EUROMOMO 
demonstrates a positive example of sustained cross-border surveillance of mortality data 
across Europe illustrating the benefits of such networks.148 The field of syndromic 
surveillance would benefit again from such international collaborative programmes. 
2.6 Conclusions 
This systematic review included 559 studies describing 115 EDSyS systems across 15 
countries/territories. EDSyS was found to provide a valuable tool for the identification and 
monitoring of trends in those seeking care within the ED setting, for both infectious and 
non-infectious disease. Although individual EDSyS systems have been developed 
independently across various geographies in multiple countries/territories, many 
similarities were identified with opportunities for cross-system learning. There is potential 
for further system developments, collaborative working and even harmonisation between 
systems in future. This review provides the first description of EDSyS globally and reveals 
how ED clinical system evolution has provided the potential for future growth of EDSyS, 
both geographically and in the development and refinement of surveillance tools for new 
and existing areas of public health concern. 
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 Establishing ED syndromic surveillance in 
England 
3.1 Background 
As described in Chapter 2, ED syndromic surveillance systems had previously been 
successfully developed outside of the UK, on local, regional and national levels, often in 
preparation for mass gathering events. The London 2012 Olympic and Paralympic Games 
(London 2012) involved over 10,000 athletes from 204 countries, a workforce of over 
200,000 and media presence of over 21,000 broadcasting to a global audience of 4 billion 
people. With 8.8 million spectator tickets, along with further non-ticketed events (including 
marathon and road cycling), London 2012 was a mass gathering on a major scale.1  
In addition to the delivery of the Games, London 2012 required the provision of an 
enhanced public health surveillance programme capable of meeting the specialist health 
needs of a major mass gathering directly involving potentially millions of people, across 
several months in multiple locations. As discussed in Chapter 1, a shortfall in surveillance 
capability around monitoring severe health outcomes during London 2012 was identified as 
a potential risk for public health authorities. The Health Protection Agency (now PHE) was 
tasked with developing a national ED surveillance system to mitigate this risk. 
The PHE ED Syndromic Surveillance System (EDSSS) was therefore designed and built as the 
first national ED surveillance system in the UK, to provide near real-time public health 
surveillance of patient presentations to EDs. The EDSSS was considered a vital component 
of the enhanced public health surveillance programme which had to be delivered for 
London 2012.2,3  
Emergency care service provision in the United Kingdom 
Healthcare in the United Kingdom (UK) has been publicly funded since the 1940s, with 
control devolved to each individual nation through the National Health Service (NHS) in 
England, Scotland and Wales,4,5 and Health and Social Care in Northern Ireland.6 The 
general principle for this healthcare provision is the same in each nation: a single payer 
system, funded through taxation and free at the point of care for all residents. Across the 
UK all primary care (GP) and hospital services, as well as some dental and ophthalmic 
services, are provided to residents without fee.7 
 
 
The provision of free health care is extended further in emergency departments (EDs). 
Emergency care in EDs is available without cost to all those in need, irrespective of 
residency status. EDs provide a range of services available from different types of 
department:8 
• Type 01 EDs are commonly associated with the term ‘Emergency Department’, a 
facility led by consultant level medical doctors, available 24 hours a day, 365 days a 
year, with the facilities and skills to see and treat the most urgent/complex 
emergencies, including full resuscitation facilities; 
• Type 02 EDs are single specialty units (e.g. ophthalmology/dental); 
• Type 03 and 04 EDs are equipped to treat less severe illness than a Type 01 ED and 
may be doctor or nurse led (i.e. walk in and minor injury units). 
At the time of the initial development of EDSSS there was no central England (or UK) wide 
standardisation of ED data collection or storage: different data items were collected and 
stored in different ways in different EDs. There was a requirement for the central reporting 
of some ED data for monitoring and payment purposes (in the form of a Commissioning 
Data Set9, specifically the now retired CDS 01010), made publicly available as monthly total 
attendances and waiting times reports11 and annual activity level reports.12 
No central dataset existed collecting ED data in sufficient detail, or the near real-time 
timeframe, required for syndromic surveillance. This absence necessitated the 
development of a new national ED syndromic surveillance network.  
3.2 ED surveillance system development 
To ensure the successful delivery of EDSSS, meeting the London 2012 deadline, system 
development was undertaken in a series of phases, over several years (Figure 3-1). 
An initial pilot provided crucial proof of concept that ED attendance data could be collected 
from EDs in England, in near real-time, and used for public health surveillance purposes. 
The first EDs recruited to EDSSS began transmitting daily data in July 2010, 2 years ahead of 
the 2012 Olympic opening ceremony. 
The network was expanded during phase II, specifically targeting EDs using the same 
patient care record software as the pilot sites and located in London/close to Olympic 
venues. By the Olympic opening ceremony in July 2012, 27 EDs were reporting to EDSSS on 
a daily basis. During the Paralympic Games (September 2012) 28 EDs were reporting to 
 
 
EDSSS. This achievement exceeded the target number of EDs that had been agreed in the 
project plan for delivering EDSSS for the Games.  
Figure 3-1: The five phases of EDSSS development, from initial pilot to national 
system 
 
*Not all EDs providing daily data as of 28 February 2021 
Remaining as an Olympic legacy, EDSSS coverage continued to grow during phase IV. ED 
recruitment was expanded to include EDs using alternative software solutions and from a 
wider geographical area. EDs located in Northern Ireland were recruited during phase IV in 
preparation for large mass gatherings in both Belfast and Londonderry during 2013 (the 
World police and fire games13 and the Fleadh Cheoil festival14).2 A total of 40 EDs were 
recruited to the sentinel EDSSS. 
Phase V, the development of a truly national EDSSS, became possible with the introduction 
of the Emergency Care Data Set (ECDS). This newly developed standard for data collection, 
storage and daily transfer from all EDs in England to a central repository is described further 
in Chapter 8.  
EDSSS technical development  
EDs were recruited individually to the sentinel EDSSS (phases I-IV). Each site required 
formal approval for recruitment and data sharing agreements prior to the technical 
preparation for the automated transfer of anonymised data each day. These processes 
 
 
involved up to five different organisations: individual NHS Trusts (the EDs and the hospital 
system in which they operate), PHE (overall EDSSS management), Royal College of 
Emergency Medicine (RCEM15: initial approach to each ED inviting them to join EDSSS), an 
external IT service provider (providing secure, automated data extraction across the NHS 
N3 network) and where appropriate the ED software supplier (for the preparation of data in 
EDSSS format). 
The recruitment of EDs took a varying amount of time. The shortest period between an ED 
agreeing to participate in EDSSS and data beginning to flow was 56 days. The longest period 
to successful recruitment was 486 days. The recruitment process was not always successful. 
A small number of EDs declined the invitation to join EDSSS, while recruitment stalled and 
was never completed at some EDs. 
The introduction of ECDS in EDs in England included provision of data to EDSSS for public 
health surveillance purposes.16 Phase V therefore required a single data sharing agreement 
between PHE and NHS Digital (which is responsible for the receipt and storage of ECDS data 
centrally), for the secure, automated, daily transfer of anonymised data. 
EDSSS Data format and quality  
The items identified to be of potential value for sentinel EDSSS, and likely to be entered into 
the electronic patient record and available for extraction on a daily frequency, included:  
• the basic demographics of the patient (age in years, sex and place of residence 
approximated by postcode district);  
• administrative information about the attendance (ED attended, date/time of arrival, 
date/time of departure);  
• the patient journey to the ED (transport used, who referred them to the ED);  
• the journey through the ED (acuity of illness on arrival, presenting complaint, 
investigations carried out, diagnoses, treatments);  
• the discharge from the ED (if admitted to hospital including ward type e.g. ICU/HDU, 
sent home including any referral for GP/outpatient care, or died). 
All EDSSS fields were requested (and provided) in coded format. In the absence of a 
nationally agreed standard for ED data collection and storage the sentinel EDSSS required 
the creation of the EDSSS codeset, based on the RCEM minimum dataset.17 The use of 
standardised coding simplified the subsequent data analysis required (i.e. no need for free 
text analysis for syndromic indicator recognition and mapping) and prevented the inclusion 
of any potential patient identifiable information (PII) in free text fields. 
 
 
The national EDSSS expanded on this list of data items, with the addition of a range of 
newly standardised injury related fields and inclusion of self-declared patient ethnicity. All 
ECDS data is collected in Snomed CT format. 
As with all PHE syndromic surveillance systems, the EDSSS (both sentinel and national) does 
not require data fields to be complete or validated. Data collection allows for only a single 
‘snapshot’ of the data as it was recorded at the time of the automated extraction. 
Therefore, records of any patient with incomplete/incorrect information (e.g. not yet 
discharged or awaiting test results) at the time of data extraction for EDSSS are not updated 
at a later date.  
Data collection and transfer 
Sentinel EDSSS was designed to complement other PHE syndromic surveillance systems, 
providing a next day service, reporting on what happened in EDs across England up to 
midnight the night before. This reporting time frame enabled daily surveillance activities to 
be carried out on the day following each patient arrival.  
At approximately 4am each morning, records of patient arrivals that had occurred from 
00:00 – 23:59 on the previous calendar day were selected and prepared for transfer to 
EDSSS. Automated routines within the NHS Trust IT systems processed the local ED data 
into the EDSSS codeset. The secure transmission of this data to PHE each day across the 
NHS N3 network was automated and maintained by a specialist IT service provider. Data 
from all EDs was batched into a single file and arrived at ReSST by 9am on the calendar day 
following the patient arrival.  
The national EDSSS is reliant on data submission through the ECDS processes. Though 
‘daily’ data transfer is required, at the time of writing this has not yet been achieved by all 
EDs in England. National EDSSS currently receives all new data by 12:00 each day, and 
surveillance is carried out with a two day delay i.e. based on attendances arriving up to 
midnight two calendar days earlier. 
Development of public health outputs 
In addition to the technical architecture development, the creation of EDSSS required the 
establishment of a network of stakeholders and specialists, who formed the EDSSS steering 
group. This group provided oversight of the strategic development of the EDSSS and 
included membership from a range of different stakeholders in EDSSS including: ReSST; ED 
consultants from pilot EDs; RCEM representation; and specialists from other areas in PHE 
(including subject area leads, e.g. influenza surveillance, statistical leads and mass gathering 
 
 
experts working specifically on London 2012). The steering group provided strategic 
support and direction for all areas of EDSSS from the development of syndromic indicators 
of public health interest, to public health outputs designed to inform on the system and the 
surveillance findings. 
Syndromic surveillance indicators 
Syndromic surveillance groups together patient diagnoses/symptoms/presenting 
complaints into indicators of public health importance. As described in Chapter 2, ED 
syndromic surveillance systems to date have generally used either presenting/chief 
complaint or diagnoses for the identification of syndromic attendances. During phase I of 
EDSSS development the real-time entry of diagnoses was found to be common. The high 
levels of diagnosis code completion made this the preferred field for indicator development 
in EDSSS, negating the need for free text analysis of the triage presentation. 
Using the experience gained from the ReSST GP in-hours and NHS Direct syndromic 
surveillance systems, alongside the WHO mass gathering guidelines,18 new syndromic 
surveillance indicators were developed for the EDSSS. These focused initially on indicators 
for infectious diseases (i.e. to identify influenza-like illnesses/gastrointestinal outbreaks). 
With RCEM input and the experience gained from phase I, other, non-infectious indicators 
of illness were also developed (particularly for the impact of environmental events, such as 
hot or cold weather). 
As far as possible EDSSS indicators are constructed in a hierarchical format. Generic 
overarching groupings of diagnoses (e.g. respiratory/gastrointestinal conditions) are 
followed where possible by more detailed specific indicators (e.g. gastroenteritis/acute 
respiratory infections) and even further to a 2nd specific level (e.g. diarrhoea/influenza-like 
illness; Table 3-1). 
The generic indicators were required during sentinel EDSSS due to the types of diagnosis 
codes received: three different diagnosis codesets were in use locally: Accident and 
Emergency Diagnosis Tables19, used for the basic reporting at a national level as required in 
the Commissioning Data Set (CDS)10; International Statistical Classification of Diseases (ICD-
10)20; and Snomed CT21). The specific coding level provided the highest level of detail across 
the largest number of EDs (those using ICD-1020 or Snomed CT21). In many cases, however, 
the 2nd specific level indicators were more detailed than was possible from the diagnosis 
pick lists available locally; i.e. all EDs could report ‘respiratory’ attendances, all EDs using 
 
 
ICD-10 or Snomed CT could report ‘acute respiratory infections’, but only a small number 
had ‘influenza’ type diagnoses available in their local diagnosis pick list. 
Table 3-1: Hierarchical format of EDSSS indicators (based on sentinel EDSSS indicators*) 






















* Sentinel EDSSS allowed for entry of symptoms as diagnoses. National EDSSS is based the ECDS data 
specification which does not allow for symptoms such as diarrhoea/vomiting in the diagnosis field  
Surveillance information for action 
EDSSS daily surveillance feeds into wider public health surveillance activities, providing 
early warning of and situational analysis during (or reassurance of an absence of impact of) 
incidents/outbreaks; including local and national incidents. The ability to monitor and 
report on public health impacts in near real-time, aids in planning, public health action and 
messaging to the public.  
Bespoke statistical analyses (rising activity, multi-level mixed effects, indicator emphasis, 
RAMMIE, method)22 and a formal risk assessment process,23 were developed for syndromic 
surveillance in England and are applied to EDSSS. Daily data from EDs are received, 
analysed and where indicated full risk assessment carried out every day. Using system 
specific statistical analysis, in combination with multi-system risk assessment of all 
syndromic systems, EDSSS has become a valued information source, reporting key 
intelligence within PHE. The daily risk assessment process flags changes in ED attendances 
of potential public health concern, and even provides further intelligence during known 




In addition to the daily surveillance activities, weekly EDSSS bulletins describing trends in 
ED attendances for a range of indicators are made publicly available. Each publication 
provides a national overview of ED attendances for respiratory, gastrointestinal and cardiac 
indicators, with the addition of seasonally relevant cold and heat/sun reporting during the 
NHS cold and health watch periods each year. The first EDSSS bulletin was made publicly 
available on 11 April 201224 and continues to be made available on a weekly basis.25 
Evaluation of public health interventions 
In addition to the contribution that EDSSS makes to the day to day surveillance activities, 
EDSSS has also played a role in the investigation and evaluation of the impact of two new 
childhood vaccination programmes. This research has been carried out alongside other 
public health surveillance information streams: 
• piloting, and subsequent monitoring following the introduction of live attenuated 
influenza vaccination in school children;26-28  
• early investigation into the impact of rotavirus vaccination of infants in England.29,30 
ED syndromic indicator utility 
An important feature of the continued development of EDSSS has been the validation of 
indicators against other public health surveillance data to assess/establish their added 
benefit for public health surveillance. This has supported and strengthened the public 
health utility of the EDSSS, determining the sensitivity of indicators for detecting public 
health incidents in the community and how they compare to other surveillance systems and 
local intelligence in terms of the trends observed and the timeliness with which changes in 
trend can be identified. 
Infectious diseases 
The surveillance of acute respiratory infections, particularly influenza, is a common (often 
primary) objective for many public health surveillance systems. The majority of these 
infections are self-limiting and of low severity (not requiring healthcare advice), however, 
the significant impact and burden of circulating respiratory pathogens has been monitored 
in EDSSS. Acute respiratory infection attendances in EDs, particularly in young children was 
found to be highly sensitive to respiratory syncytial virus (RSV) circulation in the 
community, as confirmed by statistical correlation with RSV laboratory surveillance. EDSSS 
was also found to have provided advance warning of increases in acute respiratory 




The impact of environmental incidents on human health is often difficult to monitor and 
quantify, particularly during and immediately after the incident. Short term health effects 
of environmental incidents are often acute, with rapid onset of severe symptoms requiring 
emergency treatment. EDSSS has therefore, unsurprisingly, been successful in showing 
potential in the detection and monitoring of these kinds of events, including: 
• increased asthma type attendances around the timing of thunderstorms (based on 
both day and hour of patient arrival/storm activity);32  
• increased ED attendances for the ‘cold’ indicator (based largely on a select group of 
cold related fractures, particularly in females), has been shown to be associated with 
periods of extreme cold weather;33 
• EDSSS heatstroke/sunstroke indicator attendances have been shown to increase 
during heat waves;34 
• EDSSS added evidence and support to other syndromic surveillance systems in 
England in the identification and monitoring the impact of poor air quality incidents 
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 Research questions 
A series of manuscripts are presented which address the questions raised in this thesis: 
4.1 Does near real-time emergency department syndromic 
surveillance provide additional benefit to public health 
surveillance in England? 
A wide range of well established, traditional, public health surveillance systems existed 
prior to the establishment of ED syndromic surveillance in England. Each of these generally 
focus on a particular area of human health, both infectious diseases (pathogen specific) and 
non-infectious disease (either grouped by outcome e.g. cancer, or by exposure e.g. 
chemical/radiological/environmental). Syndromic surveillance approaches surveillance 
from a different starting point, by establishing what information is available, before then 
identifying what can (or cannot) be monitored. Syndromic surveillance systems also existed 
in England prior to the creation, with the monitoring call levels to the NHS Direct and GP 
consultations. 
The implementation of EDSSS (described in Chapter 3) resulted in a surveillance system 
focussed on the more severe end of the disease spectrum, with the flexibility to provide 
valuable public health intelligence across a wide range of factors of public health 
importance: infectious diseases (Chapter 5), health effects of environmental events 
(Chapter 6) and even human behaviour (Chapter 7). 
ED syndromic surveillance, with data collection, analysis and feedback in near real-time, is 
also more timely than traditional surveillance techniques. Rather than waiting weeks, 
months or even years for fully validated ED data to be made available, syndromic 
surveillance can provide early warning of issues and enhanced monitoring of situations 
allowing for the identification of changes in the basic tenements of epidemiology i.e. time, 
person and place. The potential for this during periods of poor air quality is described in 
Chapter 6 and during mass gatherings/sporting events in Chapter 7 as well as actual use for 
near real-time reporting during a global pandemic, as shown in Chapter 9.  
Additionally ED syndromic surveillance has the potential to provide quick, early feedback on 
the implementation of public health interventions in future as evidenced by the impact of 
rotavirus vaccination described in Chapter 5 and again shown in near real-time following 
 
 
large scale public health measures (shielding and social distancing) during a pandemic in 
Chapter 9.  
Rapid identification of changes in demographic or geographic presentations of illness can 
aid in better management of incidents and targeting of interventions, including public 
health messaging. The first example of EDSSS standard outputs impacting on public health 
policy and messaging is highlighted in Chapter 9. The indirect impacts of the COVID-19 
pandemic, and public health interventions, in England were clearly visible in the routine 
reporting of ED attendances in the national EDSSS. 
Furthermore, as described in Chapter 2, the presence of ED syndromic surveillance systems 
offers the potential for collaborative working. Collaboration between ED syndromic systems 
across international borders has, so far, been limited. Cross-border collaboration is, 
however, appropriate as factors which have an adverse impact on human health, or causing 
changes in health seeking behaviour, do not only occur on a local basis. As described in 
Chapter 6, air quality incidents do not respect political borders, and as seen in Chapter 7 
population level changes in behaviour in response to international sporting events can be 
seen in geographically distinct locations. The effect of these stimuli on the local population 
may not be nation specific, and the ability to draw comparisons within collaborative studies 
is a valuable feature of ED syndromic surveillance. 
4.2 What value can ED syndromic surveillance add to 
emergency care services in England? 
Public health surveillance can often appear to be a one-way flow of information: from the 
data provider(s) to the surveillance system. Data gathered by public health surveillance 
systems provides information on the health of the population, which may then be used for 
public health action. This data held within and analysis outputs from the surveillance 
system are not necessarily used to provide feedback to the system from which the data was 
originally gathered.  
As detailed in Chapter 3, the original sentinel EDSSS network was restricted by the limited 
availability of data and lack of standardisation of coding from EDs across England. 
Collaborative working was an essential part of EDSSS from the outset. Chapter 8 describes 
how the collaboration with RCEM developed beyond the creation of a surveillance system. 
The experience gained from developing and maintaining the sentinel EDSSS provided input 
 
 
into the development and implementation of the new Emergency Care Data Set (ECDS), by 
RCEM, NHS Digital and NHS England.  
The ECDS mandates a new standard for the collection and formatting of data within the 
electronic patient care record in all EDs in England; including the requirement for daily data 
transmission to a central point (NHS Digital) on a national basis. The lessons learned from 
EDSSS in the successful creation of a sentinel ED syndromic surveillance network, collecting 
disparate data, in an EDSSS specific codeset, on a daily basis, were directly applicable to the 
development of ECDS. In this instance syndromic surveillance was able to provide feedback 
for a project which had a primary focus on the improvement of patient care through better 
record keeping. 
4.3 How can ED syndromic surveillance in England be 
further developed for improved public health 
surveillance?  
Each individual piece of work described in Chapter 5, Chapter 6, Chapter 7,Chapter 8 and 
Chapter 9 has revealed multiple areas for future development. Opportunities exist for the 
learning from past experience and future collaboration with other ED systems. There is also 
the need to develop a better understanding of how the new national EDSSS can improve 
further, making full use of the improved data quality and provision afforded by the 
introduction of ECDS.  
The findings presented within this thesis are underpinning further work programmes 
driving the expansion and continued development of the national EDSSS coordinated by 





Using emergency department syndromic 
surveillance to investigate the impact of a 
national vaccination program: a 
retrospective observational study  
Helen E. Hughes 
Alex J. Elliot 
Thomas C. Hughes 
Daniel Hungerford
Roger A. Morbey 
Gillian E. Smith 
Roberto Vivancos 
Sarah J. O’Brien 
PLoS ONE. 2020;15(10):e0240021. Crown Copyright. 
DOI: 10.1371/journal.pone. 
The real-time nature of ED syndromic surveillance provides the opportunity for the 
identification and monitoring of changing trends in demand from those severely ill and 
requiring emergency care and/or treatment. Intuitively the standard use for this information 
is for the identification of increases in trend. However, ED syndromic surveillance may also 
be used for the quick investigation and evaluation of the impact of public health 
interventions by identifying and monitoring changes (possible decreases) in disease 
outcomes presenting within EDs.  
Rotavirus vaccination was introduced into the UK childhood vaccination schedule in July 
2013. Similar to other countries, the introduction of rotavirus vaccination was reportedly 
followed by reduced the levels of childhood gastroenteritis in the community, as identified 
by laboratory and syndromic surveillance. ED syndromic surveillance has previously provided 
additional support in wider investigation of vaccine impact across multiple levels of 
healthcare provision. Here we demonstrate the potential for ED syndromic surveillance to be 
used for rapid, stand alone, investigation of vaccine impact. 
 
 
5.1 Abstract  
Background  
Rotavirus infection is a common cause of gastroenteritis in children worldwide, with a high 
mortality burden in developing countries, particularly during the first two years of life. 
Rotavirus vaccination was introduced into the United Kingdom childhood vaccination 
schedule in July 2013, with high coverage (>90%) achieved by June 2016. We used an 
emergency department (ED) syndromic surveillance system to assess the impact of the 
rotavirus vaccination programme, specifically through the demonstration of any immediate 
and continuing impact on ED gastroenteritis visits in England. 
Methods 
This retrospective, observational study used syndromic surveillance data collected from 3 
EDs in the two years before (July 2011 - June 2013) and 3 years post (July 2013 - June 2016) 
introduction of rotavirus vaccination. The weekly levels of ED visits for gastroenteritis (by 
age group and in total) during the period before rotavirus vaccination was first described 
alongside the findings of laboratory surveillance of rotavirus during the same period. An 
interrupted time-series analysis was then performed to demonstrate the impact of 
rotavirus vaccination introduction on gastroenteritis ED visit levels. 
Results  
During the two years before vaccine introduction ED visits for gastroenteritis in total and 
for the 0-4 years age group were seen to rise and fall in line with the seasonal rotavirus 
increases reported by laboratory surveillance. ED gastroenteritis visits by young children 
were lower in the three years following introduction of rotavirus vaccination (reduced from 
8% of visits to 6% of visits). These attendance levels in young children (0-4years) remained 
higher than in older age groups, however the previously large seasonal increases in children 
were greatly reduced, from peaks of 16% to 3-10% of ED visits per week. 
Conclusions  
ED syndromic surveillance demonstrated a reduction in gastroenteritis visits following 
rotavirus vaccine introduction. This work establishes ED syndromic surveillance as a 





Rotavirus infection is a common cause of gastroenteritis in children worldwide, particularly 
during the first two years of life. Clinical presentation ranges from mild, self-limited 
diarrhoea, to more serious cases requiring medical interventions, and deaths.1 Although 
deaths are less likely in developed countries, illness due to rotavirus in the youngest 
children in the community results in high numbers of contacts with health care. In the 
United Kingdom (UK), rotavirus was estimated to account for much of the National Health 
Service (NHS) health care contacts made for acute gastroenteritis in children under 5 years: 
27% of calls for advice (e.g. to the NHS 111 health advice line), 25% of visits to general 
practitioners (GPs), 20% of visits to emergency departments (ED) and 45% of hospital 
admissions.2 Rotavirus is known to follow a seasonal pattern, with activity in the UK largely 
seen between January and June, usually reaching a peak in February/March (similar 
seasonal patterns are seen throughout Europe3).  
Rotavirus vaccination (RV) with the live attenuated monovalent vaccine (Rotarix®: 
GlaxoSmithKline Biologicals)4 was introduced into the UK childhood vaccination schedule in 
July 20135 as a two dose course targeted at infants 8-15 weeks (second dose before 24 
weeks).6 High coverage was achieved with >85% coverage for both doses by February 
2014,6 a level which increased to >90% by June 2016.7 Immediately following introduction 
of the RV programme reductions in the levels of gastroenteritis were reported in young 
children (0-4 years) in England, as estimated through laboratory confirmations, GP 
consultations and ED visits,8-12 with the costs avoided resulting in economic savings 
estimated at £12.5 million per year.13 Similar results were reported in other countries 
including Australia,14 Brazil,15 Canada16 and across sub-Saharan Africa17 and Europe,18 
although reductions were also reported in the Netherlands, where vaccination had not 
been introduced.19 
Syndromic surveillance involves the near real-time collection, analysis and reporting on 
health related data20 which has been applied to a wide variety of contemporaneously 
collected patient data sources. This type of surveillance provides the potential to monitor 
and identify trends, across a wide variety of conditions and within shortened timescales 
compared to more traditional surveillance based on formal notifications and laboratory 
reporting. ED syndromic surveillance has previously demonstrated to be a valuable 
component in vaccine impact investigations alongside other data sources.9, 13, 21 Here we 
 
 
demonstrate the utility of ED syndromic surveillance for a stand-alone investigation of a 
public health intervention: the introduction of rotavirus vaccination in England. 
The principle aim of this study was to use a national ED syndromic surveillance system to 
assess the continued impact of the UK national RV programme. We first describe trends in 
ED visits for gastroenteritis during the two years prior to the introduction of the RV 
programme (2011-2013), compared to the weekly number of rotavirus confirmations 
identified in laboratory surveillance. We then explored the use of ED syndromic surveillance 
data for England to demonstrate the immediate impact of RV on young children attending 
EDs for gastroenteritis, to identify if previously reported reductions in rotavirus associated 
disease have continued. Our investigation also investigated possible changes in 
gastroenteritis ED visits across older age groups outside of the vaccination target groups, 
including any changes in seasonality.  
5.3 Methods 
Emergency department visits  
The Emergency Department Syndromic Surveillance System (EDSSS) is part of the Public 
Health England (PHE) suite of real-time syndromic surveillance systems.22 EDSSS was set up 
as a voluntary sentinel system prior to the 2012 London Olympic and Paralympic Games.23 
This system has provided an opportunity to investigate the ongoing impact of RV on ED 
visits, with surveillance data available from a number of English EDs, both prior to and 
following RV introduction. 
The EDSSS collects an anonymised record for every visit at a participating ED on a daily 
basis, including: simple non-identifiable demographic data (sex and age), and any diagnoses 
selected. Clinical diagnoses are received in the coded format used within each ED; different 
diagnostic coding systems reveal different levels of clinical detail, requiring the 
development and use of a range of EDSSS syndromic indicators (three coding systems used 
in the sentinel EDSSS: NHS Accident and Emergency Diagnosis Tables,24 ICD-1025 and 
Snomed CT26). A detailed ‘gastroenteritis’ indicator (diagnosis codes considered to indicate 
an infectious gastrointestinal disease) was used here and was only available from those EDs 
reporting sufficiently detailed diagnostic codes (ICD-10 or Snomed CT: codes included in the 




Only EDs able to report diagnosis codes mapped to the gastroenteritis indicator 
(gastrointestinal diagnoses considered due to infection), which reported throughout the 
time period and with no known changes in diagnosis coding practices or gaps in data, were 
eligible for inclusion. 
The pre-RV period used for the description of gastroenteritis before RV programme 
introduction included data from July 2011 to June 2013. The post-RV period used for the 
investigation of vaccine impact included data from July 2013 to June 2016. Only EDs which 
were capable of reporting gastroenteritis throughout the pre-RV and post-RV time periods 
were eligible for inclusion in this study. 
Laboratory reports 
Anonymised laboratory reports of rotavirus detection were accessed from the PHE Second 
Generation Surveillance System (SGSS), which contains data on isolates from diagnostic 
laboratories in England, using a range of diagnostic tests.27 These data were used as an 
indicator of the community circulation of rotavirus during the two years prior to RV 
introduction available from EDSSS (4/7/11-30/6/13), ending the day before national RV 
implementation on 1/7/2013. Each laboratory report included the specimen date, patient 
age, organism identified and specimen type. Analyses were restricted to faecal specimens 
to exclude instances of invasive disease, which would not be comparable to the 
gastroenteritis ED visits. No restriction was included on specimen location (e.g. 
hospital/community) or patient age, as laboratory confirmation was used here to indicate 
pathogen activity in the community, not disease severity or age group affected. Episode 
based de-duplication is built into the SGSS,27 and therefore no further patient-based de-
duplication was required. 
Descriptive analysis 
Both ED syndromic surveillance and laboratory data for the two-year pre-RV period were 
grouped into weekly totals in order to remove any day of the week effects (04/7/11 – 
03/07/16; International Organisation for Standardisation (ISO) weeks 2011 week 27 to 2013 
week 26). The total weekly number of rotavirus isolates (as an indicator of community 
circulation) was compared to the weekly ED gastroenteritis visits in total and individual age 
group (0-4 years, 5-14 years, 15-44years, 45-64 years and 65+ years).  
Statistical analysis of vaccine impact on gastroenteritis ED visits 
ED visit data, for number of visits with a gastroenteritis diagnosis and number of visits with 
a diagnosis code, were stratified by age group (as above) and by week. The number of total 
 
 
visits which included a diagnosis code each week was used as a denominator to calculate 
the percentage of visits due to gastroenteritis. 
Time-series were constructed for the weekly percentage of visits reported as gastroenteritis 
for each age group and in total. An interrupted time-series analysis method was used to 
estimate the impact of the introduction of RV on gastroenteritis ED visits in each age group 
and for all ages. A negative binomial regression model, selected due to over dispersion, was 
fitted to the pre-vaccination period, to calculate estimated weekly visits, and an estimation 
of the trend and seasonality in the absence of vaccination, with the weekly gastroenteritis 
visits as the dependent variable. The total number of ED visits was included as an offset 
variable, to allow for changes in total ED visits over time and a seasonal harmonic 
(sine/cosine) Fourier pair of terms to model seasonality. These models were then projected 
forward to predict the expected visit levels had RV not been implemented. These ‘no 
change’, counterfactual models were then compared with models that included terms to 
account for a change following the vaccine introduction and a change in seasonality post-
vaccine.  
Interrupted time-series analysis was carried out using the statistical software R28 (MASS, 
tsModel and epi packages29-31). 
Ethics 
This surveillance is undertaken as part of the national surveillance functions of PHE and so 
ethical approval for this work was not required. The anonymised health data used in this 
study were routinely collected as part of the public health function of PHE. 
5.4 Results 
Three EDs were eligible for inclusion in the study. They were based in two cities in England 
(one Northern, one Southern), included adult and paediatric services and reported 
consistently to EDSSS throughout both the pre-RV and post-RV periods. During the two 
years pre-RV, 596,122 visits (in the 3 study EDs) were reported to EDSSS, of which 71.5% 
included a diagnosis code (Table 5-1). In total, 2.2% of these coded visits were identified as 
due to gastroenteritis. The highest number of attendances for gastroenteritis were 
recorded in young children 0-4 years, despite this group accounting for only 10.2% of all ED 
visits (Table 5-1). Consequently, the percentage of attendances attributable to 
gastroenteritis was highest in children aged 0-4 years (8.0% of coded visits), whereas in age 
 
 
groups 5 years and over gastroenteritis was identified in less than 2.0% of ED visits (Table 
5-1). 
Table 5-1:  ED visits, those including diagnosis coding and those identified as gastroenteritis, 




(% total visits) 
Diagnosis included 
(% age group visits) 
Gastroenteritis visits 
(% age group visits 
with diagnosis) 
0-4  60,531 (10.2%) 43,354 (71.6%) 3,470 (8.0%) 
5-14 49,623  (8.3%) 34,219 (69.0%) 655   (1.9%) 
15-44 266,010 (44.6%) 189,907  (71.4%) 2,946  (1.6%) 
45-64 104,615  (17.5%) 75,731  (72.4%)    909  (1.2%) 
65+ 114,672  (19.2%) 82,839  (72.2%) 1,431  (1.7%) 
unknown 671 (0.1%) 308 (45.9%) 0 (0.0%) 
Total 596,122  (100.0%) 426,358  (71.5%) 9,411  (2.2%) 
 
A seasonal pattern was observed in gastroenteritis visits for children under 5 years during 
the 2-year pre-RV period, with increased ED attendances from week 1-17 each calendar 
year (Figure 5-1). This increase mirrored increases in rotavirus reported through laboratory 
surveillance during the same period. ED visits for gastroenteritis in all other age groups 
showed less seasonal variation (Figure 5-1).  
A separate period of increased gastroenteritis visits was also observed during the summer 
of 2012 (week 39-45), particularly in children 0-4 years.  
During the three years following the introduction of the rotavirus vaccine, 914,725 ED visits 
were reported by the three eligible EDs (Table 5-2). Diagnosis codes were received for 
71.8% of visits (very similar to the levels identified during the pre-RV period), with 2.1% of 
these identified as due to gastroenteritis. The numbers and levels of gastroenteritis were 
highest in the youngest age group, 0-4 years though lower than identified during the pre-RV 




Figure 5-1:  Weekly emergency department (ED) gastroenteritis visits (as a percentage 
of visits with a diagnosis), by age group and in total and weekly number of 
rotavirus laboratory isolations (England) during the two years pre-rotavirus 
vaccine introduction (2011 week 27 - 2013 week 26) 
 
Table 5-2  Emergency department (ED) visits, those including diagnosis coding and those 
identified as gastroenteritis, by age group during the post-RV period from 1 




(% total visits) 
Diagnosis included 
(% age group visits) 
Gastroenteritis visits 
(% age group visits 
with diagnosis) 
0-4  84,673 (9.3%) 63,411 (74.9%) 3,860 (6.1%) 
5-14 74,595 (8.2%) 52,385 (70.2%) 1,126 (2.1%) 
15-44 401,187 (43.9%) 282,915 (70.5%) 4,863 (1.7%) 
45-64 165,511 (18.1%) 119,562 (72.2%) 1,497 (1.3%) 
65+ 187,808 (20.5%) 137,815 (73.4%) 2,256 (1.6%) 
unknown 951 (0.1%) 507 (53.3%) 0 (0.0%) 
Total 914,725 (100.0%) 656,595 (71.8%) 13,602 (2.1%) 
 
Vaccine impact 
The time-series constructed for gastroenteritis visits for all ages in total showed differences 
in both visit levels and seasonality between the pre-RV and post-RV time periods (Figure 
5-2a). During the pre-RV period the weekly gastroenteritis levels ranged from 1.3-4.0% of 
 
 
all weekly visits. Post-RV slightly lower peaks were seen, ranging from 1.4-2.7% of all 
weekly visits (Figure 5-2a). As observed in the descriptive analysis, levels of gastroenteritis 
were much higher in young children (0-4 years; Figure 5-2b). 
A more pronounced seasonal pattern was identified in ED visits present in young children 
(0-4 years: Figure 5-2b). The highest peaks in weekly visits levels were identified in this 
youngest age group (pre-RV max 15.9; post-RV max 9.6%: Figure 5-2b). 
The interrupted time series models for all ages in total and for the 0-4years age group 
separately, demonstrated a clear divergence between the model fit to actual data and the 
counterfactual model (estimated trends had no vaccine been introduced). For the all age 
and 0-4 years group modelling the counterfactual models predicted large seasonal 
variation, as seen pre-RV. This degree of seasonality was not, however, seen in the post-RV 
period (Figure 5-2). 
Figure 5-2:  Weekly emergency department (ED) gastroenteritis visits, interrupted time-
series regression model with level change and harmonic adjustment for 
seasonality, a) all ages and b) young children (0-4 years), week 27 2011 to 
week 26 2016 (grey box represents the rotavirus vaccine period). 
 
In addition to the lowest levels of gastroenteritis visits being identified in other, older age 
groups (5+years) there was also less seasonal variation in visits, and less obvious differences 
between pre-RV and post-RV introduction. The modelling indicated similar results for the 
model fit to the actual data and the counterfactual model (Figure 5-3). 
There was evidence of autocorrelation in the data, as would often be expected with time-
series data. However, this was largely due to the seasonality observed in the data and 




Figure 5-3:  Weekly emergency department (ED) gastroenteritis visits, interrupted time-
series regression model with level change and harmonic adjustment for 
seasonality, a) older children (5-14 years) and adults b) 15-44 years, c) 45-
64 years and d) 65+ years, week 27 2011 to week 26 2016 (grey box 
represents the rotavirus vaccine period). 
 
5.5 Discussion 
The descriptive time-series analysis of ED syndromic surveillance data identified seasonal 
trends in gastroenteritis ED visits in England prior to RV introduction, both for all ages in 
total and for young children. Gastroenteritis ED visits increased around the time of known 
seasonal rotavirus activity, as indicated by increased rotavirus laboratory confirmations. 
Prior to RV introduction, gastroenteritis levels in the youngest age group (0-4 years) were at 
much higher levels and showed greater seasonal variation than in older age groups. During 
periods of known rotavirus activity (2011 weeks 4-16, 2012 weeks 8-16) over 10% of ED 
visits (peaking at 16% of ED visits) made by children aged 0-4 years were identified as 
having a diagnosis of gastroenteritis. 
The seasonal trends observed in all ages, and the high levels in young children implied a 
considerable burden of ED visits were associated with RV. This highlighted the usefulness of 
ED syndromic surveillance data for investigating the impact of rotavirus vaccine 
introduction into the childhood vaccination schedule. 
 
 
Following the introduction of the national RV programme, the change in the seasonal 
variability of ED gastroenteritis visits was particularly notable in the youngest age group. 
The magnitude of the seasonal trend was reduced in comparison to the counterfactual 
model in the interrupted time series analysis, becoming more similar to the more stable 
(non-seasonal) trend observed in older age groups. Although gastroenteritis visits for young 
children (0-4 years) remained higher than older age groups, the variation week on week 
became attenuated, with smaller seasonal peaks (and troughs) observed in the ED data. 
This implies a change in the case mix of the youngest children seen in EDs, particularly 
during what had previously been recognised as the rotavirus season. This reduced level of 
gastroenteritis supports previous findings of a reduction in gastroenteritis immediately 
following RV introduction in both England8-12 and other countries.14-18  
These results also highlight decreasing trends in ED attendances for gastroenteritis pre-
vaccine, and post vaccine in the counterfactual model (i.e. in the absence of vaccine). 
Previous studies in England have demonstrated longer term falls in community-based 
general practitioner consultations for infectious intestinal disease.32,33 The findings here 
may indicate that public health messaging aimed at discouraging patients using health care 
services for mild self-limiting gastrointestinal infections, and changes in health care seeking 
behaviour is continuing to reduce the community burden from gastrointestinal infections 
on healthcare services.  
There is evidence that introduction of rotavirus vaccination in infants may subsequently 
reduce gastroenteritis in adults,12,18 however no clear decreases were observed in either 
the levels or seasonality of gastroenteritis visits in older age groups post-RV. The numbers 
of severely ill patients attending EDs may be too few to have a notable impact on ED 
workload. ED gastroenteritis visits levels for older children and adults continued to make up 
a smaller percentage of total visits in those age groups (0-6% for older children 5-14yrs, 0-
3% for adults). The reduction in gastroenteritis attendances for young children did, 
however, result in reductions in the all age gastroenteritis attendances to EDs, changing the 
overall workload and case mix in EDs in general.  
The observed reduction in ED gastroenteritis visits by young children reported here was not 
as great as the reductions reported in confirmed rotavirus hospitalisations.9,13-18 though this 
was to be expected since ED syndromic surveillance gastroenteritis attendances are unlikely 
to be solely due to rotavirus. In the absence of a confirmatory testing (which is often 
unnecessary for successful treatment of gastroenteritis in an ED setting) there is no specific 
 
 
rotavirus syndromic indicator available; the gastroenteritis indicator used here for ED 
syndromic surveillance includes all pathogens and causes.  
This work has further demonstrated the ability for non-pathogen specific syndromic 
surveillance to detect and describe a change in level of health seeking behaviour in the 
community for the more severe cases of illness (i.e. in the ED setting), following the 
introduction of a vaccine programme. During 2013 an initial pilot of the live attenuated 
influenza vaccine (LAIV) in the UK childhood vaccination programme used a range of 
different syndromic surveillance data (including ED attendances) to assess the impact and 
effectiveness.34 The near real-time nature of ED syndromic surveillance data collection 
supported the timely assessment of LAIV impact in England, thereby supporting expansion 
of the pilot to the national immunisation programme.  
Strength and weaknesses 
The EDSSS provides the potential to identify, quantify and monitor the levels of illness in 
the population requiring ED care. As the largest proportion of those affected by rotavirus 
infection do not need ED care i.e. they ‘self-treat’,2 the numbers of cases eligible for 
inclusion in this study were limited and the findings should not be extended to estimate 
levels of less severe illness in the community. Despite the non-specific nature of syndromic 
surveillance, reliant on a preliminary/low detail/non-specific diagnoses from EDs (e.g. 
‘gastroenteritis’ rather than confirmed rotavirus infection), clear trends in presentations of 
illness were identified here that coincided with rotavirus seasonality.  
We have shown here the utility of EDSSS in monitoring the likely impact of rotavirus 
activity, despite the system itself being limited by the data available at both geographical 
coverage/number of EDs and the time periods available. The EDSSS was established to 
support the 2012 London Olympic and Paralympic Games using routinely collected data in a 
standardised format, allowing for identification of gastroenteritis in geographically distinct 
locations. Changes in system coverage and local work practices were unavoidable. Though 
individual EDs did provide data from late July 2010 both the pre-RV and post-RV data had to 
be limited to include data reported to EDSSS from only those EDs reporting consistently. 
This resulted in the inclusion of data from 3 EDs which reported from 2011 week 27 to 2016 
week 26 in this study.  
Syndromic surveillance in general is limited by the availability and quality of the data 
received. Here we included young children in the analysis as a 0-4 years age group. In the 
year following introduction of vaccine, the 0-4 years age group used here would have 
 
 
included those infants in the vaccine cohort and those who would not have received 
vaccine. Refining the analysis by year of age may have illustrated an increased impact of RV, 
however it was not possible to use a finer resolution of age (by year) in this youngest group 
using the data received in EDSSS for the time periods under investigation. Furthermore, 
with near real-time data extraction there is potential for incomplete records where the 
patient is still on their journey through the ED, so there may be no recorded diagnosis at 
the time of data extraction. The reasons for these gaps are unknown. Although the causes 
may be ED specific, it is assumed that they are also a constant in each site, allowing for 
comparison on trends over time. No changes in diagnosis data quality were identified in the 
EDs included in the analysis reported here.  
As ED records do not routinely include information on vaccine status it was not possible to 
ascertain the vaccine status of those ED patients during the study period. 
Future work 
ED syndromic surveillance systems exist in a number of different countries. Previous 
collaborative work has shown these systems to be compatible, with syndromic indicators 
used to describe and compare trends across international borders,35,36 giving opportunity 
for similar work on the impact of vaccination implementation on ED visits on a larger scale. 
A second period of increased gastroenteritis visits was identified during the pre-RV time 
period, particularly in those aged 0-4 years during September-October 2012. These 
increases may indicate increased activity of other gastrointestinal pathogens and coincided 
with increased seasonal laboratory reporting of cryptosporidium.37 This suggests that ED 
surveillance may be of use in identifying periods of increased gastrointestinal pathogen 
activity in the community, which merits further exploration. 
The introduction of the Emergency Care Data Set in England during 2018 has provided 
further opportunities for EDSSS.38 The newly standardised, routine, mandated collection of 
emergency care data has widened the potential of EDSSS as a surveillance tool by creating a 
data source capable of providing the data required for long term studies of public health 
importance. By January 2020, the sentinel EDSSS described here had developed from a 
voluntary, sentinel surveillance system with limited coverage, to the national EDSSS; with 
almost every ED in England providing data. This development opens the possibility for using 
ED syndromic surveillance in future rapid studies on the impact of public health 
interventions. Such examples include the future introduction of a respiratory syncytial virus 
(RSV) vaccine: EDSSS has previously been shown to be sensitive to increases in RSV 
 
 
circulation in the community thus making it a suitable tool for monitoring impact post-
vaccine implementation.39 Additionally, EDSSS has recently been used to monitor the 
impact of interventions used during COVID-19 pandemic in England. Social distancing and 
shielding measures alongside changes in guidance on how the public accessed health care 
services were introduced in England during March 2020. EDSSS was able to provide real-
time intelligence on the impact of these restrictions, demonstrating significant decreases in 
patient attendances in EDs in England during the period of the COVID-19 intervention.40-42  
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5.9 Addendum 
This addendum further describes the interrupted time series analysis model used in the 
analysis in Chapter 5. Additional modifications are also described, which could be considered 
for the application of interrupted time series analysis of EDSSS data in the investigation of 
the impact of public health interventions in future. 
The interrupted time series model constructed in this investigation of the impact of the 
introduction of rotavirus vaccination into the childhood vaccination schedule in England 
allowed for: 
• a single point for the implementation of intervention (week 27, 2013);
• no change in slope of the modelled trend post intervention;
• the modelling of seasonality (with a harmonic Fourier term);
• the model to be applied to percentage, rather than count data (through the inclusion
of the total number of ED visits as an offset).
A single point of intervention: 
The inclusion of the rotavirus vaccine into the UK childhood vaccination schedule had a 
clearly defined start point (from Monday 1 July 2013, the beginning of week 27, 2013), 
which was used as the single point of intervention for this analysis. This single point 
approach was used due to high levels of vaccine coverage being reached quickly in the 
target age group (>85% coverage by February 2014).   
Though high levels of vaccine coverage were attained quickly, the uptake of this vaccine 
did, of course, increase over time. The ability for ED syndromic surveillance to be used for 
near real-time investigation of the impact of vaccine implementation in future may require 
initial modelling to use a single point of intervention (as used in this study). A more detailed 
interrupted time series model may subsequently be constructed, including a second point 
of intervention from when herd immunity had been reached. Published vaccine coverage 
data could be used to identify the point at which sufficient coverage had been reached, 
though is not likely to be available as close to real-time as the EDSSS data is available.  
Change in slope of modelled trend: 
There is potential that post implementation of a public health intervention there may be a 
change in any overall trend of disease presentations identified pre-intervention.  
An overall decrease in gastroenteritis ED attendances was identified in the pre-vaccination 
period, similar to the long term decreasing trend in GP consultations for infectious 
intestinal disease identified elsewhere and described in the Discussion. It was considered 
unlikely that the vaccine would change the direction of this trend, i.e. cause an increase in
(or stabilisation of) ED attendances, so the model used here did not allow for a change in 
trend. 
However, it may be appropriate for future investigations using EDSSS data to allow for a 
change in slope of trend to be specifically factored into any interrupted time series
analyses carried out.
Modelling seasonal variation: 
Initial descriptive analysis showed ED gastroenteritis attendances, in total and for younger 
children in particular, followed clear seasonal trends, similar to the seasonality observed in 
rotavirus laboratory data for England. For this reason, the time period included for analysis 
both pre and post vaccine introduction included full years (rather than possibly partial 
seasons) and the interrupted time series model included Fourier terms to allow for seasonal 
increases and decreases.  
The presence of an unexpected, out of rotavirus season, increase in gastroenteritis during 
the summer 2012 was of public health interest (possibly associated with high levels of 
Cryptosporidium activity as identified in laboratory surveillance). This was not controlled 
for in the model used in this study but could be in future similar analyses as appropriate.
Model based on percentage of attendances 
The analysis carried out in this work was based on the standard surveillance activities of the 
sentinel EDSSS: reporting on the percentage of attendances due to the gastroenteritis 
indicator, rather than numbers of attendances recorded. The inclusion of an offset (total 
number of ED attendances) ensured the suitability of the interrupted time series 
methodology. 
Though the reporting on workload and case mix as a percentage of attendances is of value 
within the ED setting, the COVID-19 pandemic has changed the appropriateness of this
method of reporting from EDSSS. As detailed in Emergency department use during COVID- 
19 as described by syndromic surveillance (Chapter 9), overall ED attendances following the
introduction of COVID-19 public health intervention measures and changes in health 
seeking behaviour in general greatly reduced the overall numbers of attendances at EDs.
This unanticipated change required all national EDSSS reporting to change to numbers of 
attendances as standard, with all future analyses expected to be carried out in this format 
going forward.  
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The near real-time (next day) nature of syndromic surveillance provides opportunities for 
the improved provision of health messages, tailored to a developing situation. This 
information may enable individuals to make simple changes in behaviour, having a 
protective effect on their health and reducing the overall impact of an otherwise adverse 
event.  
Poor air quality (AQ) is a global public health issue, with exposure causing both short term 
and long-term effects in humans. Short term impacts, such as asthma, acute breathing 
difficulties and cardiac events may have an identifiable impact on attendances at EDs. 
AQ events are not contained by political borders. Poor AQ can affect large geographical 
areas, cross borders and develop over time. Using ED syndromic surveillance from England 
and France, in the first cross national study of its kind, the changes in human health 




6.1 Abstract  
Introduction 
Poor air quality (AQ) is a global public health issue and AQ events can span across countries. 
Using emergency department (ED) syndromic surveillance from England and France, we 
describe changes in human health indicators during periods of particularly poor AQ in 
London and Paris during 2014. 
Methods 
Using daily AQ data for 2014, we identified 3 periods of poor AQ affecting both London and 
Paris. Anonymised near real-time ED attendance syndromic surveillance data from EDs 
across England and France were used to monitor the health impact of poor AQ.  
Using the routine English syndromic surveillance detection methods, increases in selected 
ED syndromic indicators (asthma, difficulty breathing and myocardial ischaemia), in total 
and by age, were identified and compared to periods of poor AQ in each city. Retrospective 
Wilcoxon-Mann-Whitney tests were used to identify significant increases in ED attendance 
data on days with (and up to 3 days following) poor AQ. 
Results 
Almost 1.5 million ED attendances were recorded during the study period (27/2/14-
1/10/14). Significant increases in ED attendances for asthma were identified around periods 
of poor AQ in both cities, especially in children (0-14yrs). Some variation was seen in Paris 
with a rapid increase during the first AQ period in asthma attendances amongst children (0-
14yrs), whereas during the second period the increase was greater in adults. 
Discussion 
This work demonstrates the public health value of syndromic surveillance during air 
pollution incidents. There is potential for further cross-border harmonisation to provide 
Europe-wide early alerting to health impacts and improve future public health messaging to 
health care services to provide warning of increases in demand.  
Strengths and limitations of this study 
• routinely collected syndromic surveillance data from both England (London) and 
France (Paris) were analysed using similar health indicators; 
• a single statistical method, designed specifically for daily syndromic surveillance, was 
applied to data from both cities; 
 
 
• air quality measurements were standardised across both cities, to overcome 
differences in the standard reporting from each; 
• pollutants other than particulate matter were not included, though they may be 
responsible for impacts on human health; 
• we could not control for the potential effects of health warnings and media coverage 




6.2 Introduction  
Air quality 
Air pollution has negative impacts on human health. Short term exposure to poor air quality 
can affect lung function, including exacerbating asthma symptoms, and is associated with 
other acute deteriorations in respiratory and cardiovascular health.1 Similar health effects 
have also been reported due to long term exposure, with exposure to ambient air pollution 
associated with lung cancer and chronic respiratory and cardiovascular conditions.1 In 
addition to illness within the community and increased need for health care, air pollution is 
also associated with increased mortality, with an estimated 4.7% of deaths in the England 
attributed to air pollution2 and 9% of deaths in France attributed to PM2.5.3  
Air quality (AQ) monitoring identifies long term trends informing policy, provides evidence 
of meeting (or missing) statutory target levels and quantifies the impact of preventative 
measures.4,5 Daily AQ monitoring enables daily reporting of both actual and modelled AQ 
(predicting one or more days in advance), for whole countries and/or individual cities, as 
well as on a smaller scale around individual monitoring stations.6-8 This information is 
increasingly easy to access through websites and apps and is often reported through the 
media, especially following formal health warnings.9 
Syndromic surveillance 
Syndromic surveillance initially focussed on infectious diseases such as influenza but is 
increasingly being used for other non-infectious public health events. This type of 
surveillance uses real-time data from patient contacts with health care services (e.g. 
telephone helplines, general practice/family doctors, or emergency departments). Patient 
contacts/attendances are grouped by diagnoses/symptoms creating syndromic indicators 
such as ‘respiratory’ or ‘gastrointestinal’, providing valuable information for public health 
action.10 The use of emergency department (ED) data lends itself particularly well to the 
syndromic surveillance of non-infectious public health events, with patients seeking 
attention for a range of acute conditions.11-13 Previous investigation of periods of poor AQ 
have shown associated increases in health seeking behaviour as evidenced by syndromic 
surveillance, particularly for asthma and/or difficulty breathing and heart failure,14-16 




During March and early April 2014 there was a period of widespread poor AQ across 
Europe. In particular, the urban conurbations of London (England) and Paris (France) were 
affected by high temperatures, Saharan dust and industrial emissions, resulting in 
widespread media attention.17-19 Here, we use routine ED syndromic surveillance data 
collected across London and Paris during poor AQ periods throughout 2014 to investigate 
the compatibility of the two countries’ ED syndromic surveillance systems and describe the 
public health impact and associated short-term changes in health care seeking behaviour 
for selected respiratory and cardiac syndromes across different age groups. 
6.3 Methods  
Air quality data 
The area studied here has been limited to London and the whole Paris region (Île-de-
France), rather than a country level. In England, the Department for Environment, Food and 
Rural Affairs monitors and reports on levels of air pollution using monitoring stations and 
provides health advice using the Daily Air Quality Index (DAQI).9 Air quality in the Paris 
region is monitored by Airparif and reported using the Citeair index.20 
Both DAQI and Citeair systems monitor and report on multiple pollutants, however each 
index is reported using different methodology. Therefore the daily pollution levels across 
both London and Paris were standardised here, using the reported levels of particulate 
matter (PM2.5 and PM10). The city wide average value for each PM on each calendar day 
was calculated as a mean of the maximum values reported for each monitoring station on 
that day, in that city.21,22 Periods of poor AQ were then defined as those when the 
calculated PM2.5 and/or calculated PM10 average value corresponded to the DAQI index 
levels of 7-10, which are the particulate matter levels classified as ‘high’ to ‘very high’ 
(PM2.5 >=54 µg/m³ and/ or PM10 >=76 µg/m³). At these levels people, including those with 
no pre-existing medical conditions, are advised to consider reducing their activity levels, 
particularly outdoors.8  
Emergency department syndromic surveillance data 
The Emergency Department Syndromic Surveillance System (EDSSS), is a sentinel ED system 
coordinated by Public Health England (PHE), collecting anonymised data from participating 
EDs on a daily basis (data for the previous day 00:00 to 23:59 are transferred to PHE the 
following morning).23 Diagnosis coding in EDs in England was not standardised at the time 
 
 
of this investigation. Each ED had a list of diagnosis terms created locally which was 
available for selection in the patient attendance record. These diagnostic terms have 
associated codes linked to them with each ED using one of three codesets: Commissioning 
Data Set (CDS) Accident and Emergency Diagnosis Tables,24 ICD-1025 or Snomed CT.26 EDs 
eligible for inclusion in this study were defined as those reporting using ICD-10 or Snomed 
CT diagnosis coding systems which provide the level of detail required for the identification 
of the indicators of interest; EDs using the CDS coding system were not able to provide the 
coded diagnosis data in this detail. This investigation included 5 eligible EDSSS participating 
EDs in London (all located within the London PHE Centre). 
The French national ED syndromic surveillance system collects daily data from the 
Organisation de la Surveillance COordonnée des URgences (OSCOUR®) network of EDs, 
coordinated by Santé Publique France27 (data for the previous day 00:00 to 23:59 are 
transferred and analysed the following morning for 85% of attendances at participating 
OSCOUR® EDs. The OSCOUR® system allows for updates and delayed reporting, the missing 
15% of ED attendances from OSCOUR® EDs are reported in the following 2 days28). All EDs 
reporting to OSCOUR® use ICD-10 for the coding of diagnoses selected in the patient 
attendance record.28 Aggregated, anonymised daily data for the Paris region (including 58 
eligible EDs) were made available for this analysis. 
Epidemiological analysis 
Syndromic indicators (asthma, difficulty breathing and myocardial ischaemia (MI); Table 
6-1) were selected from the comparable indicators already created for each system, based 
on clinical knowledge and experience of the potential health effects linked to air pollution 
and those used in previous syndromic surveillance work.  
These syndromic surveillance indicators, which are routinely used in both EDSSS and 
OSCOUR®, are an aggregation of relevant diagnostic codes representing similar diagnostic 
terms and available in the patient record. These ‘diagnoses’ may not be confirmed or final 
and may be based on the symptoms presented, with no level of certainty indicated. The 
overall asthma and MI indicator groupings were very similar in each system, with the terms 
included all describing either asthma or myocardial ischaemic conditions. Differences were 
found in non-asthma difficulty breathing type indicators; EDSSS included symptomatic 
wheeze/difficulty breathing type diagnoses whereas OSCOUR® included 
dyspnoea/respiratory failure diagnoses (Appendix C). Please note: not every code listed 
was reported by – or even available for selection from – every ED. More relevant codes may 
 
 
exist for each indicator than described here, however only codes reported to 
EDSSS/OSCOUR® in this study are included. Though each system was found to include 
different codes and even numbers of codes within each indicator, they would identify most 
of the same patients for inclusion within the indicators used here.  
Table 6-1: Syndromic surveillance indicators included in the EDSSS (London) and OSCOUR® 
(Paris) emergency department systems and used in the study 
EDSSS (London) OSCOUR® (Paris) Reported here as 






Myocardial ischaemia  Ischémie myocardique  Myocardial Ischaemia (MI) 
 
For each syndromic surveillance system, attendances were aggregated by age group 
defined as 0-14, 15-44, 45-64 and 65 years and over. 
The epidemiological analysis of ED attendance data included construction of trends in 
attendances for each syndromic indicator, both for all ages and for each age group, and 
city. The daily percentage(s) of attendances for each indicator were calculated using the 
number of attendances within an indicator (numerator) and the daily number of total (all 
cause) attendances with a diagnosis code within each surveillance system (denominator). 
Statistical analysis 
The EDSSS and OSCOUR® are both live public health surveillance systems prospectively 
collecting data with automated contemporaneous statistical algorithms underpinning the 
detection of unusual activity. We applied the routine syndromic surveillance statistical 
detection algorithm from England: the RAMMIE method (Rising Activity, Multi-level Mixed 
effects Indicator Emphasis).29 RAMMIE was applied to both English and French ED data, 
including to age specific data. Using RAMMIE two separate statistical thresholds were 
calculated: a ‘2-year’ threshold (based on the previous 2 years of data) to identify 
significant activity compared to previous years, and a ‘2-week’ threshold (based on the 
previous two weeks) to identify recent, statistically significant, increases in daily activity. 
RAMMIE routinely allows for the prioritisation of alarms to facilitate the identification of 
significant activity, however, this function was not used here to ensure that all statistically 
significant activity was identified, and not just those signals prioritised by RAMMIE. 
 
 
To ensure that sufficient data were included here to cover each of the AQ events identified, 
a study period of a minimum of 7 days pre the first and 7 days post the final period of poor 
AQ identified in London/ Paris during 2014 was selected. A further period of 2 years of data 
prior to the first AQ event provided required baseline data for the RAMMIE method.  
In addition to the RAMMIE analysis, the Wilcoxon-Mann-Whitney non-parametric test was 
used to test for significant differences in the syndromic indicators during the 2014 study 
period, by age group between those days with poor AQ and those without. To allow for the 
possibility of a delayed response, separate analyses were conducted incorporating lags of 
one to three days following a day of poor AQ. 
All analyses were undertaken using Stata v13.1.30 
6.4 Results  
Air quality events 
During 2014, several periods of poor AQ were identified where the ‘high’ or ‘very high’ air 
pollution thresholds for particulate matter (PM2.5 and/or PM10) had been breached in 
both London and Paris (Figure 6-1). Periods of poor air quality in Paris were generally 
observed to be of a longer duration and with higher DAQI levels than in London, though 
more individual days of poor AQ were identified in London. Two main periods of poor AQ 
overlapped in these cities in mid-March and early April. AQ1 was the largest event in both 
locations and where transboundary dust from the Sahara contributed to the makeup of the 
particulate matter fraction.14 AQ2 was apparent mainly in London (though a 1 day PM10 
spike in Paris was recorded). A third, less severe period occurred in both cities during 
September within a 7 day period (AQ3; Table 6-2).  
Table 6-2: Dates of poor air quality, coinciding in London and Paris during 2014 
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An overall study period was defined as 27 February 2014 – 1 October 2014 (216 days), to 
encompass each period where poor AQ occurred in both London and Paris, including 7 days 
before and after the first and final AQ events identified (Table 6-2).  
 
 
Figure 6-1: Calculated mean daily PM value and corresponding Daily Air Quality Index band, 





Over the study period 1,436,163 ED attendances were recorded across both London and 
Paris (Table 6-4). Total attendances were higher in Paris (1,163,353; from 58 EDs; >75% of 
all attendances31) than London (272,810; from 5 EDs, 3 using ICD-10, 2 using Snomed CT; 
<25% of attendances). A comparable level of diagnosis coding was included in each city 
with 79% of London attendances and 72% of Paris attendances including a clinical diagnosis 
code. 
On a weekly basis, total ED attendances in both London and Paris showed similar trends, 
with a peak observed on a Monday. Examination of indicator trends illustrated that there 
were further similarities between EDSSS and OSCOUR® with highest levels of asthma 
attendances (as a percentage of attendances with a diagnosis code); and lowest levels of MI 
attendances, reported on Sundays (Figure 6-2).  
 
 
Table 6-3: Attendances recorded in EDs, by city, over the study period (27/02/14-01/10/14)  
    ED Attendances Attendances with a diagnosis Indicator attendances 
City EDs ICD-10 Snomed Total ICD-10 Snomed Total Asthma Difficulty breathing Myocardial ischaemia 
London 5* 115,539 157,271    272,810 




214,730         
(79%) 
  1,893 
(0.9%) 
    812               
(0.4%) 
1,370                
(0.6%) 








5,433            
(0.6%) 
1,685               
(0.2%) 
   *1 small ED (which used ICD-10) stopped reporting to EDSSS on 10/09/2014. All 5 EDs were included in descriptive and RAMMIE analysis; 4 EDs that reported throughout were 
included in Wilcoxon-Mann-Whitney testing.
 
 
Figure 6-2: Mean emergency department attendances by day of week, 27 February 2014 – 
1 October 2014, by syndromic indicators, London reported to EDSSS: a) total 
attendances, c) Asthma and Difficulty breathing, e) Myocardial Ischaemia and 
Paris reported to OSCOUR®: b) total attendances, d) Asthma and Difficulty 




ED attendances during poor air quality periods 
London ED attendances 
Small increases in asthma attendances (all ages) in London EDs were observed following 
AQ1 (Figure 6-3a). ED asthma attendances continued to increase during and immediately 
following AQ2. RAMMIE 2-week alarms were reported for the increases in asthma (all ages) 
immediately following AQ1 in London, indicating an attendance level higher than the 
previous 2 weeks. However, single 2-week alarms were not unusual in these data and were 
also observed during periods with no reported AQ issues. 2-year asthma alarms were not 
observed in the all ages asthma attendances data during the study period. 
The observed increase of asthma attendances during the AQ2 episode in London was most 
evident in children aged 0-14 years, and young adults (15-44 years) with each age group 
reaching a peak in attendances 1 to 2 days later (Figure 6-3b). Asthma attendances for 
older adults showed no evidence of increase around periods of poor AQ (data not shown).  
An additional peak in asthma (all ages) attendances was observed on 20/7/14 (Figure 6-3a), 
particularly in children (0-14yrs; Figure 6-3b), though there was no poor AQ identified at 
that time. During early September increases in all age attendances for asthma, largely 
driven by child attendances (0-14yrs), were observed to have started prior to AQ3. 
A small increase in difficulty breathing attendances (all ages) immediately following AQ2 
(Figure 6-3c), was most apparent in the older adults (65 and over years; Figure 6-3d). This 
single day peak was the highest level seen in this age group, around double the usual level, 
though not significantly higher than historical data. Other age groups were not affected. 
MI attendances were less common than asthma attendances in London EDs (Table 6-3) and 
affected the adult age groups almost exclusively, as would be expected. Though a peak 
(resulting in both 2-week and 2-year alarm) in MI attendances was observed during AQ2, 
particularly in those aged 65yrs and over, a similar peak also occurred in late September, 
several days prior to the AQ3. 2-week alarms occurred quite frequently throughout the year 




Figure 6-3: Daily percentages of London ED attendances for syndromic surveillance indicators 
of a) asthma all ages, b) asthma 0-14 and 15-44years, c) Difficulty breathing all 
ages, d) Difficulty breathing 15-44 and 65+ years, e) Myocardial Ischaemia all ages 








Alarm type:    2 week    2-year 
 
 
Paris ED attendances 
Clear increases in ED attendances (all ages) for asthma occurred during both AQ1 and AQ2 
in Paris (Figure 6-4a) and were statistically significant (2-year and 2-week alarms). However, 
when broken down by age, the increase in asthma attendances in the 0-14 years age group 
occurred during AQ1, but not AQ2; while asthma attendances in young adults (15-44yrs) 
were greater during AQ2 than AQ1. No statistical alarms were observed for asthma in 
children around AQ2, though they were present for young adults (Figure 6-4b). 
The largest peak in asthma attendances was observed on 20/07/14, for all ages apart from 
65yrs and over (data not shown), matching the spike seen in London, despite air quality not 
being identified as poor on that day. One further peak in asthma attendances, apparent in 
all ages and individual age groups, was observed on 9-10/6/14 (Figure 6-4a & b). The 
observed peaks were not concomitant with any period of poor AQ in Paris, nor London.  
Similar to London, an increase in asthma attendances was observed in Paris at the 
beginning of September, prior to AQ3, driven predominantly by children (0-14 years).  
Difficulty breathing attendances in Paris were much lower than for asthma overall, with a 
single increase after AQ2 (Figure 6-4c). Within the 15-44yrs age group there was, however 
an increase in difficulty breathing attendances following AQ1 (Figure 6-4d). 
Attendances for MI in Paris showed no evidence of increase in Paris during/ following days 
of poor AQ (Figure 6-4e & f), though some statistical alarms were observed throughout the 
year, particularly a series of three 2-year alarms during late August and September in those 




Figure 6-4: Daily percentages of Paris ED attendances for syndromic surveillance indicators 
of a) asthma all ages, b) asthma 0-14 and 15-44years, c) Difficulty breathing all 
ages, d) Difficulty breathing 15-44 and 45-64 years, e) Myocardial Ischaemia all 








Alarm type:    2 week    2-year 
 
 
Retrospective statistical analysis 
Wilcoxon-Mann-Whitney test results provide further evidence, alongside the descriptive 
epidemiology and RAMMIE results, that there is a strong association between days of poor 
AQ and asthma attendances all ages and particularly in children 0-14 years (Table 6-4). 
Furthermore, the statistical significances of the associations between asthma attendances 
and poor AQ were highest when modelled with a lag between the day of poor AQ and 
attendances; two days for London and three days for Paris. Though there was some 
evidence of increased attendances for difficulty breathing and MI in some age groups in 
London one day after poor AQ, these alarms were single significant values (rather than the 
grouping of significant asthma results by age group; Figure 6-3d & f). These increased MI 
and difficulty breathing attendances in the day following poor AQ were not seen in the 




Table 6-4: Results of the Wilcoxon-Mann-Whitney test illustrating the standardised value (z value) and significance (P value) of syndromic indicators to days 




all ages 0-14yrs 15-44yrs 46-64yrs 65yrs+ 
z value p value z value p value z value p value z value p value z value p value 
Asthma 
London 
0 -0.227 0.8204 -2.857 0.0043 1.287 0.1982 1.077 0.2813 -1.009 0.3128 
1 -1.443 0.1490 -3.213 0.0013 0.556 0.5784 -0.791 0.4291 -1.026 0.3048 
2 -1.713 0.0867 -3.838 0.0001 0.787 0.4310 -0.558 0.5768 -1.438 0.1503 
3 -1.627 0.1038 -2.574 0.0100 -0.141 0.8876 -0.442 0.6586 0.816 0.4145 
Paris 
0 -0.963 0.3356 -1.566 0.1173 0.529 0.5971 -0.624 0.5326 0.000 1.0000 
1 -2.035 0.0419 -2.576 0.0100 -0.330 0.7418 -1.582 0.1137 -0.354 0.7237 
2 -2.706 0.0068 -3.090 0.0020 -0.943 0.3454 -2.558 0.0105 -0.194 0.8464 




0 -0.055 0.9563 -0.963 0.3357 1.311 0.1898 -0.361 0.7181 -0.140 0.8889 
1 -1.261 0.2073 -2.975 0.0029 1.797 0.0723 0.445 0.6564 -0.728 0.4666 
2 -0.444 0.6573 -1.385 0.1659 0.223 0.8236 1.452 0.1464 -0.580 0.5620 
3 -1.552 0.1207 -1.236 0.2166 -0.695 0.4872 -0.01 0.9916 -0.296 0.7670 
Paris 
0 -0.604 0.5459 0.031 0.9749 -0.585 0.5582 -0.736 0.4615 -0.147 0.8830 
1 -0.057 0.9547 -1.032 0.3021 -0.490 0.6242 0.603 0.5466 -0.078 0.9376 
2 -1.364 0.1725 -1.095 0.2735 -0.674 0.5004 -0.565 0.5722 -1.521 0.1283 







all ages 0-14yrs 15-44yrs 46-64yrs 65yrs+ 
z value p value z value p value z value p value z value p value z value p value 
MI 
London 
0 -0.605 0.5452 - - -0.084 0.9327 -1.275 0.2022 0.027 0.9787 
1 -0.588 0.5565 - - 0.329 0.7421 -1.994 0.0461 0.374 0.7084 
2 -0.081 0.9354 - - -0.084 0.9327 -0.61 0.5419 0.053 0.9574 
3 -0.571 0.5680 - - 0.544 0.5862 -1.415 0.1571 -0.695 0.4873 
Paris 
0 -0.364 0.7158 0.546 0.5850 -1.257 0.2089 -0.089 0.9293 0.367 0.7138 
1 0.243 0.8082 0.546 0.5850 -1.257 0.2089 -0.022 0.9828 1.594 0.1110 
2 -0.331 0.7408 0.546 0.5850 -0.522 0.6016 -0.235 0.8141 0.635 0.5253 
3 -0.676 0.4992 0.546 0.5850 -0.578 0.5630 0.384 0.7011 -0.403 0.6872 
Figures in bold are significant to the 90% significance level; those bold and underlined to the 95% significance level. 
 
 
6.5 Discussion  
Main findings 
We used two national ED syndromic surveillance systems to describe and compare the 
short-term changes in ED indicators during periods of poor AQ in two European capital 
cities. The AQ events reported here in Paris and London were related to the same 
pollutants (PM2.5/ PM10), and were very similar in terms of the dates and duration, and 
changes in public health outcomes in terms of ED attendances. 
The most sensitive ED indicator during periods of poor AQ was asthma, with the impact 
most apparent up to 3 days after a day of poor AQ. The breakdown of attendances by age 
group revealed some differences, with the strongest associations overall seen between 
poor AQ and asthma attendances in children. This finding was consistent with previous 
studies which have shown children to be more susceptible to exacerbation of asthma 
symptoms requiring health care in association with air pollution.32 
The investigation of individual AQ incidents demonstrated the potential for differing levels 
of impact on different age groups at different times. Though generally children were most 
affected by AQ, a large increase in adult asthma attendances was observed during and 
immediately following AQ2 in both London and Paris. Within England this increase in 
attendances around AQ2 has previously been described.33 As the second period of poor AQ 
to occur in a short period of time, media coverage and the associated communication of 
health warning information and interventions put in place during AQ2 may have resulted in 
changes in behaviour which affected the levels of exposure of different age groups. 
In addition to the increases observed during AQ periods, a sharp increase in asthma 
attendances (all ages) was observed in Paris on 9-10/06/14, and in both London and Paris 
on 20/07/14. These peaks did not coincide with any AQ event identified here, however, 
additional meteorological data (not presented) revealed periods of major thunderstorm 
activity within each city at the time.34-36 These findings match those previously reported, 
including from the EDSSS, describing the health effects of ‘thunderstorm asthma’, where 
sudden exacerbation of asthma symptoms results in increased health care seeking 
behaviour over a short time period,13,37-40 possibly due to increased levels of pollen and 
fungal spores, though the mechanism has not yet been confirmed.37 
We also observed further increases in asthma attendances in both Paris and London 
towards the start of September. This increase was particularly evident in children and is 
 
 
likely linked to an annual ‘back to school’ increase in asthma type attendances in EDs during 
September.41-43 
Other syndromic indicators investigated showed little (difficulty breathing), to no (MI) 
association with the AQ incidents identified here.  
Strengths and limitations 
The OSCOUR® system includes greater representative coverage nationally, with more EDs 
participating than the sentinel EDSSS system (540 EDs across France were reporting to 
OSCOUR®.44 While 34 EDs across England and Northern Ireland were reporting to EDSSS at 
20 March 2014, the five reported here were located in London making the EDSSS more 
representative in London than at the national level45). The large number of OSCOUR® EDs 
reported here resulted in much more stable data from Paris, reducing background noise 
and allowing clearer differentiation of spikes/increases in attendances. The smaller number 
of attendances within the EDSSS data made identifying spikes ‘harder’, however the use of 
RAMMIE enables significant increases in attendances to be identified, even when not 
initially obvious.29 
Despite underlying differences in the method of data collection, with EDSSS taking a single 
snapshot of daily attendances and OSCOUR® allowing the initial snapshot data to be 
updated retrospectively, both systems reported over 70% completion of the clinical 
diagnosis field making diagnostic data comparable. Furthermore, though these systems 
were developed individually, it was found that the syndromic indicators used within each 
system were similar, making comparisons of health impact possible. However, the EDSSS 
used a wheeze/difficulty breathing indicator whereas OSCOUR® used a difficulty 
breathing/respiratory failure indicator. This difference is, in part, likely to be related to the 
use of different clinical coding systems, with the identification of symptoms (e.g. wheeze) 
more difficult using ICD-10 (as used in France) than Snomed CT (used by some EDs in 
England). 
The percentage of ED visits (with a diagnosis code), as an indication of ED attendances, as 
reported here (rather than actual numbers) may be impacted by the overall levels of ED 
attendances (and levels of diagnostic coding) on any one day. Though travel and outdoor 
activities are discouraged during AQ events, there are other factors which have a much 
greater impact on ED attendances (such as national and school holiday periods). The 
patterns and total numbers of attendances during 2014, including AQ periods, were not 
different from those seen in other years. The normal levels of overall ED attendances 
observed during periods of poor AQ, though travel was discouraged, contrasts with the 
 
 
reduced overall ED attendances in the English EDSSS seen during extreme cold weather 
when transportation is not physically possible for most people.11 By using percentage of 
attendances the impact of events, such as periods of poor AQ, can be clearly seen in terms 
of changes in ED workload, such as changes in case mix and/ or age groups attending. 
The levels of attendances for each indicator were different between cities, with respiratory 
indicators higher in Paris (asthma 1.5%, difficulty breathing 0.7%), than London (asthma 
0.9%, difficulty breathing 0.4%) and MI attendances higher in London (0.6%) than in Paris 
(0.2%). This disparity in attendance levels between countries may be due to differences in 
diagnosis coding practices, clinical procedures used for treating patients (e.g. immediate 
transfer to cardiac care rather than ED for MI patients) or even areas of specialty for each 
ED (e.g. some London EDs are part of specialist heart care hospitals so may see more MI 
patients). However, the trends observed within weeks were very similar in both systems, 
implying they are broadly comparable (Figure 6-2).  
A limitation of the statistical methods used here is that the occurrence of previous events 
(e.g. poor AQ or weather systems) influencing the indicators were not identified or 
removed from the 2 years of historical data used as RAMMIE training data. The potential 
inclusion of unrecognised events may impact on the RAMMIE model thresholds, though 2 
years is considered sufficient for meaningful results (personal communication with R. 
Morbey).  
This study focussed solely on particulate matter, though other pollutants impact on human 
health. The application of the DAQI levels to both London and Paris mean daily data 
allowed for an international comparison, based on days with higher than usual PM2.5 and/ 
or PM10 specific to each city. The use of the highest daily PM2.5/ PM10 values was 
considered, but these values were found to be at the high/ very high on the DAQI scale on 
the majority of days of 2014. 
The impact of health warnings and media reporting associated with actual and predicted 
periods of poor AQ could not be controlled for here. The intention of health warnings, 
which are reported in the media, is to reduce the impact on human health, encouraging the 
public to reduce exposure as recommended.9, 46 There were increases in asthma 
attendances in children during and following AQ1 in Paris in particular, though these 
younger age groups appeared unaffected during later events, whereas young adults were 
more greatly affected by AQ2. These differences of impact by age group in AQ2 may have 
been due to changes in behaviour of younger age groups so soon after AQ1 and subsequent 
reduced exposure to poor AQ, rather than a biological response observed in adults only. In 
 
 
addition to the impact of media reporting, France has introduced several other measures 
when air quality limit values are exceeded in major cities; speed limits, alternate driving 
days (to limit the number of cars on the road) and free public transportation. The 
implementation of these measures could have had an impact on the results presented 
here. 
It is important here to underline that variations of near real-time indicators are not easy to 
attribute directly to poor AQ. An absence of short term variation (e.g. MI in this study) 
cannot not be interpreted as a total lack of any longer term impact. Similarly, the 
identification of a significant increase in syndromic indicators reported here (e.g. asthma) 
has not formally accounted for other associated factors such as climatic conditions (e.g. 
weather and allergens) or viral circulation. Further time series analysis should be completed 
to control potential confounding factors. 
Future work 
This work has prompted the systematic investigation of asthma attendances by age group 
around AQ events in England and Northern Ireland, using the EDSSS. In France (following 
the March 2014 periods of poor AQ reported here), the health authorities requested and 
are now provided with, systematic surveillance of OSCOUR® ED attendances for asthma by 
age group during poor quality events. This work shows the potential of real-time syndromic 
surveillance to enhance the public health response to air pollution incidents, even if real-
time changes observed through syndromic surveillance data cannot be absolutely related to 
air pollution. As the evidence base for the utility of syndromic surveillance during air 
pollution events increases, it is hoped that it will, in combination with environmental data, 
be used by authorities to provide public health messaging during future events: messages 
to the public to advise about risks and preventative measures, and to EDs and other health 
service providers about increases in patient numbers and changes to the case mix of 
patients attending.  
The increases in attendance levels for specified indicators, particularly asthma in children, 
provides an insight into not only the age groups affected, but also how the workload and 
case mix within EDs can rapidly change. Contemporaneous feedback may be given on the 
utility of health warnings issued which may aid in the targeting of advice to particular age 
groups and also the preparations made in EDs in terms of staffing and materials required.  
Where increased ED attendances were observed during periods of no known changes in 
AQ, there is potential for further investigation of the potential causes. The identification of 
 
 
periods of thunderstorm activity on the days of the highest asthma attendances reported 
here should be investigated further.  
This study is the first example of the RAMMIE method being applied to a syndromic 
surveillance system outside the UK, identifying and highlighting increases in ED attendances 
during periods of known poor AQ. This work has illustrated the potential for RAMMIE to be 
applied to countries developing new syndromic surveillance systems, or without the 
infrastructure to support bespoke statistical developments. However, the limitations of this 
method must always be considered, where increased levels resulting in statistical alarms 
(either 2-week or 2-year) must be viewed alongside local intelligence and knowledge, not 
every alarm will be due to poor AQ, but the indicators can be used for monitoring the 
impact of AQ events on public health. 
This work also promotes further collaboration between different countries to explore 
methods to harmonize syndromic surveillance systems. Other public health surveillance 
initiatives have been adopted across Europe to provide a means of reporting singularly 
comparable variables and statistics across several countries, including: the European 
monitoring of excess mortality for public health action (EuroMOMO);47 the European 
Influenza Surveillance Scheme (EISS);48 establishment of epidemic thresholds for influenza 
surveillance;49 the European Antimicrobial Resistance Surveillance Network (EARS-net);50 
harmonised norovirus surveillance systems also exist.51, 52 Within this study, although ED 
indicators were not entirely harmonized, they had been developed to be the most 
appropriate for each system and country. This work has also stimulated opportunities to 
explore other areas of public health that could be enhanced using a multinational 
syndromic surveillance system in particular those due to non-infectious causes such as 
injury surveillance and these will be addressed in future work.  
The apparent difference in the noise to signal ratio between OSCOUR® and EDSSS i.e. 
background variation was likely due to the size of each respective network. Peaks of 
abnormal activity were easier to identify in OSCOUR® and therefore future work within PHE 
is currently focusing on expanding the EDSSS to improve its geographical 
representativeness and increase the attendance numbers thereby reducing the noise to 
signal ratio.  
The potential for the harmonisation of syndromic surveillance across national borders is 





We acknowledge the contribution and support from the ED clinicians and Trust staff; the 
on-going support of the Royal College of Emergency Medicine; the technical support 
provided by EMIS Health and L2S2 Ltd in developing the EDSSS system in England and 
Northern Ireland. We also acknowledge the contribution from the ED structures and 
clinicians involved in the OSCOUR® network in France; the on-going support of the 
Federation of the Regional Observatories of Emergencies; the Scientific Society of 
Emergency Medicine; the air and climate team of Santé publique France and the Regional 
Unit of Santé publique France in Paris-Ile-de-France region.  
We acknowledge and thank Sylvia Medina (Santé Publique France) for their professional 
input and critical revision of this manuscript. 
HEH receives support from the National Institute for Health Research Health Protection 
Research Unit (NIHR HPRU) in Gastrointestinal Infections. AJE and GES receive support from 
the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in 
Emergency Preparedness and Response. The views expressed are those of the author(s) 




Ethical approval for this work was not required. The anonymised EDSSS health data used in 
this study were routinely collected at part of the public health function of PHE. The 
collection and analysis of data provided by the OSCOUR network in the frame of public 
health surveillance and epidemiological studies has been authorized by the French National 
Commission for Data protection and Liberties (CNIL). 
Funding 
This research received no specific grant from any funding agency, commercial or not-for-
profit sectors. This surveillance is undertaken as part of the national surveillance functions 
of Public Health England and Santé Publique France. 





HEH contributed to the study design, prepared the ED data for England, completed the 
statistical analyses, drafted the manuscript and provided critical revision and final approval 
of the manuscript. 
RM contributed to the study design, completed the statistical analyses, drafted the 
manuscript and provided critical revision and final approval of the manuscript. 
AF contributed to the study design, prepared the ED data for France and provided critical 
revision and final approval of the manuscript. 
CCS contributed to the study design, critical revision and final approval of the manuscript. 
AD contributed to the study design, prepared the air quality data and provided critical 
revision and final approval of the manuscript. 
TCH contributed to the study design, critical revision and final approval of the manuscript. 
GES contributed to the study design, critical revision and final approval of the manuscript. 
AJE contributed to the study design, critical revision and final approval of the manuscript. 
Data sharing statement 




6.8 References  
1. World Health Organisation. Air Quality Guidelines Global Update 2005. Particulate 
matter, ozone, nitrogen dioxide and sulfur dioxide: WHO2006. 
2. Public Health England. Public Health Outcomes Framework: 3.01 - Fraction of mortality 
attributable to particulate air pollution. 2017. [Available from: 
http://www.phoutcomes.info/public-health-outcomes-
framework#page/6/gid/1000043/pat/15/par/E92000001/ati/6/are/E12000007/iid/30101
/age/230/sex/4. Accessed 30 Mar 2017]. 
3. Pascal M, de Crouy Chanel P, Wagner V, Corso M, Tillier C, Bentayeb M, et al. The 
mortality impacts of fine particles in France. Sci Total Environ. 2016;571:416-25. 
4. DIRECTIVE 2008/50/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 21 
May 2008 on ambient air quality and cleaner air for Europe, 2008/50/EC (2008). 
5. Air quality guidelines. Global update 2005. Particulate matter, ozone, nitrogen dioxide 
and sulfur dioxide, (2006). 
6. World Air Quality Index project. Air Pollution in the World: Real time Air Quality map. 
2016. [Available from: http://waqi.info/. Accessed 01 Mar 2016]. 
7. CITEAIR. Air Quality in Europe. Compare the current air quality in different European 
Cities. 2007. [Available from: http://www.airqualitynow.eu/. Accessed 01 Mar 2016. 
8. Department for Environment Food & Rural Affairs. UK-AIR: Information Resource. 2016. 
[Available from: http://uk-air.defra.gov.uk/. Accessed 18 March 2016]. 
9. Department for Environment Food & Rural Affairs. Daily Air Quality Index. 2013. 
[Available from: http://uk-air.defra.gov.uk/air-pollution/daqi. Accessed 18 Mar 2016]. 
10. Triple S Project. Assessment of syndromic surveillance in Europe. Lancet. 
2011;378:1833-4. 
11. Hughes HE, Morbey R, Hughes TC, Locker TE, Shannon T, Carmichael C, et al. Using an 
Emergency Department Syndromic Surveillance System to investigate the impact of 
extreme cold weather events. Public Health. 2014;128:628-35. 
12. Josseran L, Caillere N, Brun-Ney D, Rottner J, Filleul L, Brucker G, et al. Syndromic 
surveillance and heat wave morbidity: a pilot study based on emergency departments in 
France. BMC Med Inform Decis Mak. 2009;9:DOI: 10.1186/472-6947-9-14. 
13. Elliot AJ, Hughes HE, Hughes TC, Locker TE, Brown R, Sarran C, et al. The impact of 
thunderstorm asthma on emergency department attendances across London during July 
2013. Emerg Med J. 2013. Doi: 10.1136/emermed-2013-203122 
14. Smith GE, Bawa Z, Macklin Y, Morbey R, Dobney A, Vardoulakis S, et al. Using real-time 
syndromic surveillance systems to help explore the acute impact of the air pollution 
incident of March/April 2014 in England. Environ Res. 2015;136:500-4. 
15. Johnson J, Ginsberg M. Monitoring health effects of wildfires using the biosense system. 
MMWR Wkly. 2008;57. 
16. Rappold AG, Stone SL, Cascio WE, Neas LM, Kilaru VJ, Carraway MS, et al. Peat bog 
wildfire smoke exposure in rural North Carolina is associated with cardiopulmonary 
emergency department visits assessed through syndromic surveillance. Environ Health 
Perspect. 2011;119:1415-20. 
17. Le Monde. Pollution : plus de 30 départements en alerte, transports gratuits en Ile-de-




en-alerte-transports-gratuits-en-ile-de-france_4382974_3244.html. Accessed 26 May 16]. 
18. RT news. London to be ‘smogged’ by polluted Paris. 2014. [Available from: 
https://www.rt.com/uk/154368-london-smog-pollution-paris/. Accessed 26 May 16]. 
19. BBC. UK air pollution: How bad is it? 2014. [Available from: 
http://www.bbc.co.uk/news/uk-26851399. Accessed 26 May 2016]. 
20. Airparif. Airparif: Air quality monitoring network. 2016. [Available from: 
http://www.airparif.asso.fr/en/. Accessed 18 Mar 2016]. 
21. Affairs DfEFR. Data Selector. [Available from: https://uk-
air.defra.gov.uk/data/data_selector. Accessed 19 Jul 2016]. 
22. Airparif. Téléchargements: Results pollutant. [Available from: 
http://www.airparif.asso.fr/telechargement/telechargement-polluant. Accessed 06 Jun 
2016]. 
23. Elliot AJ, Hughes HE, Hughes TC, Locker TE, Shannon T, Heyworth J, et al. Establishing an 
emergency department syndromic surveillance system to support the London 2012 
Olympic and Paralympic Games. Emerg Med J. 2012;29:954-60. 
24. NHS digital. Accident and Emergency Diagnosis Tables. 2013. [Available from: 
http://www.datadictionary.nhs.uk/web_site_content/supporting_information/clinical_co
ding/accident_and_emergency_diagnosis_tables.asp?shownav=1. Accessed 1 Nov 2013]. 
25. World Health Organisation. International Classification of Disease (ICD). 2010. [Available 
from: http://www.who.int/classifications/icd/en/. Accessed 23 Jan 2020]. 
26. International Health Terminology Standards Development Organisation. SNOMED CT. 
2012. [Available from: http://www.ihtsdo.org/snomed-ct/. 
27. Caserio-Schonemann C, Bousquet V, Fouillet A, Henry V. Le système de surveillance 
syndromique SurSaUD®. Bulletin Epidémiologique Hebdomadaire. 2014:38-44. 
28. Fouillet A, Bousquet V, Pontais I, Gallay A, Schönemann CC. The French Emergency 
Department OSCOUR Network: Evaluation After a 10-year Existence. Online Journal of 
Public Health Informatics. 2015;7:e74. 
29. Morbey RA, Elliot AJ, Charlett A, Verlander NQ, Andrews N, Smith GE. The application of 
a novel 'rising activity, multi-level mixed effects, indicator emphasis' (RAMMIE) method 
for syndromic surveillance in England. Bioinformatics. 2015;31:3660-5. 
30. Stata version 13.1. College Station, TX 77845 USA: Stata Corporation; 2013. 
31. Santé publique France. Réseau OSCOUR® - Organisation de la surveillance coordonnée 
des urgences. 2015. [Available from: http://invs.santepubliquefrance.fr/Espace-
professionnels/Surveillance-syndromique-SurSaUD-R/Reseau-OSCOUR-R]. 
32. Alhanti BA, Chang HH, Winquist A, Mulholland JA, Darrow LA, Sarnat SE. Ambient air 
pollution and emergency department visits for asthma: a multi-city assessment of effect 
modification by age. J Expos Sci Environ Epidemiol. 2016;26:180-8. 
33. Elliot AJ, Smith S, Dobney A, Thornes J, Smith GE, Vardoulakis S. Monitoring the effect of 
air pollution episodes on health care consultations and ambulance call-outs in England 
during March/April 2014: A retrospective observational analysis. Environmental Pollution. 
2016;214:903-11. 
34. EUMETSAT. Severe thunderstorms over parts of France. 2014. [Available from: 
http://www.eumetsat.int/website/home/Images/ImageLibrary/DAT_2238698.html. 
Accessed 25 May 2016]. 
 
 
35. RFI. Storms to return to France after night of hail, rain, thunder, lightning. 2014. 
[Available from: http://en.rfi.fr/visiting-france/20140609-storms-return-france-after-
night-hail-rain-lightning-damage. Accessed 25 May 2016]. 
36. MetOffice. UK Climate, Climate Summaries, July 2014. 2015. [Available from: 
http://www.metoffice.gov.uk/climate/uk/summaries/2014/july. Accessed 27 May 16 
2016]. 
37. Dabrera G, Murray V, Emberlin J, Ayres JG, Collier C, Clewlow Y, et al. Thunderstorm 
asthma: an overview of the evidence base and implications for public health advice. QJM. 
2013;106:207-17. 
38. Wallis DN, Webb J, Brooke D, Brookes B, Brown R, Findlay A, et al. A major outbreak of 
asthma associated with a thunderstorm: experience of accident and emergency 
departments and patients' characteristics. BMJ. 1996;312:601-4. 
39. Hajat S, Goubet SA, Haines A. Thunderstorm-associated asthma: the effect on GP 
consultations. Br J Gen Pract. 1997;47:639-41. 
40. BBC. 'Thunderstorm asthma' deaths in Melbourne rise to eight. 2016. [Available from: 
http://www.bbc.co.uk/news/world-australia-38121579. Accessed 23 Jan 2017]. 
41. Julious SA, Osman LM, Jiwa M. Increases in asthma hospital admissions associated with 
the end of the summer vacation for school-age children with asthma in two cities from 
England and Scotland. Public Health. 2007;121:482-4. 
42. Fleming DM, Cross KW, Sunderland R, Ross AM. Comparison of the seasonal patterns of 
asthma identified in general practitioner episodes, hospital admissions, and deaths. 
Thorax. 2000;55:662-5. 
43. Lincoln D, Morgan G, Sheppeard V, Jalaludin B, Corbett S, Beard J. Childhood asthma and 
return to school in Sydney, Australia. Public Health. 2006;120:854-62. 
44. Institut de Veille Sanitaire. Surveillance syndromique SurSaUD®: Bulletin du réseau 
OSCOUR®: Institut de Veille Sanitaire2014 1 October 2014 Contract No.: 496. 
45. Health Protection Agency. Emergency Department Syndromic Surveillance System 
Bulletin: Health Protection Agency, Team R-tSS;2014 23 March 2014. 
46. McLaren J, Williams ID. The impact of communicating information about air pollution 
events on public health. Sci Total Environ. 2015;538:478-91. 
47. EuroMOMO. European monitoring of excess mortality for public health action. 2017. 
[Available from: http://www.euromomo.eu/index.html. Accessed 30 Mar 2017]. 
48. Paget J, Marquet R, Meijer A, van der Velden K. Influenza activity in Europe during eight 
seasons (1999–2007): an evaluation of the indicators used to measure activity and an 
assessment of the timing, length and course of peak activity (spread) across Europe. BMC 
Infect Dis. 2007;7:1-7. 
49. Vega T, Lozano JE, Meerhoff T, Snacken R, Mott J, Ortiz de Lejarazu R, et al. Influenza 
surveillance in Europe: establishing epidemic thresholds by the Moving Epidemic Method. 
Influenza Other Respir Viruses. 2013;7:546-58. 
50. European Centre for Disease Prevention and Control. European Antimicrobial Resistance 
Surveillance Network (EARS-Net). [Available from: 
http://ecdc.europa.eu/en/activities/surveillance/EARS-
Net/Pages/index.aspx#sthash.5U9aDN1w.dpuf. 




51. Vega E, Barclay L, Gregoricus N, Williams K, Lee D, Vinjé J. Novel Surveillance Network 
for Norovirus Gastroenteritis Outbreaks, United States. Emerg Infect Dis. 2011;17:1389-
95. 
52. National Institute for Public Health and the Environment R. NoroNet. [Available from: 
http://www.rivm.nl/en/Topics/N/NoroNet. Accessed 8 Jun 2016]. 
6.9 Co-author declaration 
I confirm the specific contribution of Helen Hughes to this publication is as described in 




Roger A. Morbey Date 
 
13/02/2020 
Anne Fouillet Date 
 
30/11/2020 
Céline Caserio-Schönemann Date 
 
12/02/2020 
Alec Dobney Date 
 
30/11/2020 
Thomas C. Hughes Date 
 
02/03/2020 
Gillian E. Smith Date 
 
12/02/2020 






 The influence of a major sporting event 
upon emergency department attendances; 
a retrospective cross-national European 
study 
Helen E. Hughes 
Felipe J. Colón-González 
Anne Fouillet 
Alex J. Elliot 
Céline Caserio-Schonemann 
Thomas C. Hughes 
Naomh Gallagher 
Roger A. Morbey 
Gillian E. Smith 
Daniel Rh. Thomas 
Iain R. Lake 
PLoS One. 2018; 13(6): e0198665. Crown Copyright. 
DOI: 10.1371/journal.pone.0198665 
Attendances at emergency departments can be caused by and impacted upon by human 
behaviour. During each 24 hours the lowest numbers of attendances are through the night, 
when the majority of the population is sleeping. During holiday periods the numbers of 
attendances can decrease overall, or may even increase for particular types of conditions, 
particularly when celebrations do not go to plan.  
Sporting events have been reported previously to be associated with fluctuations in ED 
attendances. Wins are celebrated and losses commiserated, often on a large scale. These 
impacts can occur either in the vicinity of the actual event, or remotely with fans following 
progress from home or in social gatherings. Here we discuss the impact of a large sporting 
event (2016 UEFA European Football Championship: Euro 2016) in not only France, the host 
country, but also in England, Northern Ireland and Wales, countries where large numbers of 
the population followed the progress of national teams through the tournament.  
 
 
7.1 Abstract  
Major sporting events may influence attendance levels at hospital emergency departments 
(ED). Previous research has focussed on the impact of single games, or wins/losses for 
specific teams/countries, limiting wider generalisations. Here we explore the impact of the 
Euro 2016 football championships on ED attendances across four participating nations 
(England, France, Northern Ireland, Wales), using a single methodology. Match days were 
found to have no significant impact upon daily ED attendances levels. Focussing upon 
hourly attendances, ED attendances across all countries in the four hour pre-match period 
were statistically significantly lower than would be expected (OR=0.97, 95% CI 0.94-0.99) 
and further reduced during matches (OR=0.94, 95% CI 0.91-0.97). In the 4 hour post-match 
period there was no significant increase in attendances (OR=1.01, 95% CI 0.99-1.04). 
However, these impacts were highly variable between individual matches: for example in 
the 4 hour period following the final, involving France, the number of ED attendances in 
France increased significantly (OR=1.27, 95% CI 1.13-1.42). Overall our results indicate 
relatively small impacts of major sporting events upon ED attendances. The heterogeneity 
observed makes it difficult for health providers to predict how major sporting events may 
affect ED attendances but supports the future development of compatible systems in 
different countries to support cross-border public health surveillance.  
7.2 Introduction 
Major sporting events have the potential to influence the behaviour of the general public; 
wins are celebrated and losses commiserated, both locally at the event and for those 
following remotely (e.g. television). This public response to sporting events may have an 
effect on the numbers and types of attendances seen in emergency departments (EDs). The 
organisation of ED staffing and equipment (e.g. inpatient bed availability) in preparation for 
these events rely on planning assumptions, though few studies have examined the impact 
of major sporting events on ED attendances in detail.  
Where daily ED attendances have been investigated in relation to sports events (both live 
and televised) there have been contrasting results; from no impact observed,1,2 to 
increased assault related attendances either overall,3 or in the event of a home team win.4 
Previous investigation of daily ED attendances may have missed important hour-by-hour 
impacts, especially where events are of a short duration. Where potential intra-day impacts 
have been described there have been reported decreases directly before and during 
 
 
sporting events for ED attendances5,6 and ambulance callouts,7 as well as increases 
immediately following some events.6,8 The impact of sporting events on EDs has further 
been reported to differ by age, gender and reason for attendance, including; age and 
gender associations with violence related daily ED attendances;3,4 increased daily 
cardiovascular9 and hourly alcohol-related8 attendances and decreased daily and hourly 
paediatric attendances.10  
These earlier studies, from a range of geographical settings, employed a variety of 
analytical techniques and investigated a mixture of outcome variables. Here we present, to 
our knowledge, the most comprehensive study to date examining the impacts of a major 
sporting event on ED attendances. Focussing on one major tournament, the 2016 UEFA 
European Football Championship (Euro 2016), we use a consistent methodology across four 
nations involved in the tournament (England, France, Northern Ireland [NI] and Wales). 
Syndromic surveillance data were used (where available) as a source of ED attendance data 
from multiple, geographically distinct EDs, collected using standardised methodology. 
Differential impacts were explored by country, time of day, age, gender and type of 
diagnosis. Alcohol-related and myocardial ischaemia (MI) attendances, increases in which 
have been linked to sporting events previously,8,9 were readily identifiable as syndromic 
indicators (groupings of diagnoses codes).  
7.3 Methods 
Data sources 
In England and NI the ED Syndromic Surveillance System (EDSSS) is a voluntary network of 
sentinel EDs covering around 10% of all emergency care attendances in England and over 
30% of attendances at type 1 (major) EDs in NI during Euro 2016.11 The OSCOUR® network 
in France, initially created as a voluntary network of EDs, became a mandatory national ED 
syndromic surveillance network during 2014. During Euro 2016 86% of all EDs in France and 
its overseas territories reported to OSCOUR®.12 EDs which reported to EDSSS or OSCOUR® 
throughout the Euro 2016 period and the previous 2 years were eligible for inclusion in this 
study. Attendance data for all EDs in Wales were obtained using a bespoke query of the ED 
dataset held by the National Health Service Wales Informatics Service.13 
Overall attendance data (for any condition) were obtained for 1 June - 14 July 2016, 
encompassing the entire period of the tournament, as well as for corresponding periods in 
2014 and 2015 (matched by day of the week: 3 June - 16 July 2015 and 4 June - 17 July 
 
 
2014), subdivided by gender and age (0-4, 5-14, 15-44, 45-64, 65+ years). The data from all 
EDs, were sub-divided by hour of arrival.  
Using the syndromic surveillance indicators available in EDSSS (restricted to EDs recording 
ICD-1014/ SNOMED CT15 diagnosis codes) and OSCOUR® (all EDs report ICD-10 diagnosis 
codes), daily data on ED attendances with a diagnosis of MI or related to alcohol (EDSSS – 
acute alcohol intoxication; OSCOUR® – any alcohol related diagnosis) were obtained for 
each country, 1 June 2014 – 31 July 2016, plus corresponding periods in 2014 and 2015 
(matched by day of the week). It is important to note that different codes were used in 
different countries (and indeed in different EDs), however this is most likely due to the 
diagnoses available for selection in the patient record, rather than a true difference 
between presentations. The codes available in each ED would have been likely to identify 
similar diagnoses (Appendix D). Wales was excluded from the syndromic indicator analysis 
as attendances could not be grouped by diagnosis code. 
Statistical analyses 
ED attendances are influenced by hour of day, day of the week, holiday periods and time of 
year,16 requiring statistical analysis to differentiate between changes in attendance levels 
related to Euro 2016 and other effects. 
Expected hourly numbers of attendances were estimated using negative binomial models, 
to account for possible over-dispersion in the syndromic surveillance data. The impact of 
matches was modelled with the inclusion of three Boolean variables (1/0) representing the 
‘pre-match’ (4 hours before), ‘during match’ (2 hours: 3 hours for the final), and ‘post-
match’ (4 hours after) periods. The pre-match and post-match periods were chosen based 
upon previous research.7,8,17 
Models were developed to investigate their effects on the expected hourly number of 
attendances, for all data pooled and for each nation individually and:  
• subdivided by weekend/ weekday;  
• subdivided by each individual game separately;  
• stratified by gender and age.  
Models were specified as: 
𝑔(𝜇𝑡) = 𝛼 +∑𝛽𝑥𝑡
𝑄
𝑞=1
+𝐻𝑜𝐷 + 𝐷𝑜𝑊 +𝑀𝑜𝑌 + 𝑌 + 𝛾(𝐵𝐻𝑜𝑙) 
Where: g(µt) is a logarithmic link function of the expectation E(Yt ≡ µt) (expected number of 
cases at time t); α denotes the intercept; xt are Boolean variables indicating ‘pre-match’, 
 
 
‘match’ and ‘post-match’ periods. The variables xt enter the model linearly with related 
coefficients β. Potential effects of long-term and seasonal trends were controlled by 
categorical variables for hour of the day (HoD), day of the week (DoW), month of the year 
(MoY), and year (Y). Bank holidays (BHol) were accounted for with a Boolean variable (1/0) 
with coefficient γ. 
The analysis of daily attendances for MI and alcohol-related attendances utilized a negative 
binomial model with the same specification. The impact of matches was modelled using 
Boolean variables (1/0) to represent ‘day before’, ‘match day’ and ‘day after’. All analyses 
were carried out using the MASS package in R software.18 
7.4 Results 
Euro 2016 was held in France from 10 June to 10 July 2016.19 Of the 51 matches played, 19 
involved the England (n=4), France (n=7), NI (n=4) and Wales (n=6) national teams (Wales 
played matches against both England and NI).  
During the study period over 2 million ED attendances were identified for the analysis of 
total attendances by day/hour, with the largest number of attendances from France, 
followed by England and Wales and much lower numbers from NI (Table 7-1). Attendance 
levels were similar between males and females (approx. 50/50) and age distributions were 
similar in each country, although NI included a lower percentage of paediatric attendance 
levels.  
Analysis by syndromic indicator was restricted to those EDs where detailed diagnostic 
coding was available, including all EDs reporting to syndromic surveillance in France and NI, 
a limited number of EDs in England (~6% of all ED attendances) and no data available from 
Wales (Table 7-2). France had the highest completion of diagnostic coding (91% of 
attendances coded). MI attendances compromised 1% of attendances in England and NI 
and 0.4% in France, with alcohol attendances (all alcohol-related attendances in France and 
acute alcohol intoxication in England and NI) accounting for 0.6%, 0.8% and 1.2% of 




Table 7-1: Emergency department attendances for all causes, 1 June - 14 July 2016, by 
nation, age and gender 
  
England         
(9.8%  coverage) 
France           
(86% coverage) 
Northern Ireland 
(31.8%  coverage*) 
Wales         
(100%  coverage) 
Total  286,166 1,837,733     23,966 127,911 
Males 143,005 50.0% 956,300 52.0% 11,980 50.0% 64,320 50.3% 
Females 143,088 50.0% 880,989 47.9% 11,980 50.0% 63,587 49.7% 
Unknown  73 0.0% 444 0.0% 6 0.0% 4 0.0% 
Age 0-4 26,783 9.4% 205,743 11.2% 846 3.5% 9,422 7.4% 
Age 5-14 30,814 10.8% 227,616 12.4% 1,417 5.9% 16,639 13.0% 
Age 15-44 113,293 39.6% 690,259 37.6% 10,675 44.5% 47,542 37.2% 
Age 45-64 55,735 19.5% 345,233 18.8% 5,854 24.4% 25,963 20.3% 
Age 65+ 59,213 20.7% 368,882 20.1% 5,166 21.6% 28,337 22.1% 
Unknown  328 0.1% 0 0.0% 8 0.0% 8 0.0% 
*NI coverage of type 1 (major) ED attendances 
Table 7-2: Emergency department attendances by syndromic indicator, 1 June - 14 July 
2016, by nation 
  
England             
(5.8% coverage) 




Total  169,870  1,837,733  23,958  
Diagnosis 
included 
128,005 75.4% 1,672,825 91.0% 20,727 86.5% 
MI  1,328 1.0% 6,405 0.4% 180 0.9% 
Alcohol*  758 0.6% 19,718 1.2% 172 0.8% 
Mean daily attendances 
Total  3,861  41,767  545  
MI  30  146  4  
Alcohol*  17  448  4  
Estimated national mean daily attendances (calculated from coverage) 
Total  66,563  48,566  1,712  
MI  520  169  13  
Alcohol*  297   521   12   
* alcohol attendances are included as ‘acute alcohol intoxication’ in the EDSSS  
and ‘all alcohol attendances’ in OSCOUR® 
 
 
Similar temporal patterns in ED attendances were found in all countries. The lowest hourly 
attendances occurred during the night  (Figure 7-1) and the highest daily numbers were 
recorded on a Monday (Figure 7-2). For the two syndromic indicators of interest (England, 
NI and France only) the highest alcohol-related attendances were recorded during 
weekends (Figure 7-3) while MI attendances were highest during the week (Figure 7-4). 
Figure 7-1: Hourly emergency department attendances 1 June - 14 July 2016, as a 
percentage of the total, by country. 
 
Figure 7-2: Day of the week emergency department attendances 1 June - 14 July 2016, 




Figure 7-3: Alcohol related emergency department attendances 1 June - 14 July 2016, as 
a percentage of attendances with a diagnosis code, by day of the week and 
by country. 
 
Figure 7-4: Myocardial ischaemia emergency department attendances 1 June - 14 July 
2016, as a percentage of attendances with a diagnosis code, by day of the 
week and by country. 
 
Descriptive analysis of temporal trends by day showed very little difference between daily 
numbers of attendances on match days compared with non-match days, in total and for 
alcohol-related or MI attendances (data not shown). Analysis of hourly attendances did, 
however, show some indication of reduced ED attendances during, and possible increases 
immediately following matches, particularly in France. The France national team played 
four Sunday matches during the tournament. The hourly attendances at EDs in France 
through Sunday afternoon into the early hours of Monday morning showed decreased 
attendance levels during matches and increased attendance levels immediately following 
 
 
matches, particularly following the afternoon match 26 July and the evening final 11 July 
(Figure 7-5). The pattern of attendances on each Monday following a Sunday match was 
consistent with the usual pattern observed, though possibly running an hour later on 11 
July, the day after the final (Figure 7-5)  
Figure 7-5: Hourly ED attendances, France, selected Sunday/Monday 48 hour periods 
during Euro 2016; football match times involving France are highlighted. 
 
Overall odds ratios (OR) for hourly ED attendances (all countries) compared to the number 
expected indicate a statistically significant impact, although small, with pre-match and 
during-match reductions in ED attendances (Figure 7-6). Across the whole dataset (all 
nations, all matches) there was a reduction in pre-match attendances (OR 0.97, CI 0.94-
0.99), with a stronger reduction observed on weekdays than weekends (Figure 7-6). Pre-
match reductions were observed in each country individually and were statistically 
significant in France and Wales. During match periods statistically significant reductions in 
ED attendances were observed in all instances, though not statistically significant for 
Northern Ireland (Figure 7-6).  
In the post-match 4-hour time period there was no change in ED attendances across all four 
countries as a whole (OR 1.01, CI, 0.99-1.04). This obscured divergence between the 
impacts observed in individual countries, with England, France and Wales having non-
significant increases while Northern Ireland experienced reductions in ED attendances. Few 
 
 
differences were apparent between games played on weekends versus those played on 
weekdays. 
Figure 7-6:  Odds ratios of ED attendance levels compared to the same time of day with 
no match for all matches, in total, by country and by weekday/weekend (in 
total). 
 
Country specific odds ratios calculated for pre-match, during and post-match periods 
indicated consistency between age groups with increases/ decreases seen in all age groups 
together. A stronger effect was seen in school aged children (5-14yrs) and young adults (15-
44yrs), with indications of a slightly larger effect in males than females (Figure 7-7).  
Country specific ORs for individual matches showed differences between games (Figure 
7-8). Relatively large, statistically significant drops in attendances in France were identified 
prior to France games 3, 5 and 7, though increases were seen prior to the first two matches. 
ED attendances in France during all games were lower than the same times of non-match 
days. The most significant post-match impacts, in terms of magnitude, were increases in 
attendances in France following the French semi-final (G6: OR=1.25; CI 1.11-1.40) and final 




Figure 7-7:  Odds ratios of ED attendance levels compared to the same time of day with 




Figure 7-8:  Odds ratios of ED attendance levels compared to the same time of day with 




Across EDs in England, decreased attendances were observed during all matches. The 
biggest impact was around game 1, the only weekend game played by England (Figure 7-8): 
a relatively large decrease in attendances before the match (OR=0.87; CI 0.8-0.95) was 
followed by a large increase afterwards (OR=1.22; CI 1.1-1.35).  
In Wales the greatest impact on ED attendances was during the later stages of the 
tournament. The first statistically significant increase in post-match attendances in Wales 
followed match 4, the first game of the knockout stage. The largest, statistically significant, 
pre-match/ during match reductions and post-match increases were around match 5, a 
quarter-final (pre OR=0.82; CI 0.73-0.93: during OR=0.74; CI 0.63-0.87: post OR=1.23; CI 
1.05-1.45).  
No significant changes in ED attendances occurred in NI around or during matches involving 
the NI team. 
The estimated change in total numbers of attendances for each match, varied by country 
though overall decreases were observed immediately before and during matches, while 
increases were observed immediately following matches (Table 7-3).  
The mean post-match increase calculated for France (1%) was the lowest of the four 
countries reported here. However, the two largest post-match increases were also in 
France, following the semi-final (France-v-Germany) and the final (France-v-Portugal; Figure 
7-8). For these two games the nationwide increase in the four hour post-match period 
attendances were 772 (semi-final: 25% increase above baseline 3130 attendances) and 772 
(final: 27% increase above 2912 baseline attendances). Though relatively small numbers 
across the country, this large percentage increase occurred late Sunday night/ early 
Monday morning, a time when EDs are usually quiet.  




Pre-match During match Post-match 
Baseline Change (%) Baseline Change (%) Baseline Change (%) 
All 
Countries 
29,798 -1,577 *(-5) 12,041 -1,247 *(-10) 14,538 281 (2) 
England 16,480 -347 (-2) 6,913 -709 *(-10) 9,429 235 (2) 
France 12,193 -1,133 *(-9) 4,658 -495 *(-11) 4,487 39 (1) 
N Ireland 409 -25 (-6) 182 5 (3) 280 -9 (-3) 
Wales 716 -72 *(-10) 287 -47 *(-16) 343 17 (5) 
* Effect significant in the statistical model presented in Figure 7-6  
 
 
Investigation of daily alcohol related and MI attendances showed no statistically significant 
changes in attendances levels, though for both indicators the ORs calculated were 
consistently higher at weekends than weekdays (Figure 7-9). 
Figure 7-9: Odds ratios of daily ED attendances for alcohol and myocardial ischaemia 
(MI), in England, France and Northern Ireland, compared to days with no 
match: pre-match, match and post-match days, by weekday/weekend 
 
7.5 Discussion  
To our knowledge, this is the first cross-national study of the public health impact of a 
major sporting tournament upon ED attendances. This provides a unique insight into the 
impact on both the host nation, and countries with fans following the tournament from 
home. The use of standard public health data and a single methodology across multiple 
countries contrasts with previous studies which used a variety of different public health 
data and varying methods. This study focussed on ED attendances only, though there is no 
reason to believe other measures (e.g. ambulance attendances, hospital admissions) would 
not have shown similar results. 
No significant changes in ED daily attendance levels were observed in any country, similar 
to the reports for England (host nation) during Euro 96.2 No impact was found here on 
alcohol-related or myocardial ischaemia daily ED attendances, however the day of the week 
may have influenced this result. When separated, the individual ORs for weekdays and 
weekends do not span the ORs for all attendances, demonstrating that weekends are a 
confounding factor.  
Total ED attendances were further analysed by hour of attendance to identify any intra-day 
effects. Statistically significant decreases in ED attendances during matches were seen in all 
 
 
countries, except for Northern Ireland. This overall impact on EDs was estimated to be 
relatively minor, with minimal public health/ service impact (overall OR=0.93; individual 
country ORs=0.89-0.92, NI OR=1). Other changes appear highly variable between countries 
and individual games, with wins and losses both associated in increases/ decreases in ED 
attendances.  
The most significant impacts were demonstrated during the later stages of the tournament, 
particularly following the semi-final and final matches involving France. Though relatively 
small post-match increases in terms of actual numbers attending EDs across France (<800 
during a 4-hour period), these equated to fairly large percentage increases (>25% more 
than would usually be expected), not necessarily evenly spread across all EDs. These 
particular matches ended late on a Sunday evening, with the post-match period extending 
into the early hours of Monday morning, a period that is usually a quiet in EDs which may 
be affected by even a small number of extra attendances.  
The increased attendances in France following the final match of Euro 2016 contrasts with 
reports from a previous, similar event: during the 2003 Rugby World Cup, the host country 
lost in the final match, following extra time. However, following the Rugby World Cup final 
no significant increase in ED attendances was observed in Australia,5 contrasting with our 
results that ED attendances increased in France. The lack of an effect in Australia was 
attributed to the late end to the final match (23:00 hours) but in France the final game 
ended even later (00:00 hours).  
The next similar football event will be the 2018 FIFA World Cup, to be staged in Russia. 
England and France are the only two nations included in this study to have qualified for the 
tournament. Looking further ahead, the Euro 2020 tournament may include all four of the 
nations included here, though will be hosted across 12 different European countries.20 Each 
of these events do allow for the potential to carry out a follow-up study, though without 
the opportunity to investigate the impact on a single host country as included here. 
Strengths and limitations 
The main strength of this study was the inclusion of four nations, all competing in the same 
sporting tournament (including the host nation), with discrete competition times and high 
levels of public interest. This allowed the examination of the impact of an international 
sporting event on a more local level. 
The levels of alcohol related attendances reported here (0.6%-1.2% of attendances) are 
likely to have been an underestimate, since attendances where alcohol consumption was a 
 
 
contributing factor (e.g. injuries from falls/ fights) would not have been identified as alcohol 
related without an ‘alcohol’ diagnosis. The investigation of falls/ fights as a separate 
indicator was not possible: although the resulting diagnosis code would be readily 
identifiable in the ED data used here (e.g. wrist fracture) the mechanism by which this 
occurred (e.g. fall/fight) was not available. This type of surveillance would require much 
more detailed information to be available on the mechanism and intent of a presenting 
injury, as well as any role played by alcohol or other substances.  
The pre-tournament period used for the development of model baselines was limited to 2 
years due to the availability of data from the EDSSS system. This two year period was found 
to give the best balance between maximising the number of EDs included and the length of 
time available. This time period was replicated for both France and Wales to ensure a 
standardised methodology.   
A possible limitation of this approach was that the two year pre-tournament period 
included the 2014 FIFA World Cup, staged in Brazil. However, Northern Ireland and Wales 
did not participate in the tournament, England did not perform well and did not progress 
past the initial group stage, with only France (of the nations included here) progressing as 
far as the quarter-finals of the tournament. Therefore, although the inclusion of this event 
may have introduced potential confounding during the baseline period developed, the 
failure of teams in the present study to progress to the more exciting, later matches on the 
2014 World Cup implies that there will have been no discernible impact on ED attendance 
levels. 
Another possible limitation of this study is that the possible impact of meteorological 
conditions on ED attendances was not controlled for. The time period included here was 
during the first part of the European summer, however the potential impact of heat on ED 
attendances was not included in the analysis. Although heat specific indicators have been 
developed and used to successfully identify public health impacts of extreme hot weather 
using ED attendances in both England and France,21,22 the numbers involved are generally 
relatively small and unlikely to affect overall attendances as investigated here, particularly 
when examined by hour of attendance. During the early summer period (June - mid July) in 
the years reported here (2014-2016) there was no evidence of extreme levels of hot 
weather: only a single day of ‘heatwave’ was reported in the United Kingdom (1 July 
2015)23-25 and though hotter than usual summers and several periods of ‘heat spike’ were 
reported in France, these were not countrywide.26-28 
 
 
A further potential limitation is that the whole of the Euro 2016 tournament was included 
in the analysis for each country, introducing a possible bias caused by non-home nation 
games (a total of 51 games were played across the entire tournament). Matches involving 
other national teams may have been watched as eagerly as a home nation game (especially 
if the result could affect tournament progression), potentially reducing the apparent impact 
of home nation games. This is especially possible in France, which hosted many fans from 
other countries. It is also worth highlighting that initiatives specifically targeted at reducing 
the impact of major tournaments on the local population, such as the “Drink Less Enjoy 
More” campaign,29 may successfully reduce risky behaviour and the subsequent need for 
ED attendances. 
One major challenge is understanding the human behavioural reasons behind these 
changes in attendances around match times. There is little research on this subject, but 
during the 2010 Olympic men’s ice hockey significant reductions ED attendances with lower 
triage severity were reported.30 Similarly decreases in attendances with lower acuity scores 
at triage in the EDSSS system (England and NI) have been observed during the Christmas 
period.31 Syndromic surveillance often includes the collection of indicators of severity of 
illness on presentation to the ED and presents opportunity for future investigation of triage 
severity around events/ holiday periods. 
Conclusion 
In summary, we highlight that the overall influence of football games within a major 
European tournament upon ED attendances is relatively minor and only detectable when 
hourly attendances are examined. The heterogeneity between countries and the games 
played by individual countries (win/lose/draw and level of tournament progression) make it 
difficult for health providers to predict how major sporting events may affect ED 
attendances. However, the overall indication is that in the immediate build up to and 
during the period of an event, such as a football match, the numbers of attendances at EDs 
where the local population have an interest in the match (including fans watching from 
home) may be lower than usually expected, while attendances may increase immediately 
following the conclusion.  
The ability to monitor the impact of large events, including sports and mass gatherings, to 
identify any need for public health action, is a challenge. The speed with which syndromic 
surveillance data is collected, processed and analysed enables changes compared to the 
norm to be detected in near real-time, making it a valuable tool in these situations. The 
 
 
implementation of compatible systems and analysis in different countries would make this 
possible not only locally but across international borders. 
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Public health surveillance is often described as information for action. The lessons learned 
through the act of surveillance do not have to be limited to public health specific actions. 
The technical work behind the scenes may be of an identified use to those involved in other 
areas of the healthcare provision, particularly with regard to data collection, processing and 
sharing. 
Data collected during a patient’s journey through an ED is important for the care of that 
patient. Improved accuracy, timeliness and availability would result in improved care 
provision. These data are also vital for the monitoring of local processes and activity levels, 
information which may also be combined nationally to describe how EDs are performing 
and to identify any pressures being faced. Syndromic surveillance is classed as secondary 
use of ED data. However, as discussed in Chapter 3, sentinel EDSSS showed that although 
there were differences in data between EDs, many items were broadly similar and it was 
possible to map them to a standard format. Also, sentinel EDSSS had demonstrated the 
successful use of passive, automated processes to enable near real-time data collection.  
Through collaboration with the RCEM, the EDSSS team became involved in the development 
of the new Emergency Care Data Set (ECDS): a single standardised format required to be 
used in all EDs in England. This, we believe, is the first example of a syndromic surveillance 
system having input in the wider workings of EDs, which will, in turn, result in improvements 




Though emergency department (ED) care in the United Kingdom is provided under the 
control of a single body (the National Health Service, NHS), the collection, format and 
storage of attendance data is currently varied, decided upon locally by individual EDs to suit 
local work practices. The Public Health England (PHE) Emergency Department Syndromic 
Surveillance System (EDSSS) is a sentinel surveillance system, recruiting new EDs 
individually, working with and harmonising the variety of ED data formats available. The 
resulting process is complex and resource intensive. 
The Emergency Care Data Set (ECDS) project has developed a single dataset for 
implementation throughout EDs in England, with potential for syndromic surveillance to 
become a standard secondary user of this information. The evolution of the emergency 
care electronic health care record into a harmonised dataset, used throughout England, will 
result in a revolution in ED syndromic surveillance in the UK, delivering a national system 
that can provide an enhanced surveillance capability for years to come. The benefits to 




8.2 Emergency medicine data in the United Kingdom 
Emergency medicine is a recognised specialty in the United Kingdom (UK), with formal 
training and accreditation conducted and governed by the Royal College of Emergency 
Medicine (RCEM).1 Healthcare within the UK is publicly funded and provided through a 
residence (not insurance) based system provided by the National Health Service (NHS). 
Emergency care within emergency departments (ED) is currently provided free at the point 
of delivery for everyone, including non-residents. 
Though emergency care within the UK is under the control of a single-payer provider, the 
NHS, there is currently no single clinically-driven standardised dataset for emergency care 
in the UK. The collection and storage of information related to individual patients, as 
required for their care, is managed by each individual ED through locally developed 
processes for electronic data collection, format and storage. These processes may still 
include the use of paper records during treatment, to be transcribed to an electronic 
patient record at a later date. A number of electronic clinical information systems are 
currently in use, with many differences in data formats between locations, even for those 
using the same software. 
In England there is requirement for a subset of the patient record of each attendance to be 
collected nationally for basic monitoring of activity and for payment purposes. This, the 
Commissioning Data Set (CDS) type 0102 was created in the 1980s3 and is maintained by 
NHS Digital, as required by the NHS and the Department of Health. The CDS is not collated 
centrally in real-time, but is submitted by each hospital approximately monthly following a 
series of completion and validation processes, before transmission to NHS Digital.  
As well as being used for payment purposes the CDS is also made available in certain 
circumstances not related to direct patient care through the Secondary Uses Service (SUS)4 
for further reporting and analysis to support the delivery of NHS healthcare, as well as for 
public health purposes.  
8.3 Emergency department syndromic surveillance in 
England 
ED syndromic surveillance uses an anonymised feed of electronic records of ED attendances 
to identify and monitor trends in human health at the more severe end of the disease 
spectrum i.e. those requiring acute hospital care. The Public Health England (PHE) 
Emergency Department Syndromic Surveillance System (EDSSS) was originally developed as 
 
 
part of the public health preparations for the London 2012 Olympic and Paralympic Games 
in order to meet the surveillance requirements of hosting such a large mass gathering 
event.5  
Though ‘public health’ is listed as a purpose for SUS, there is no provision or potential for 
real-time surveillance usage given the time delays between patient attendances and data 
submission to CDS. This limited the potential for developing real-time ED surveillance 
systems in the UK, requiring EDSSS to be developed as a sentinel surveillance system, 
relying on the recruitment of individual EDs on an ad hoc basis. This approach required the 
agreement of each ED, gaining initial clinical support followed by a complex and often 
lengthy process of liaison with (and providing reassurance to) information governance 
teams.  
Without a single centralised data source the opportunity was taken for EDSSS to be 
developed, in collaboration with RCEM, from a ‘blank page’. The types of clinical 
information that would be useful for syndromic surveillance (including basic patient 
demographics, diagnoses using coded information not free-text, dates/time of attendance 
and the destination of the patient on leaving the ED), were first identified, then plans 
developed to access this information in existing ED clinical software systems. Working with 
local IT teams, the technical access to the ED attendance data has involved translation and 
mapping of the ED fields from the data format stored on the local clinical system to a 
standardised, anonymised data format based upon the RCEM suggested minimum dataset 
for emergency care.5 The process of secure data extraction and daily transfer to PHE is 
automated, with no additional resource required by participating EDs, resulting in a unique 
anonymised EDSSS dataset collected, stored and used solely for public health purposes. 
The EDSSS provided a valuable contribution to the overall surveillance during the 2012 
Olympics and continued to develop beyond the initial Olympic period, remaining as a public 
health legacy of the Games, contributing to national surveillance programmes, vaccine 
impact studies and supporting the response to public health incidents.6-10 
By December 2016 a total of 35 different EDs across England and Northern Ireland were 
reporting to EDSSS.11 A further 5 EDs have reported previously, however the bespoke 
nature of the EDSSS data transfer set up has meant that where the software system in a 
reporting ED changes (resulting in differences in the local dataset format and storage), the 
EDSSS data transfer set up is no longer valid and the site is lost.  
 
 
8.4 The Emergency Care Data Set: emergency care evolution 
The Emergency Care Data Set (ECDS) project is a collaborative project initiated by the RCEM 
in early 2015, with representation from government and non-government bodies on its 
Board.3,12 The ECDS aims to improve data collection, quality and completeness in English 
EDs using a single mandated, standardised data format to be implemented during 2017/18 
in all EDs, across all software systems. The primary aim is for clinical information captured 
within EDs to improve in quality, thus improving the delivery of clinical care and treatment 
of patients. Furthermore, the ECDS aims to make better use of information captured within 
the EDs, including streamlining local methods for forwarding information on for individual 
patient care, such as letters to general practitioners. The promotion of the completion of 
the patient care record in electronic systems in real-time, through use of ECDS, would also 
make information more readily available locally on capacity, demand for services and 
workload within each department.  
Additionally, some ED locations already collect additional details on patient attendances to 
fulfil specific project needs/ research interests, such as details on injuries resulting from 
violence. The ECDS would, for the first time, make this a standardised capability across all 
English EDs.  
The ECDS project is to next develop and replace the existing CDS, allowing collection of an 
updated and extended dataset enabling the activity across English EDs as a whole to be 
described more accurately than is currently possible. This would expand the potential 
information capture availability for SUS, enabling better provision for performance 
management, surveillance and research, in addition to the local commissioning of and 
payment for ED services delivered. This process also has the potential to make CDS 
submission a contemporaneous process, making information available nationally in near 
real-time, giving a global picture of supply and demand in a more timely manner than is 
currently possible. Implementation of the ECDS, which will be known as CDS Type 011 – 
ECDS is mandated in Type 1 and Type 2 emergency departments from October 2017 and in 
Type 3 and Type 4 departments by October 2018. 
8.5 How EDSSS helped ECDS 
Syndromic surveillance systems utilise electronic health data collected for patient care in 
order to provide information for public health action on a population rather than individual 
level. Each NHS ED currently has its own way of collecting patient information, focussed on 
 
 
an individual patient level, not population. The EDSSS has helped to identify the similarities 
across existing ED systems, where details can be extracted in a standard format and 
transmitted securely in an anonymised daily feed. EDSSS successfully provided proof of 
concept of this process, without having caused additional work within the EDs themselves. 
EDs have been passively providing more detail in the surveillance picture for both infectious 
diseases (including influenza and respiratory syncytial virus surveillance6,10) and the impact 
of other events (such as air pollution, heat waves and extreme cold weather7-9). 
As part of this process a number of EDs reporting to EDSSS adopted a unified set of clinical 
diagnoses codes, a first step to make diagnosis recording easier in the ED, with the 
intention that a patient with a condition e.g. croup should receive the same diagnosis code, 
regardless of which ED they attend and which ED clinician they are seen by. The results of 
this pilot illustrated improved levels of coding compared to other EDSSS EDs using existing 
coding datasets (Figure 8-1). 
Figure 8-1:  Daily percentage of ED attendances reported to EDSSS with a diagnosis 
code recorded. EDs are grouped by type of diagnosis coding in use 
(Snomed-CT, ICD-10, CDS or the new RCEM unified dataset [UDDA]). 
 
8.6 How ECDS may help EDSSS 
The implementation of ECDS would immediately remove the primary hurdle which has 
inhibited the growth of EDSSS: the current lack of standardised data capture across all EDs. 
Additionally, proposed changes to the infrastructure for the CDS would result in a single 
national ED data repository which, if collected in near real-time, would potentially make 
available all English EDs for recruitment to EDSSS through a central resource, rather than 
each ED individually. The expansion of the EDSSS to all English EDs would increase the 
ability of the system to report on local public health incidents, improve data quality with 
 
 
regard to signal to noise ratio, and result in the EDSSS being a leading national ED 
syndromic surveillance system internationally.  
The extension of data recording to include simplified injury fields, as proposed in ECDS,3 
would also further expand the utility of EDSSS, able to provide real-time detail on accidental 
injuries and violence, both across the country and at more localised geographies. Though 
many EDs may already collect information on injuries for local public health initiatives/ 
research, this is not currently done in a manner accessible for EDSSS or other public 
health/research organisations.  
The ECDS project is currently focussed on English EDs, but is being watched closely by 
colleagues in devolved administrations (Scotland, Wales and Northern Ireland). Northern 
Ireland already participates in the EDSSS, with five EDs reporting on a daily basis. As the 
implementation of ECDS is likely to allow the simple expansion of EDSSS across more (if not 
all) ED locations in England it would have the potential of becoming a standard throughout 
the UK. A single formal, standardised ED dataset, mandated by the NHS would enable 
harmonisation of surveillance activities across the UK. The publication of both the ECDS 
structure and EDSSS outputs also has the potential to harmonise surveillance efforts across 
country boundaries, into Europe and further afield. The data need not be shared, yet would 
allow direct comparison across borders if it is more easily understood and similarities can 
be identified, improving resilience to and providing information for action during large 
incidents e.g. influenza pandemics or volcanic ash clouds.  
8.7 What’s new in this approach? 
Mandated changes to national clinical emergency care datasets, such as that proposed in 
ECDS, do not happen very often, though it has been done before, for example in France.13 
The workload required to implement ECDS is significant, including needs and impact 
assessments, stakeholder consultations and pilot trials of potential technological solutions. 
This process has, however, allowed ECDS to be developed in a novel way where the 
consultation has included all stakeholders in emergency care, from the ED clinicians and 
patient representatives, through to potential secondary users of the data including those in 
public health.  
Syndromic surveillance usually aims to have no impact on front line staff and this principle 
remains here: patient care and NHS operational benefits are the driving factor for 
implementation of ECDS. In this instance, rather than remaining behind the scenes, 
 
 
syndromic surveillance has become part of a wider multidisciplinary conversation, having 
demonstrated what could be possible.  
Following the introduction of ECDS, EDSSS could become a standard, mandated item in 
English public health surveillance. Again, this has been achieved elsewhere (participation in 
OSCOUR®, the French equivalent of EDSSS, became mandatory from July 2013)13, though as 
far as we are aware this would be the first example of syndromic surveillance being 
included in the development of national ED data changes. 
Improvements in the collection and delivery of more timely and better quality ED data will 
have a wider reaching impact beyond that of syndromic surveillance, bringing benefit to 
other areas of the public health system. The evolution of emergency care electronic health 
care record in England will result in a revolution in ED syndromic surveillance, delivering a 
national system that can provide an enhanced surveillance capability for years to come. 
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As described in Chapter 5, the implementation of public health interventions and, as 
described in Chapter 7, human behaviour and decision making can each play a notable role 
in the demand for urgent health care and subsequent levels of attendances seen in 
emergency departments. In 2018, following the implementation of ECDS (the development 
of which is described in Chapter 8), the EDSSS transitioned from a small, sentinel 
surveillance system, to a much larger national EDSSS with more complete geographical 
coverage across England. The sentinel EDSSS had successfully reporting during London 2012. 
The first, high profile test for national EDSSS was not a planned mass gathering, but a global 
pandemic of a novel pathogen.  
During the initial stages of the COVID-19 pandemic a wide range of public health 
interventions were implemented aiming to reduce spread, alongside public health 
messaging encouraging the public to ‘protect the NHS’. Here we describe the impacts seen 
on ED attendances in England, with focus on age, severity of illness and select syndromic 
indicators of interest.  
 
 
9.1 Abstract  
Background 
On 12 March 2020 the UK entered the ‘delay phase’ of the COVID-19 pandemic response. 
The Public Health England Emergency Department Syndromic Surveillance System (EDSSS) 
carries out daily (near real-time) public health surveillance of ED attendances across 
England. This retrospective, observational analysis of EDSSS data aimed to describe changes 
in ED attendances during March-April 2020, and identify the attendance types with the 
largest impact. 
Methods 
Type 1 ED attendances were selected from 109 EDs that reported data to EDSSS for the 
period 01/01/19-26/04/20. The daily numbers of attendances were plotted by age group 
and acuity of presentation. 
The 2020 ’COVID-19’ period (12/03/20-26/04/20) attendances were compared to the 
equivalent 2019 ’pre-COVID-19’ period (14/03/20-28/04/20): in total; by hour and day of 
the week; age group (<1, 1-4, 15-14, 15-44, 45-64 and 65+ years); gender; acuity; and for 
selected syndromic indicators (acute respiratory infection, gastroenteritis, myocardial 
ischaemia). 
Results  
Daily ED attendances up to 11/03/20 showed regular trends, highest on a Monday and 
reduced in children during school holidays.  
From 12/03/20 ED attendances decreased, across all age groups, all acuity levels, on all 
days and times. Across age groups the greatest percentage reductions were seen in school 
age children (5-14 years). 
By acuity, the greatest reduction occurred in the less severe presentations. 
Syndromic indicators demonstrated that the greatest reductions were in non-respiratory 
indicators, which fell by 44-67% during 2020 COVID-19, whilst acute respiratory infection 
was reduced by -4.4% (95% CI: -9.5%,0.6%). 
Conclusion 
ED attendances in England have been particularly affected during the COVID-19 pandemic, 
due to changes in healthcare seeking behaviour: EDSSS has enabled real-time daily 
monitoring of these changes, which are made publicly available to facilitate action. The 
EDSSS provides valuable surveillance of ED attendances in England. The flexibility of EDSSS 
 
 





9.2 Background  
The COVID-19 pandemic has had major health and societal impacts worldwide. In the UK, 
the ‘delay phase’ was introduced in stages from 12 March 2020, including social distancing 
and shielding measures.1 These have had a major impact on population movement, day-to-
day activities and health care seeking behaviours.  
The Public Health England (PHE) Emergency Department Syndromic Surveillance System 
(EDSSS) is a public health legacy of the London Olympic and Paralympic Games 2012, 
receiving routine data from emergency departments (EDs) across England, captured 
through the Emergency Care Dataset (ECDS).2-4 This anonymised subset of ECDS data, is 
received on a daily basis, enabling a near real-time syndromic surveillance service, which 
feeds into PHE public health monitoring activities (including the COVID-19 response) and 
with weekly EDSSS surveillance bulletins made publicly available.5,6 The EDSSS is an 
unvalidated ‘snapshot’ of raw ED data (updates or completion of missing data are not 
included), which can be used for timely analysis and identification of trends for public 
health purposes. 
In this short report, we use routine EDSSS data to describe the changes in ED attendances in 
England from 12 March 2020, and the subsequent challenges that this has brought to 
undertaking ED syndromic surveillance. 
9.3 Methods  
Attendance data 
Daily ED attendance data were accessed from EDSSS from 01/01/19 to 26/04/20 (routine, 
anonymised, public health surveillance data, no ethical approval required). Selection 
criteria for inclusion were: Type 1 ED attendances; EDs reporting attendances for every day 
during the study period. EDSSS includes only EDs located in England. 
ED attendances categorised by syndromic indicator were identified based on the primary 
diagnosis listed for each attendance (if any). In this report, syndromic indicators routinely 





Daily attendances were visualised by calendar years (2019 full year; 2020 to 26/04/2020), 
by age group (0, 1-4 and 15-14, 15-44, 45-64 and 65+ years) and separately by acuity of 
attendance (ECDS values from 1: immediate, to 5: low acuity). 
Separate comparable time periods, matched on day of the week, were identified for the 
2019 ‘pre-COVID-19’ period (Thursday 14/03/19 – Sunday 28/04/20) and 2020 ’COVID-19’ 
period during the delay phase (Thursday 12/03/20 – Sunday 26/04/20). The mean number 
of all cause, all age attendances were plotted by hour of day and day of week for both pre-
COVID-19 and COVID-19 periods. 
The average daily attendances were calculated with the percentage difference between 
pre-COVID-19 and COVID-19 in total; by sex; by age group; by acuity; by day of the week 
and by selected syndromic surveillance indicators. 
9.4 Results  
In total 109 Type 1 EDs met the inclusion criteria, reporting a total of 13,861,889 
attendances to EDSSS, from 1/1/2019 to 26/4/2020. 
Daily attendances by age group to 11/3/20 showed similar trends: peak attendances on 
Monday and a notable reduction in child attendances during school holidays. From 12/3/20 
the numbers of daily attendances rapidly decreased across all age groups (Figure 9-1).  
The largest percentage change reduction in attendances were in school age children (Table 
9-1). There was no clear difference by gender (Table 9-1). Age and gender were reported 
for >99.5% of all attendances in both years. 
The level of acuity was identifiable in 83.6% of all attendances (82.9% pre-COVID-19; 83.5% 
COVID-19). Those with an acuity of ‘1: immediate’ accounted for the smallest numbers of 
ED attendances and saw the smallest reduction in levels during COVID-19 (31%), and those 
‘4: Standard’ the largest (54%; Table 9-1; Figure 9-2). 
Attendance levels were reduced throughout the 24-hour period (Figure 9-3). The largest 
decrease was seen Monday-Wednesday, previously the busiest days of the week (Table 
9-1). 
Syndromic indicators demonstrated the greatest reductions were in non-respiratory 
indicators. While there was only a 4% reduction in ARI, non-respiratory indicators fell by 44-
67% during COVID-19 (Table 9-1). 
 
 
Figure 9-1: Daily EDSSS attendances, 2019 and 2020 by age group a) children; b) adults 








Table 9-1: Differences in ED attendances between 2019 pre-COVID-19 and 2020 COVID-19 
(based upon the periods 14/03 – 28/04/20 and 12/03 - 26/04/20 respectively, 






(95% confidence interval) 
Total 30,412 16,217 -46.7% (-50.4%, -42.9%) 
Age 
<1yr 954 471 -50.6% (-55.2%, -46.1%) 
1-4yrs 2,318 1,068 -53.9% (-59.4%, -48.5%) 
5-14yrs 3,026 1,075 -64.5% (-70.8%, -58.2%) 
15-44yrs 10,982 5,636 -48.7% (-53.0%, -44.4%) 
45-64yrs 5,842 3,596 -38.5% (-42.0%, -34.9%) 
>=65yrs 7,143 4,360 -39.0% (-42.1%, -35.8%) 
Gender 
Female 15,438 8,171 -47.1% (-50.6%, -43.5%) 
Male 14,959 8,020 -46.4% (-50.4%, -42.4%) 
Day of the week 
Monday 33,594 16,778 -50.1% (-59.3%, -40.9%) 
Tuesday 31,394 15,627 -50.2% (-59.2%, -41.2%) 
Wednesday 30,498 15,385 -49.6% (-55.4%, -43.7%) 
Thursday 30,241 16,752 -44.6% (-55.3%, -33.9%) 
Friday 29,682 16,456 -44.6% (-53.5%, -35.6%) 
Saturday 28,675 16,358 -43.0% (-52.8%, -33.1%) 
Sunday 29,410 16,042 -45.5% (-54.2%, -36.7%) 
Acuity 
1: Immediate 370 256 -30.7% (-33.9%, -27.6%) 
2: Very Urgent 2,336 1,504 -35.6% (-38.2%, -33.0%) 
3: Urgent 9,416 5,642 -40.1% (-43.5%, -36.7%) 
4: Standard 11,818 5,455 -53.8% (-58.0%, -49.7%) 
5: Low Acuity 1,284 684 -46.7% (-54.3%, -39.0%) 
Selected syndromic indicators 
Acute Respiratory Infections 1,757 1,679 -  4.4% (-  9.5%,     0.6%) 
Gastroenteritis 356 118 -66.9% (-71.4%, -62.4%) 




Figure 9-2: Daily EDSSS attendances, 2019 and 2020, by acuity, where known (n=109 EDs). 
The 2020 COVID-19 period (12/03/20-26/04/20) is marked in grey. 
 
 
Figure 9-3: EDSSS attendances by hour of day and day of week during 2019 pre-COVID-19 
and 2020 COVID-19 (based upon the periods 14/03 – 28/04/20 and 12/03 - 





During the 2020 COVID-19 period there were fewer daily ED attendances than the 2019 
pre-COVID-19 period. The largest percentage reductions were observed Monday-
Wednesday (previously the busiest days of the week) and in the youngest age groups 
(particularly school age children). The reduction was observed across all acuity categories, 
though less marked in the most severe attendances presentations. These findings support 
and quantify a recent Royal College of Emergency Medicine position statement in the UK 
and also corroborate similar recent findings from the United States.7,8  
EDSSS reports on high level groupings of disease/condition indicators; this provides 
additional depth of understanding of ED activity, particularly with respect to infectious 
diseases. While other official sources of ED activity data in the UK (e.g. the NHS England 
weekly and month admission statistics9) provide information about overall attendance 
activity, they include other service metrics e.g. patient wait times, to inform performance 
management. Routine reporting of EDSSS data supplements these other sources and 
illustrates a differential impact of the changes in health care seeking behaviour (in real-
time) e.g. ARI attendances decreased very little, however non-respiratory indicators 
reported here decreased by 44-67%. Monitoring these changes in healthcare utilisation 
through surveillance is key to understanding the impact of COVID-19 in the population. 
These syndromic surveillance data demonstrate possible indirect impacts of social 
distancing/shielding, both positive (e.g. reduced need for gastroenteritis attendances) and 
negative (e.g. emergency cardiac care potentially avoided). Recent public health messaging 
has urged patients to continue to seek medical care as required.10  
The routine nature of the EDSSS enabled the rapid comparison of pre- and current COVID-
19 periods to describe impact using a large subset of English Type 1 ED attendances. 
However, this analysis is limited by the intentional exclusion of: all non-Type 1 ED 
attendances; and some Type 1 EDs due to inconsistency in the frequency of data 
submission. The intent is for NHS acute data to be submitted to NHS Digital, using ECDS, on 
a daily basis.4 
One of the biggest challenges for EDSSS has been changes in the total attendances, which 
resulted in difficulty interpreting syndromic indicators as a percentage of attendances, 
resulting in false signals. EDSSS reporting was subsequently rapidly adapted, with 
attendance counts (as used here) presented in all standard EDSSS reporting from 
 
 
19/03/20.5 Supplementary EDSSS developments will include severity indicators to provide 
enhanced intelligence in future. 
The EDSSS now reports on COVID-19-like attendances (including new COVID-19 Snomed CT 
codes).11 This information now feeds into the PHE COVID-19 response, demonstrating that 
the information is actionable, as well as in regular weekly EDSSS surveillance bulletins.5 6 
Furthermore, EDSSS outputs are also utilised by the UK Government to support and guide 
management of the pandemic. EDSSS will continue to be used during the COVID-19 
pandemic, delivering real-time monitoring of indicators of both direct (respiratory) and 
indirect (non-respiratory) healthcare demand. It will also provide valuable surveillance 
information during any future waves and inform on healthcare pressures during winter 
2020/21 when SARS-CoV-2 and other seasonal respiratory pathogens will impact on 
emergency care services.12  
Conclusion 
ED attendances in England have been affected by changes in healthcare seeking behaviour 
during the COVID-19 pandemic. EDSSS has enabled real-time daily monitoring of these 
changes, providing publicly available information to facilitate action. The EDSSS provides 
valuable surveillance of ED attendances in England. The flexibility of EDSSS allowed rapid 
development of new indicators (including COVID-19-like) and changes to reporting methods 
as required. 
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 Overall discussion and conclusions 
The peer reviewed manuscripts presented in this thesis address each of the questions 
raised in Chapter 4. 
10.1 Does near real-time emergency department syndromic 
surveillance provide additional benefit to public health 
surveillance in England? 
The flexibility and near real-time nature of syndromic surveillance affords opportunities for 
the identification and monitoring of public health threats which may not be possible using 
traditional public health surveillance methods. The evidence presented in this thesis has 
demonstrated where the EDSSS has added value for public health surveillance in England, 
utilising: 
• system flexibility;  
• timeliness of reporting;  
• cross system/international collaborative working.  
System flexibility 
The papers presented in the previous chapters demonstrate the flexibility of the EDSSS for 
monitoring of a wide range of health conditions, outcomes and behavioural factors. This 
thesis includes several peer reviewed examples of how EDSSS has been used to support 
existing public health surveillance and intervention programs on a wide range of different 
public health needs. The flexibility of the EDSSS has made for a system capable of many 
different surveillance functions using information gathered from a single, digitally recorded 
(automatically transmitted) data source, rather than requiring multiple similar surveillance 
systems likely developed in isolation from one another:  
a. Infectious disease (Chapter 5): a previously developed EDSSS syndromic indicator 
successfully identified seasonal changes in gastroenteritis attendances at EDs. This 
variation in trend corresponded with the seasonal patterns of rotavirus activity as 
reported from laboratory confirmations, the traditional surveillance used for 
monitoring gastrointestinal disease. Despite rotavirus infection generally being 
considered to cause a relatively mild self-limiting disease in the UK, its impact on ED 
visits overall (and in young children in particular) was notable. The EDSSS 
 
 
demonstrated the considerable burden that ‘non-severe’ disease can place on NHS 
emergency care services delivered by EDs. 
b. Impact of public health interventions (Chapter 5): ED attendances for 
gastroenteritis decreased following the introduction of the rotavirus vaccine into 
the childhood immunisation schedule in England. EDSSS was used to further 
investigate this post-intervention decrease and confirmed that the reduction in ED 
visits for gastroenteritis, particularly in young children, continued into the third 
year following vaccine introduction. The flexibility of EDSSS offers the potential for 
other vaccine impact assessments, such as the previous inclusion in monitoring of 
the live attenuated influenza vaccination in school children.1,2 The opportunity for 
development of other syndromic indicators (and ability to create new ones) allows 
EDSSS to have the potential to report on any other vaccine (assuming the vaccine 
prevents severe illness likely to be seen in the ED), without the need to establish a 
whole new surveillance system. 
Chapter 9 further demonstrated the ability of EDSSS to monitor the impact of 
public health interventions. During the early stages of the COVID-19 pandemic 
strict, public health measures including shielding, social distancing and ‘lockdown’, 
were implemented across England, resulting in a large, rapid reduction in ED 
attendances. EDSSS provided valuable information for Government and the NHS on 
this rapid, unanticipated, indirect impact of the COVID-19 pandemic and the 
interventions put in place. 
c. Impact of environmental events (Chapter 6): periods of poor air quality were 
shown to have an association with asthma attendances in EDs in London (and 
Paris), demonstrating an increase in illness severe enough to require emergency 
treatment. This confirmed the utility of the existing EDSSS indicators for monitoring 
the acute, short term public health impact of poor air quality. 
d. Human behaviour (Chapter 7): in addition to the impact of external factors (such as 
infectious disease or environmental events), human behaviour may also play a role 
in the health seeking behaviour and the decision-making processes which may 
result in ED visits. EDSSS data demonstrated that international football matches 
may cause changes in ED presentation patterns, such as delaying healthcare 
seeking behaviour, or may even delay/cause the incident resulting in the healthcare 
need (e.g. risky behaviour may not occur until after the match is over/may be more 
likely to occur depending on the result of the match). 
 
 
e. Novel disease surveillance (Chapter 9): the arrival of a new pathogen, SARS-CoV-2, 
causing the COVID-19 pandemic required the EDSSS to rapidly adapt to make use of 
new diagnostic codes for the creation and implementation of a new syndromic 
indicator to monitor and report on COVID-19-like ED attendances.  
Timeliness of reporting 
As discussed in Chapter 1, syndromic surveillance is generally considered more timely than 
traditional public health surveillance; collecting and analysing data, and providing feedback 
in (near) real-time to inform public health action. Prior to the introduction of EDSSS routine, 
rapid analysis across EDs in England was not possible. The pre-existing central collection of 
data from EDs, as described in Chapter 3 and Chapter 8, allowed for reporting of 
attendance levels, use for payment purposes, as well as some provision for some purposes 
not directly related to patient care, including non-rapid public health analyses. Though 
regular and including all EDs in England, the information collected was not of sufficient 
detail or timeliness for syndromic surveillance purposes. The evidence presented in this 
thesis has confirmed the surveillance capabilities of EDSSS, which is an important step in 
providing an evidence base for the continued use and application of the system in the 
future.  
EDSSS has now been shown to have surveillance indicators sensitive to a range of different 
public health threats, evidencing the potential to provide real-time information for action: 
a. Rapid intervention impact assessment: Chapter 5 demonstrated the potential for 
the EDSSS to be used for rapid, standalone analysis and feedback on the impact of 
public health interventions, such as introduction of new vaccines. The ability to 
provide this feedback in near real-time, ahead of traditional public health 
surveillance (i.e. laboratory) datasets provides new opportunities for more rapid 
assessments to be carried out in future.  
b. Real-time identification of risk groups: The investigation of individual periods of 
poor air quality in Chapter 6 demonstrated the identification of differing levels of 
impact in different age groups, at different times. These distinctions were made 
despite the air quality events themselves being very similar in terms of duration 
and type of exposure. This highlights the value of near real-time surveillance and 
feedback; the ability to identify changes in presentation of disease enables public 
health actions and messaging to be tailored and targeted quickly.  
 
 
c. Rapid changes in human behaviour: The ability of EDSSS to identify changes in 
attendance behaviour in near real-time, as described in Chapter 7, and provide 
timely feedback tailored to the situation, is valuable for both public health 
authorities and emergency care providers. Though individual EDs (and those 
working within them) may have anecdotal evidence gained through local 
experience, the EDSSS provides evidence from EDs across England, helping to 
identify and highlight similarities (or differences) both geographically and 
temporally. This detailed intelligence may be used to support and aid resource 
allocation in EDs to prepare for and manage quiet(er), as well as busier, periods.  
d. Real-time analysis and reporting: The ability to identify and provide timely warning 
of public health events severe enough to warrant an ED visit is something which 
had been previously been limited within the UK. The central collection of data has 
traditionally been slow, with validation steps and delays in data transfer making 
data available long after both an event has occurred, and the patient had attended 
the ED. The importance and value of EDSSS in the monitoring and reporting of 
overall ED attendances is demonstrated in Chapter 9, where the impact of the 
COVID-19 pandemic on ED attendances (monitored in near real-time) was clearly 
demonstrated.  
Cross system/international collaborative working 
EDSSS was initially designed and established as a standalone surveillance system for 
England. Despite this, the development included consideration for future collaborative 
working with other ED syndromic systems, both with devolved administrations within the 
UK and internationally. As detailed in Chapter 3, the sentinel EDSSS network was extended 
to include Northern Ireland in 2012, though the national EDSSS has subsequently been 
restricted to England only. A major step towards international, cross border surveillance 
collaboration was achieved in the two studies described in Chapter 6 and Chapter 7, 
research projects completed using data from both EDSSS and OSCOUR®, the ED syndromic 
surveillance system in France. 
The EDSSS and OSCOUR® systems were found to be broadly compatible, with similar 
syndromic indicators available and in use in both. There is potential for further 
collaborative working and even harmonisation of indicators in future. 
 
 
10.2 What value can ED syndromic surveillance add to 
emergency care services in England? 
Data collection within the ED is of primary importance for patient care. The ED electronic 
patient record describes a patient’s journey through the ED, used for the direct care of the 
patient, both within the ED and any subsequent follow up outside of the emergency care 
setting. This information can additionally be used on a population rather than individual 
patient basis, from the ED to NHS Trust, up to the national level, providing valuable 
intelligence for the identification and management of local (within a single ED/hospital/NHS 
Trust) or even national pressures.  
At the time of the development of the initial sentinel EDSSS there was no standardisation of 
ED data collection or formatting across England. The structure and completion of the 
patient care record was unique to each ED, dependent on local work practices and the 
software solutions used locally. A wide range of different information was collected in a 
variety of ways, including the use of free text, local coding or recognised codesets (CDS3, 
ICD-104 or Snomed CT5). This variation limited the capability for the patient care record to 
provide an auditable record of relevant and consistent information across EDs, as well as 
inhibiting communication between health professionals. As described in Chapter 3, the 
establishment of the sentinel EDSSS provided evidence of what was achievable, even in a 
relatively small sentinel network:  
• the secure, automated, daily collection of data from across different EDs; 
• the reformatting of disparate datasets into a single, standardised codeset;  
• the demonstration of the successful use of this data for public health surveillance 
purposes. 
The close working relationship of the EDSSS project group with RCEM began with the initial 
planning and pilot phase of EDSSS and continued beyond the initial development of and 
recruitment of EDs to the system. The sentinel EDSSS provided initial evidence of the 
benefit that may be realised by the standardisation of data collection and storage by EDs in 
England. The sentinel EDSSS also provided valuable experience and insight into the 
development of standardisation, used by the RCEM, NHS Digital and NHS England in the 
development of the Emergency Care Data Set (ECDS),6 as described in Chapter 8. 
The subsequent development and roll out of ECDS presented new opportunities to improve 
data collection to aid in patient care, as well as NHS resource planning. The information 
 
 
collected in the patient care record in EDs in England is now standardised, meaning that any 
patient attendance should result in the same final record, regardless of which ED is 
attended or which health care professional is consulted. This will enable improvement in 
patient care and facilitate better communication between health care professionals. The 
ECDS also requires the regular (daily) transfer of a specified portion of the electronic 
patient care record to be transferred to a central collection point (NHS Digital). This rapid 
transfer of information will allow for improved and more timely identification of issues on a 
national level as well as resource planning within the NHS. Additionally this centrally 
collected and held dataset, including updates and corrections sent through in addition to 
the daily feed, may also be used for future (longer term, rather than real-time) public 
health surveillance activities. 
The continued (business as usual) operation and ongoing routine weekly public reporting of 
EDSSS throughout the COVID-19 pandemic has made rapid standardised analysis available 
for emergency care (within EDs and at governmental/policy level). The previously 
established historical baselines which determine what is considered ‘normal’ for ED 
attendance levels, have been invaluable for identifying the indirect impacts of both the 
pandemic and control measures, as described in Chapter 9. This particular use of EDSSS has 
been picked up and reported by others.7 
10.3 How can ED syndromic surveillance in England be 
further developed for improved public health 
surveillance? 
The introduction of the ECDS into EDs in England (as described in Chapter 8), including the 
requirement for (at least) daily transmission of data to a central point (NHS Digital), has had 
a major impact on the EDSSS. The sentinel EDSSS ceased to receive data on 31 March 2018, 
ending almost 8 years of continuous, daily reporting marking the end of phases I-IV 
described in Chapter 3.  
From 1 April 2018 the new national EDSSS began receiving data, on a daily basis, from EDs 
in England, in the newly standardised ECDS format via NHS Digital. As EDs have adopted the 
ECDS and developed their central daily reporting capability, so the number of EDs included 
in the anonymised data feed to national EDSSS has increased. The EDSSS has benefited in 
terms of the use of standardised coding, the breadth of information included, and the 
geographical coverage achieved.  
 
 
During the first years of this new national EDSSS, analyses and reporting remained broadly 
similar to that of the sentinel EDSSS, maintaining continuity of surveillance and reporting. 
This business as usual approach, reporting on broad health indicators (such as respiratory 
and cardiac type attendances), with baseline levels included as standard, proved to be of 
value during the initial phase of the COVID-19 pandemic in England. As described in 
Chapter 9 the national EDSSS provided rapid feedback on ED attendance levels during the 
initial period of intervention measures (including shielding, social distancing and 
‘lockdown’).  
The national EDSSS also now offers much greater opportunities for future ED syndromic 
surveillance development. The following list of potential areas for development of ED 
syndromic surveillance in England is not exhaustive. Public health surveillance needs are 
constantly evolving and as the new ECDS data items are used more frequently as standard, 
new areas of interest are likely to be identified in future. 
Refinement of syndromic indicators 
The inclusion of ECDS data now offers greater opportunities for developing new ED 
syndromic surveillance indicators within national EDSSS, resulting from the standardisation 
of: 
• diagnosis information: Snomed CT coding is now used across all EDs and diagnoses 
are expected to be based on only true diagnoses, with a qualifier for 
suspected/confirmed (signs/symptoms such as ‘chest pain’ or ‘vomiting’ are no 
longer permitted); 
• chief complaint field: the use of ECDS has ensured the availability of a newly 
standardised and Snomed CT coded list from which signs/symptoms may be 
selected for each patient, ensuring the availability of this information for use in 
syndromic indicators in future. Use of this field allows for the identification of 
signs/symptoms which are no longer permitted to be recorded as diagnoses. 
Chapter 2 illustrated that the use of diagnosis information for the mapping of syndromic 
indicators was intentionally avoided in a large number of ED syndromic surveillance 
systems, generally due to the low levels of field completion in real-time. ED syndromic 
surveillance systems operating in (or using a surveillance tool developed in) North America 
prefer the use of the chief complaint (entirely based on signs and symptoms) over 
diagnosis. The national EDSSS now presents an opportunity for the exploration of the use of 
 
 
both diagnosis and chief complaint for development and refinement of syndromic 
indicators in future. 
Identification and use of severity indicators  
Although the ED setting is expected to see patients with the most severe presentations of 
illness, there is still a range in the levels of severity seen. The ECDS encourages the 
recording of standardised fields describing the severity of illness throughout the patient 
journey through the ED including: 
• acuity (i.e. how quickly the patient needs to be seen on arrival); 
• investigations and treatments administered; 
• the type of care the patient moves on to on discharge from the ED (if any).  
The further refinement of EDSSS indicators to enable the identification and monitoring of 
changes in levels of severity of illness will supplement and support surveillance activities 
and provide valuable intelligence for public health action in future. 
New areas of syndromic surveillance 
Non-communicable diseases and conditions 
The surveillance of non-communicable disease is often carried out based on traditional 
surveillance methods, such as described in Chapter 1. Relatively slow reporting schedules 
limit the opportunities for public health responses/interventions where rapid response may 
be appropriate. 
Research into the most severe injuries presenting at EDs (such as participation in the 
Trauma Audit & Research Network8) and local collaborations in Violence Reduction Units9 
(and predecessor groups) have highlighted the potential utility of public health surveillance 
of injuries in EDs. However, prior to the introduction of ECDS, information collected in EDs 
around injuries was often ad hoc and developed locally. While the recording of free text, 
non-standardised fields or project specific information on injuries may be of benefit for 
individual patient care, or discrete research projects, it is generally not suitable for onward 
transmission for secondary purposes at a national level. An inbuilt ‘flag’ in ECDS now aids in 
the identification of injury type attendances. An additional standardised injury section of 
the patient care record has also been included, facilitating the collection of standardised 
detail of injury type, location and intent, from all EDs in England. This promotes the 
possibility for EDSSS to expand to include a new area of near real-time surveillance, not 
previously possible on a continual, national basis. 
 
 
Within ECDS, flags are also included within the patient record to mark where alcohol and/or 
drugs are involved in each ED attendance. Current identification of acute alcohol 
intoxication attendances in EDSSS is based solely on the primary diagnosis of each 
attendance. The new alcohol flag will likely provide a better estimate of alcohol related 
attendances (particularly where the main reason for attending is not obviously alcohol 
related e.g. the primary diagnosis may be the result of an injury). The further extension of 
this to the ability to identify and monitor drug related attendances may aid in the 
identification of changing trends (in both numbers and severity of illness), again with 
potential to provide monitoring of potential public health interventions, if appropriate. 
During the initial phases of the COVID-19 pandemic in England, one of the most valuable 
features of EDSSS was identified as the monitoring of indirect impacts of COVID-19 on ED 
attendances. Rapid reductions in indicators other than COVID-19-like attendances, such as 
cardiac conditions, provided information for public health messaging promoting the 
accessing of emergency care whenever necessary. This has posed further questions as to 
the impact on other areas such as mental health or cardiovascular disease, including 
strokes. 
Investigation of health inequalities  
To date, basic breakdowns of attendances by age are analysed as standard for 
investigations within EDSSS, with patient sex additionally used in an impact of cold weather 
indicator.10 The more detailed data now available in national EDSSS will enable future 
investigation into the (patient stated) ethnic category, residential status (e.g. homelessness 
or nursing/residential homes) and drug/alcohol use (as described above). This inclusion of 
previously unavailable demographic detail is expected to enable the identification of and 
monitoring for changes in health inequalities in the population attending ED.  
The national EDSSS should eventually receive daily data from all EDs in England. The 
resulting improved ability for geographical based analyses will add strength to the 
investigation of any disparities identified. 
Inclusion of all ED types in EDSSS 
To date, EDSSS has focussed on type 01 ED attendances. The introduction of ECDS was 
initially also focussed on type 01 EDs, then extended to all ED types including: type 02 single 
specialty EDs; type 3 &4 walk in centres and minor injury units; and the newly formed type 
05 ambulatory care.11 This has subsequently enhanced the national EDSSS, creating an 
additional all-England all-types ED surveillance network, now including emergency care 
 
 
attendances for less severe illness and injuries than seen in type 01 EDs alone. Further work 
will be required to identify how this can add value, complementing both the existing EDSSS 
and the other community based PHE syndromic surveillance systems. 
The future of ED syndromic surveillance globally 
As described in Chapter 2, the use of ED syndromic surveillance internationally has 
increased and the systems themselves have evolved over time. The development of truly 
national systems has occurred in several countries/territories, with England now also fully 
achieving this status.  
With a collective 20 years of global ED syndromic surveillance experience, many lessons 
have been learned, from which future developments have yet to be made. The potential for 
cross system learning is ever present and the sharing of the technical details should be 
encouraged. The further potential for cross system collaboration and possibly even 
harmonisation of indicators for use across international borders is a very real prospect.  
10.4 Limitations 
Syndromic surveillance is an opportunistic, secondary use of health care information and is 
ultimately limited by the coverage attainable and the quality, completeness and availability 
of the data it uses.  
In addition to improving the timeliness of surveillance, the passive nature of EDSSS is 
intended to aid the ability for this system to respond during periods of service pressure 
within the ED. All of the information within each patient record is collected primarily for the 
purpose of managing and recording patient care. EDSSS requires no extra fields, or 
additional options selected specifically for syndromic surveillance purposes. The provision 
of data to EDSSS does not require any extra work in terms of data collection, or data 
transmission. This ‘business as usual’ approach enables EDSSS data preparation and 
transfer to function in the background of the ED clinical management system. This 
approach also ensures that during periods of high workload or pressure within the ED, the 
local processes for patient care and recording of information remain unchanged. Data 
continues to flow to EDSSS, providing valuable information for public health action from a 





As described in Chapter 3, the sentinel EDSSS required EDs to be individually recruited, 
through a long, complex recruitment process. In total 40 EDs were successfully recruited to 
the sentinel EDSSS network, although only a maximum of 36 EDs reported at any one time. 
Sentinel EDSSS initially focussed on London and cities hosting London 2012 events, but was 
designed to be expanded as an ongoing Olympic Legacy; to include EDs in large, 
geographically dispersed cities across England. However, the complexities of recruitment 
meant the sentinel EDSSS did not achieve fully representative, national coverage. Not all 
PHE centre areas were included in the network (with no EDs in the North East or East 
Midlands areas), limiting the ability for public health surveillance to only those areas with a 
participating ED.  
The slow recruitment of EDs over several years further impacted the usable system 
coverage for research and investigations across extended time periods. In Chapter 5 the 
interrupted time series analysis required a stable number of EDs to be included over the 
maximum time period possible (both before and after the implementation of the rotavirus 
vaccine); only three EDs met the eligibility criteria over a sufficient length of time for the 
analysis carried out.  
The investigation into the impact of air pollution on ED visits, presented in Chapter 6, 
focussed solely on London which limited the number of EDs eligible for inclusion. Though 
the relatively short investigation time period (a single calendar year - 2014) helped to 
maximise the number of EDs eligible, only five EDs in London were included. In contrast, 58 
EDs in Paris were available from the OSCOUR® system, which has been a mandatory 
national surveillance system in France since 2013.12 Though similar impacts of air quality 
incidents on human health were observed in both London and Paris, this study clearly 
showed the advantages of the larger number of EDs from which data was available in Paris: 
with much more stable data, reduced background noise and clearer distinction of 
exceedances in attendance levels. 
Data quality and completion 
EDSSS data collection is restricted to the inclusion of a ‘snapshot’ of ED data at the time of 
first extraction, with no provision for inclusion of subsequent updates or corrections made 
to the patient record. This approach enables the comparison of each day on a like-for-like 
basis. Whilst this brings the benefit of timely reporting (next day in sentinel, currently 
second day in national EDSSS), it can also limit both the completeness and correctness of 
the data. The reasons for missing/incorrect data are assumed to be consistent over time 
 
 
within each ED, i.e. local working practices affect the speed of completion of the electronic 
patient record. As a secondary user of this information, the quality of the information 
captured in EDs is an important factor in success of the EDSSS in meeting its goal of 
providing timely information for public health action.  
EDSSS relies on the use of coded diagnosis information to underpin the development and 
construction of syndromic indicators. These diagnoses may be related to signs/symptoms 
as presented by the patient. Not all conditions seen in the ED require confirmatory testing 
for effective treatment, so for many attendances tests may not be carried out to reach a 
confirmed, final diagnosis. Additionally, where tests are carried out in the ED, there is 
potential for the results and subsequent final diagnosis to not have been entered into the 
patient record at the point the data was extracted for EDSSS. 
Using this ‘snapshot’ method, around 70% of visits were found to include a diagnosis code 
in both the air quality study (Chapter 6) including 5 EDs in London during 2014 and the 
rotavirus vaccine impact study (Chapter 5) which included 3 (non-London) EDs from 2011-
2016. This level of diagnosis coding was very similar to the level reported from the Paris EDs 
during 2014 in the AQ study (Chapter 6), despite the OSCOUR® system in France allowing 
for updates to records in the days immediately following the first report.  
Data format and specificity 
At the time of establishment of the sentinel EDSSS (2010), there was no standardised 
minimum requirement for the collection and storage of patient care information in EDs in 
England. The recruitment of EDs to EDSSS involved the mapping from the local electronic 
patient care records to a single EDSSS codeset, as described in Chapter 3. Different data 
items, relevant to each patient attendance, were found to be available (or not) in different 
EDs. Coded diagnosis information was available in all EDs, however, the use of different 
‘pick lists’ to choose from within each ED (with background mapping to the different 
diagnosis coding systems in use locally) limited compatibility for some syndromic indicators. 
In each of the research studies presented in Chapter 5, Chapter 6 and Chapter 7, which 
were carried out using the sentinel EDSSS, these limitations were controlled for where 
possible, such as the inclusion of only EDs using ICD-10 or Snomed CT diagnosis coding 
systems in the rotavirus vaccine impact study (Chapter 5). The excluded EDs, those not 
using either of these diagnosis coding systems, were only able to report ‘gastrointestinal’ 
conditions, not the ‘gastroenteritis’ indicator (i.e. gastrointestinal conditions considered to 
be due to infection) required for the study. While some did provide ‘gastrointestinal’ 
 
 
diagnoses throughout the time period required, they still had to be excluded from the study 
because not enough detail was included in the coding system used. 
The national EDSSS, as reported from in Chapter 9, now receives all data in Snomed CT 
coded format. This standardisation ensures that all EDs are now reporting in a consistent 
way, making them all eligible for future studies (where the time period criteria for reporting 
are met), which will greatly increase the power and confidence in such studies. 
10.5 Recommendations  
The evidence presented in this thesis supports the continuation and further development 
of ED syndromic surveillance in England.  
Future research areas identified 
Each of the studies in Chapter 5, Chapter 6, Chapter 7 and Chapter 9 presented further 
investigations which should be followed up: 
Use for rapid vaccine impact studies  
As an ongoing, routine surveillance system, EDSSS holds an ever-growing historical dataset. 
This may be used in future as a baseline (pre-vaccination) period, against which the impact 
of vaccine implementation may be measured, as shown in Chapter 5. Such future vaccines 
may include those currently under development and undergoing clinical trials, such as RSV13 
and norovirus,14 as well as the rapidly developed, approved and rolled out COVID-19 
vaccines.15-17  
Trends in gastroenteritis ED attendances  
Although the introduction of rotavirus vaccination in infants clearly reduced gastroenteritis 
attendances in EDs overall (Chapter 5), the identification of a summer increase during 2012, 
warrants further investigation. This increase occurred during a year of increased 
cryptosporidium activity as reported by laboratory surveillance, indicating that EDSSS may 
be sensitive to increased circulation of this pathogen in the community. 
This introduces a wider programme of future work to establish how EDSSS can specifically 
support national gastrointestinal surveillance programmes, through the development of 
EDSSS indicators sensitive to specific pathogens. 
Trends in asthma ED attendances 
Chapter 6 focussed specifically on the health impact of poor air quality on ED attendances 
for asthma, however, as with all ED syndromic indicators there is potential for other events 
 
 
to have an impact on ED visits. The study period (2014 calendar year) included 
thunderstorms and the return to school following the long summer break, which have each 
been associated with increased levels of asthma.18,19 These events appear to have had an 
impact on asthma ED attendances in both London and Paris during the study period. This is 
an area of research for which there is a limited evidence base and therefore further 
exploration of these areas is warranted. 
Development of severity indicators 
The investigation into the impact of events on the timing and types of attendances in EDs 
described in Chapter 7 and the initial analysis of ED attendances during the first wave of the 
COVID-19 pandemic in Chapter 9 both recommended further investigation of the use of 
severity indicators, as described above. 
Service delivery 
This thesis has outlined the successful development of a national ED surveillance system 
and the integration of the system into the public health service in England for routine use.  
The work carried out and presented in this thesis has shaped and aided the growth of 
EDSSS as a system. Having been under constant development from the first establishment 
of a live data feed in 2010, the EDSSS has continued to grow in terms of the range 
surveillance activities carried out. The geographical coverage of the system continues to 
grow, with all type 01 EDs expected to be reporting, via NHS Digital, on daily basis. 
The breadth of the system is also under development with other ED types (types 02, 03, 04 
and the newly created type 05) also adopting ECDS, both in terms of data collection and 
daily data provision at a national level. The expansion of national EDSSS from the type 01 
EDs, providing urgent care to the most severely ill, to all ED types and the less severe 
presentations, will increase the surveillance capabilities of EDSSS and potentially the public 
health actions that may be taken as a result. 
The existence and utility of EDSSS has become increasingly well publicised during the 
COVID-19 pandemic. The next set of challenges will be to realise the potential for this 
system to provide near real-time surveillance support enabling improved public health 
response to an increasing range of areas of public health (including non-communicable 
disease and investigation of health inequalities, as described above), whilst also retaining 
the flexibility to respond to public health threats not yet identified. Further development of 
reporting capabilities will also be required to ensure surveillance outputs are readily 
available and easily visible  
 
 
The future of EDSSS  
The evolution of EDSSS, from a sentinel to national surveillance system, and its 
collaborative input into the standardisation of ED data collection across England, stands as 
a model that may be reproduced elsewhere. As the EDSSS continues to grow, in terms of 
geographical coverage, ED type inclusion and areas of public health interest monitored, so 
does its reputation on the world stage.  
The EDSSS has enhanced public health surveillance programmes in England, added benefit 
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AI  Artificial Intelligence 
AQ  Air Quality 
ARI  Acute Respiratory Infection 
CDS  Commissioning Data Set 
CI Confidence Interval 
CNIL  French National Commission for Data protection and Liberties 
DAQI  Daily Air Quality Index 
EARS  Early Aberration Reporting System  
EARS-net  European Antimicrobial Resistance Surveillance Network 
ECDS  Emergency Care Data Set 
ED  Emergency Department 
EDSSS Emergency Department Syndromic Surveillance System 
EDSyS  Emergency Department Syndromic Surveillance 
EISS  European Influenza Surveillance Scheme 
ESSENCE  Electronic Surveillance System for the Early Notification of Community-Based 
Epidemics 
Euro 2016  2016 UEFA European Football Championship 
EuroMOMO European monitoring of excess mortality for public health action 
FIFA Fédération Internationale de Football Association 
GP General Practitioner (family doctor) 
HDAS Healthcare Databases Advanced Search: provided by Health Education 
England and NICE 
HPA Health Protection Agency: predecessor of PHE 
HUS Haemolytic Uraemic Syndrome 
ICD International Classification of Disease 
ICD-10  International Statistical Classification of Diseases and Related Health 
Problems-version 10 
ISDS International Society for Disease Surveillance 
ISO International Organisation for Standardisation  
IT Information Technology 




MI  Myocardial Ischaemia 
NHS  National Health Service 
NHS 111 NHS telephone health advice line (in England): successor of NHS Direct 
NHS Digital National information and technology partner to the NHS 
NHS Direct NHS telephone health advice line (in England): predecessor of NHS 111 
NHS Trust NHS organisation which provide goods and services for the purposes of the 
health service 
NI  Northern Ireland 
NICE National Institute for Health and Care Excellence 
NIHR HPRU  National Institute for Health Research Health Protection Research Unit 
NSSP National Syndromic Surveillance Program 
ODS Organisation Data Service 
OR  Odds Ratio 
OSCOUR®  Organisation de la surveillance coordonnée des urgences 
PHE Public Health England: successor of HPA 
PII Patient Identifiable Information 
PM Particulate Matter 
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
RAMMIE Rising Activity, Multi-level Mixed effects, Indicator Emphasis: statistical 
method used by ReSST 
RCEM Royal College of Emergency Medicine 
ReSST Real-time Syndromic Surveillance Team 
RODS Real-time Outbreak and Disease Surveillance 
RSV Respiratory Syncitial Virus 
RV Rotavirus vaccination 
SARS Severe Acute Respiratory Syndrome 
SGSS Second Generation Surveillance System 
Snomed-CT Clinical terminology 
SPMSD Sanofi Pasteur-MSD  
SUS Secondary Uses Service 
UDDA RCEM unified diagnostic dataset 
UEFA  Union of European Football Associations 
UK United Kingdom 
USA United States of America 
 
 
Appendix A: Additional table used in Chapter 2 
Emergency Department syndromic surveillance (EDSyS) systems identified in the systematic 
review in Chapter 2, detailing:  
• the country/territory, state/province, county/region and city/hospital included;  
• the number of EDs in each EDSyS system; 
• the year the EDSyS system started;  
• the year of latest data and year of last publication identified; 
• the references identified for each EDSyS, separated into journal articles and 
conference abstracts. 
The full list of all 559 studies identified for inclusion in the systematic review in Chapter 2 



























Albania - - - National 
Hospitals in all 
36 districts 




- - State 
68 hospitals, 
85% of ED 
activity 
2003 2014 2016 (2-17) (18, 19) 
Victoria - Melbourne Hospital(s) 2 EDs 2005 2009 2011 (20)   
Victoria - Melbourne Hospital 1 ED 2006 2008 2010 (21)   
Canada 




- (2007) 2011 2013   (22, 23) 
Manitoba - Winnipeg City 7 EDs (2006) 2011 2014 (24) (25, 26) 
Ontario 
- - Province 
132 hospitals, 
>80% of ED 
visits in Ontario 







- (2009) 2015 2017 (36, 49) (48) 
  Toronto City - (2002) 2002 2004   (47) 
Quebec - Montreal City 
5 hospitals, 
28% ED visits 
(2006) 2001 2015 (50)   
China 
- - Beijing City 
2 major 
hospitals 
(2004) 2004 2006   (51) 


























France - - - National 
>650 EDs, 88% 
of all ED visits 
2004 2016 2017 (53-59) (60-84) 




Multi city 17 hospitals 2002 2003 2003   (85, 86) 
Italy 
- - Genoa City 72% of ED visits 2007 2013 2015 (87-90)   
- Lazio - Region 36/61 EDs 2000 2004 2009 (91)   
Jamaica - - - National - 2007 2007 2007   (92) 
Republic 
of Korea 
- - - National 125 EDs 2002 2009 2010 (93, 94) (95) 
New 
Zealand 
- - Wellington Hospital 1 ED 2008 2008 2009 (96)   
Singapore - - - National 7 hospitals (2013) 2013 2013   (97) 
Spain - - Santander Hospital 1 ED (2010) 2012 2014 (98, 99)   
Taiwan 
- - - National 
170 hospitals: 




no % value) 




- - Taipei City 5 Hospitals (2005) 2008 2008   (104-106) 




















































DiSTRIBuTE - - National 
>50 state/ local 
health dept ED 
syndromic 
systems 
2005 2009 2012 (124) (125-133) 
Biosense/ 
NSSP 
    National 
4,000 hospitals, 
55% ED visits 
2003 2016 2017 (134-141) (142-173) 





(1999) 2016 2010 (174) (175-178) 
Multistate (not 
named) 
    MultiState - (2003) 2003 2008 (27)   
Arizona 
- - State 15 EDs 2001 2001 2004 (179) (180) 
Maricopa  - County 11 hospitals 2001 2004 2005   (181, 182) 
California 
Los Angeles  - County 
>65% of ED 
patients 
2003 2016 2017 (183) (184-195) 
Santa Clara  - County 12 EDs 2001 2002 2002   (196) 
San Diego  - County 
16 hospitals - 
86% ED visits 
1999 2007 2013 (197) (198-202) 
Colorado 
- - State 17 EDs (2015) 2015 2015   (203) 
- Denver City 9 EDs 2003 2003 2003   (204) 





















































- - State 
231 of 240 EDs, 
96% of EDs 
2006 2016 2016 (213, 214) (215-230) 
Broward  - County - 2005 2007 2007   (231, 232) 
Cook - County - 2007 2007 2007   (233) 







9 EDs 2001 2001 2006   (240, 241) 
Miami-Dade - County 
17 largest of 23 
EDs 
2005 2010 2011   (233, 242-257) 
Georgia - - State 112 EDs 2005 2016 2016   (258-267) 
Illinois 
- - State - (2012) 2013 2013   (268) 
Champaign  - County - (2007) 2011 2011   (269) 
Cook  - County 45 EDs (2012) 2015 2017 (270) (271-273) 
- Chicago City 1 ED (2012) 2012 2012   (274) 
Indiana 
- - State 
110 hospitals, 
90% of ED visits 
2004 2010 2014 (275, 276) (233, 277-285) 
Marion  - County 14 EDs 2007 2011 2011   (233, 286) 
Kentucky   Louisville City 9 EDs  2002 2002 2005 (287) (288) 
Louisiana - - State 
11 EDs ( in 
2013) 
2005 2016 2016   (289-294) 





















































- - State 
47 EDs 100% of 
EDs 
2005 2012 2013   (310-320) 
- Baltimore City 11/11 EDs - - 2002   (321) 
Maine 






Hospital 1 ED 2002 2004 2004   (323) 












Hospital 1 ED (2001) 2003 2003   (328) 
Missouri - - State 
84 EDs, 90% 
visits 
2001 2013 2013   (329-335) 
Montana - - State - - - 2008   (336) 
North Carolina 





1999 2015 2017 (337-341) (342-374) 





















































North Dakota - - State 1 ED (2005) 2008 2008   (376, 377) 
Nebraska - - State 32 facilities (2011) 2016 2016   (378-380) 
New 
Hampshire 




2001 2015 2017 (381) (382-386) 
New Jersey 
- - State 79/80 EDs 2001 2016 2017 (387, 388) (389-399) 
Bergen  - County 6/6 EDs 2001 2004 2004   (400, 401) 
New Mexico - Albuquerque City 
2 EDs in 1 
hospital 
2002 2003 2005 (402)  
New York 
- - State 
140 EDs, 4 
million visits 
per year 
(2004) 2012 2017 (403) (404-411) 




2003 2003 2003   (412, 413) 
- New York  City 
51 EDs (98% of 
ED visits) 
2001 2003 2017 (414-433) (239, 434-475) 
Ohio 
- - State 96% of EDs 2003 2012 2012   (285, 476-481) 
- Akron City 3 EDs 2003 2003 2003   (204) 
Oklahoma Tulsa  - County 7 hospitals 2002 2006 2007   (482) 
Oregon - - State 60/60 EDs (2011) 2016 2017 (483) (484-488) 
Pennsylvania 
SW state   Regional - 1999 2002 2004 (489)   
Allegheny  - County 7 EDs 2009 2009 2010   (490) 




















































Rhode Island - - State all 11 EDs (2006) 2013 2013   (492-494) 
South Carolina 






a level I trauma 
center plus 3 
smaller 
outlying ERs 
2003 2007 2007   (500, 501) 
Tennessee Knoxville  - County 3 EDs 2002 2002 2005 (502)   
Texas 
- Dallas  City - (2012) 2012 2013 (503)   
- Fort Worth City 2 hospitals 2003 2003 2003   (204) 
Harris  - County 
34 hospitals, 
70% ER beds 
2004 2014 2014   (504-509) 
Travis - County 14 hospitals 2010 2011 2011   (510) 
Health service 
region 8 
- Region 3 hospitals 2006 2006 2007   (511) 
Utah Salt Lake  - County 
15 sites (EDs + 
Urgent Care 
Centres) 
(2009) 2009 2010   (512) 
Virginia 





















































3 EDs (2004) 2006 2007   (532-534) 
Pierce  - County 
5 EDs (approx 
80% of ED 
records in 
county) 
(2004) 2005 2007   (532, 535) 










- - State 
14 acute-care 
hospitals in 6 
counties 
2008 2009 2009   (537) 
- Milwaukee City 
11 
departments 





Hospital 1 ED (2007) 2009 2011 (541) (542, 543) 
Washington 
DC 






30% of acute 
care hospitals 
in state, 90% in 
national capital 
region 

































Unknown Unknown Unknown Unknown Unknown - (2013) 2016 2016   (555, 556) 
*(estimated/ earliest data reported) 
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Appendix B: Diagnosis codes used in Chapter 5 
Diagnostic codes mapped to the gastroenteritis syndromic surveillance indicator included in 
the EDSSS and used in Chapter 5. 
Codes* Codesystem 
A09, R11.X ICD-101 
62315008, 249519007, 75258004, 25374005, 111407006, 266071000, 
16932000, 83227006, 11840006, 111843007, 422400008 
Snomed CT2 
*Only codes actually reported to EDSSS and used in this analysis are shown, additional relevant codes may exist 
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Appendix C: Diagnosis codes used in Chapter 6 
Diagnostic codes mapped to for syndromic surveillance indicators included in the EDSSS 
(London) and OSCOUR® (Paris) emergency department systems and used in Chapter 6. 
EDSSS 
Asthma 
ICD-10 J450, J459 
Snomed CT 
30352005, 31387002, 55570000, 57546000, 161527007, 
182728008, 195967001, 266364000, 281239006, 
304527002, 312453004, 370204008, 370218001, 
370219009, 389145006, 401135008, 409663006, 
425969006, 445427006, 201031000000108, 




ICD-10 R06.0, R060, R062, R068 
Snomed CT 
9763007, 18197001, 23141003, 24612001, 55442000, 
56018004, 58596002, 60845006, 62744007, 68095009, 
70407001, 161941007, 161947006, 162891007, 
162894004, 230145002, 233683003, 267036007, 
301703002, 301826004, 307487006, 386813002, 
427354000, 427679007, 442025000, 276191000000107, 
498001000000107, 498011000000109, 502631000000100, 




ICD-10 I200, I209, I219, I2510 
Snomed CT 
22298006, 48447003, 53741008, 54329005, 57054005, 
59021001, 67682002, 73795002, 155308009, 194828000, 
233819005, 233822007, 233843008, 394659003, 










J960, J961, J961+0, J961+1, J969, R060 
Ischémie myocardique 
(Myocardial ischemia) 
I20, I200, I200+0, I201, I208, I209, I21, I210, I2100, I21000, 
I2108, I211, I2110, I21100, I2118, I2, I212, I2120, I21200, 
I2128, I213, I2130, I21300, I2138, I214, I2140, I21400, 
I2148, I219, I2190, I21900, I2198, I22, I220, I2200, I22000, 
I2208, I221, I2210, I22100, I2218, I228, I2280, I22800, 
I2288, I229, I2290, I22900, I2298, I23, I230, I231, I232, 
I233, I234, I235, I236, I238, I24, I240, I241, I248, I249, I25, 
I250, I251, I252, I253, I254, I255, I256, I258, I259 

Appendix D: Diagnosis codes used in Chapter 7 
Diagnostic codes mapped to syndromic surveillance indicators included in the EDSSS 
(England & Northern Ireland) and OSCOUR® (France) emergency department syndromic 
surveillance systems and used in Chapter 7. 
Indicator Country Codes Codesystem 
Alcohol 
England 
F100, T519 ICD-10 
160573003, 160592001, 18653004, 191802004, 
191806001, 222103001, 228273003, 25702006, 
269765000, 2804500, 390941000000103, 




F100, F1000, F1001, F1002, F1003, F1004, 
F1005, F1006, F1007, F102, F1020, F10200, 
F10201, F10202, F1021, F1022, F1023, F1024, 
F10240, F10241, F1025, F1026, F103, F1030, 




25702006, 67426006 Snomed CT 
MI 
England 
I200, I209 ,I219, I2510 ICD-10 
155308009, 194828000, 22298006, 233819005, 
233822007, 233838001, 394659003, 
398274000, 401303003, 401314000, 
414545008, 414795007, 53741008, 54329005, 
57054005, 59021001, 623341000000106, 
67682002, 73795002, 73999000 
Snomed CT 
France 
I20, I200, I200+0, I201, I208, I209, I21, I210, 
I2100, I21000, I2108, I211, I2110, I21100, I2118, 
I212, I2120, I21200, I2128, I213, I2130, I21300, 
I2138, I214, I2140, I21400, I2148, I219, I2190, 
I21900, I2198, I22, I220, I2200, I22000, I2208, 
I221, I2210, I22100, I2218, I228, I2280, I22800, 
I2288, I229, I2290, I22900, I2298, I23, I230, 
I231, I232, I233, I234, I235, I236, I238, I24, I240, 
I241, I248, I249, I25, I250, I251, I252, I253, I254, 




155308009, 194828000, 22298006, 233819005, 
394659003, 401303003, 401314000 
Snomed CT 
